https://pharmadevicenews.com/ 2026-04-18T06:04:30+00:00 https://pharmadevicenews.com/fda-approval-gives-jjs-akeega-a-first-mover-edge-in-brca2-mutated-metastatic-prostate-cancer/ 2025-12-13T07:45:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/could-nanologys-targeted-intratumoral-cisplatin-rewrite-the-outlook-for-dipg-in-children/ 2025-12-13T09:53:10+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-kvp-internationals-safepath-ivd-buy-could-reshape-veterinary-and-human-diagnostics/ 2025-12-13T10:03:57+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/could-utrophin-become-the-next-frontier-in-dmd-care-inside-ractigens-rnaa-push/ 2025-12-13T10:12:13+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-peijia-medicals-taurustrio-system-finally-solve-the-ar-treatment-gap-in-china/ 2025-12-13T10:21:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/marengos-invikafusp-alfa-shows-early-promise-in-metastatic-breast-cancer-with-dual-immunotherapy-and-adc-combination/ 2025-12-13T10:47:26+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-akesos-cadonilimab-unlock-pd-l1-agnostic-immunotherapy-for-gastric-cancer-patients/ 2025-12-13T11:07:03+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/proton-therapy-delivers-survival-gain-in-head-and-neck-cancer-could-this-lancet-trial-shift-payer-and-policy-resistance/ 2025-12-13T11:16:09+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-neurizons-entry-into-the-healey-als-trial-means-for-the-future-of-nuz-001/ 2025-12-13T11:34:09+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-geneva-pes-nxxim-platform-fix-fragmentation-in-diagnostic-imaging/ 2025-12-13T14:13:51+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/inside-xtant-medicals-strata-launch-what-sets-it-apart-from-legacy-bone-grafts/ 2025-12-13T14:41:44+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/will-ttx-mc138-in-ctdna-positive-patients-provide-a-new-model-for-mrd-intervention/ 2025-12-13T14:43:59+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-twice-yearly-dosing-the-future-of-autoimmune-care-inside-amgens-uplizna-playbook-for-chronic-neurology/ 2025-12-13T14:57:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/twice-yearly-dosing.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/twice-yearly-dosing.webp https://pharmadevicenews.com/can-biohavens-bhv-1510-avoid-the-safety-pitfalls-of-existing-trop2-adcs-in-solid-tumors/ 2025-12-13T15:10:49+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-eli-lillys-triple-agonist-may-become-the-first-obesity-drug-with-dual-indications/ 2025-12-13T15:22:04+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-ideayas-darovasertib-finally-redefine-first-line-therapy-in-metastatic-uveal-melanoma/ 2025-12-13T15:26:50+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-otr-therapeutics-give-zealand-pharma-an-edge-in-non-peptide-metabolic-therapies/ 2025-12-13T15:39:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-nitinotes-ease-trial-tells-us-about-the-future-of-bariatric-endoscopy/ 2025-12-13T15:56:39+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-arcus-biosciences-star-221-failure-reveals-about-tigit-fatigue-in-immunotherapy/ 2025-12-13T16:09:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-anti-tfpi-drugs-like-hympavzi-reshape-the-standard-of-care-in-inhibitor-positive-hemophilia/ 2025-12-13T17:34:13+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/subcutaneous-injection-for-hemophilia-management.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/subcutaneous-injection-for-hemophilia-management.webp https://pharmadevicenews.com/is-ai-finally-ready-to-close-the-equity-gap-in-breast-cancer-screening-in-the-united-states-and-beyond/ 2025-12-13T17:45:51+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/AI-breast-cancer-screening.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/AI-breast-cancer-screening.webp https://pharmadevicenews.com/privos-prv131-enters-first-in-human-dosing-can-injectable-cisplatin-change-oral-cancer-surgery/ 2025-12-13T17:54:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Scientist_with_PRV131_10DEC25_Picsart_AiImageEnhancer.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/Scientist_with_PRV131_10DEC25_Picsart_AiImageEnhancer.webp https://pharmadevicenews.com/new-ai-model-from-caris-and-ecog-acrin-predicts-breast-cancer-relapse-up-to-15-years/ 2025-12-13T17:54:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/acadia-expands-daybue-delivery-formats-for-rett-syndrome-with-powder-based-stix/ 2025-12-13T17:54:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/17808_Daybue_Carton_Foil_Group_3D_Render_US-scaled-e1765642662742.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/17808_Daybue_Carton_Foil_Group_3D_Render_US-scaled-e1765642662742.webp https://pharmadevicenews.com/can-next-gen-immunotherapy-combos-finally-crack-the-code-in-metastatic-breast-cancer/ 2025-12-13T17:54:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/next-gen-immunotherapy-combos.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/next-gen-immunotherapy-combos.webp https://pharmadevicenews.com/is-kazias-paxalisib-becoming-the-new-backbone-for-checkpoint-combos/ 2025-12-13T17:54:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-perimeters-685m-move-on-mmt-could-reshape-the-medtech-supply-chain/ 2025-12-13T17:54:26+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-staccato-technology-positions-lees-pharmaceutical-for-cns-drug-delivery-leadership/ 2025-12-13T17:54:26+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Lees_Pharmaceutical.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/Lees_Pharmaceutical.webp https://pharmadevicenews.com/can-diakonos-oncologys-doc1021-reawaken-immune-response-in-refractory-melanoma/ 2025-12-13T17:54:42+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-the-mirador-study-may-redefine-therapeutic-timing-in-hr-her2-patients/ 2025-12-13T17:54:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/mercks-winrevair-clears-major-eu-hurdle-with-chmp-backing-for-who-fc-iv-patients/ 2025-12-13T17:55:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-makes-lnk01006-a-potentially-best-in-class-tyk2-inhibitor-with-central-immune-impact/ 2025-12-13T17:55:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-senhwas-cx-5461-finally-turn-cold-tumors-hot-in-immunotherapys-toughest-challenge/ 2025-12-13T17:55:13+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/impetusdx-launches-rapid-oral-microbial-test-to-bring-real-time-diagnostics-to-dental-care/ 2025-12-13T17:55:20+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/ImpetusDX.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/ImpetusDX.webp https://pharmadevicenews.com/can-bio-techne-and-wyss-geneva-make-3d-spatial-biology-mainstream/ 2025-12-13T17:55:26+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-doxa-the-multi-mechanism-small-molecule-newcelx-needs-for-narcolepsy-and-als/ 2025-12-13T17:55:46+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/NewcelX_Ltd_Photo.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/NewcelX_Ltd_Photo.webp https://pharmadevicenews.com/how-the-brii-openbench-deal-could-redefine-early-stage-drug-discovery-economics/ 2025-12-13T17:55:52+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/could-matelasers-vcsel-based-laser-shift-clinical-recovery-into-self-care/ 2025-12-13T17:55:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/MATELASER_W1_REGEN.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/MATELASER_W1_REGEN.webp https://pharmadevicenews.com/will-ifx-2-0-and-tbs-2025-push-tuhura-into-the-frontline-of-resistance-focused-oncology/ 2025-12-13T17:56:05+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-eu-backed-cdmo-projects-redefine-pharma-supply-chains-in-post-industrial-europe/ 2025-12-13T17:56:12+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/CDMO-led-aseptic-drug-manufacturing-facilit.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/CDMO-led-aseptic-drug-manufacturing-facilit.webp https://pharmadevicenews.com/can-vesalios-envast-reshape-coronary-thrombectomy-with-stent-based-retrieval/ 2025-12-13T17:56:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/atossa-pivots-into-rare-disease-with-fda-nod-for-z-endoxifen-in-duchenne-muscular-dystrophy/ 2025-12-13T17:56:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-alk-abellos-investment-in-allegria-signals-a-strategic-shift-in-allergic-disease-treatment/ 2025-12-13T17:56:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-cro-backed-equity-deals-change-biotech-trial-economics-sen-jams-sjp-001-may-be-the-test-case/ 2025-12-13T17:56:40+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-solaria-bios-new-gut-bone-research-could-disrupt-standard-osteoporosis-care/ 2025-12-13T17:56:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/SOLARIA_BIO_Health.jpg https://pharmadevicenews.com/why-illuminas-investment-in-myome-could-reset-expectations-for-genome-based-prevention/ 2025-12-13T17:56:50+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-pillar-biosciences-china-move-means-for-decentralized-oncology-diagnostics/ 2025-12-13T17:56:55+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-instameds-oral-peptide-strip-the-needle-free-breakthrough-peptide-delivery-has-been-waiting-for/ 2025-12-13T17:57:01+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/InstaMed_Strip_Tasting.jpg https://pharmadevicenews.com/wp-content/uploads/2025/12/InstaMed_Strip_Tasting.jpg https://pharmadevicenews.com/how-anixas-breast-cancer-vaccine-could-change-immunoprevention-strategies/ 2025-12-13T17:57:14+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-b-cell-depletion-change-how-we-treat-generalized-myasthenia-gravis/ 2025-12-13T17:57:19+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/mazdutide-shows-weight-loss-efficacy-in-chinese-teens-phase-1b-results-raise-hopes-for-approval/ 2025-12-13T17:57:24+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-orphalans-orphelia-pharma-acquisition-reveals-about-the-next-phase-of-rare-pediatric-drug-consolidation/ 2025-12-13T17:57:30+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-gotenfia-finally-unlock-biosimilar-competition-for-simponi-in-europe/ 2025-12-13T17:57:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-are-retired-proteins-the-hottest-new-targets-in-cancer-immunotherapy-research/ 2025-12-13T17:57:44+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/next-generation-cancer-vaccine-research.jpg https://pharmadevicenews.com/wp-content/uploads/2025/12/next-generation-cancer-vaccine-research.jpg https://pharmadevicenews.com/inside-insilico-medicines-ckd-push-ai-driven-ism4808-heads-to-greater-china-with-taigen/ 2025-12-13T17:57:49+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-alphyns-multi-target-strategy-disrupt-dermatology-why-zabalafins-25m-backing-matters/ 2025-12-13T17:57:54+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/will-aspaveli-reshape-rare-kidney-disease-treatment-in-europe-chmp-greenlight-sets-regulatory-milestone/ 2025-12-13T17:57:59+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-actiniums-atnm-400-radiotherapy-reshape-treatment-for-resistant-breast-cancer/ 2025-12-13T17:58:06+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-roivios-juxtaflow-device-redefine-kidney-support-in-heart-failure-and-cardiac-surgery-patients/ 2025-12-13T17:58:11+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-sanyou-biopharmaceuticals-and-kanrybio-biotechnology-disrupt-the-global-companion-diagnostics-market/ 2025-12-13T17:58:16+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/could-ahb-137-set-a-new-benchmark-for-hbv-cure-rates-insights-from-ausperbios-24-week-monotherapy-trial/ 2025-12-13T17:58:21+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-eli-lillys-inluriyo-outpace-rivals-in-esr1-mutated-breast-cancer-after-ember-3/ 2025-12-13T17:58:30+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/will-the-tricvalve-pivotal-trial-finally-solve-the-unmet-needs-in-severe-tricuspid-regurgitation/ 2025-12-13T17:58:37+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-indivumeds-biospecimen-strategy-is-powering-functional-tumor-model-development/ 2025-12-13T18:01:03+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/ruthless-spines-rjb-device-approved-in-israel-expanding-navigation-tech-reach/ 2025-12-13T18:03:09+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/gonorrhea-resistance-crisis-can-innovivas-zoliflodacin-rewrite-treatment-guidelines/ 2025-12-13T18:05:54+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/from-waste-to-curbside-veritivs-fiber-based-palletshield-reshapes-pallet-shipper-expectations/ 2025-12-13T18:09:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Veritiv_TempSafe_PalletShield-e1765649351658.webp https://pharmadevicenews.com/ema-backs-anktiva-for-bladder-cancer-what-it-means-for-eu-patients-and-future-immunotherapies/ 2025-12-13T18:17:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-ck0804-overcome-jak-inhibitor-resistance-in-myelofibrosis-and-reshape-the-treg-cell-therapy-landscape/ 2025-12-13T18:21:59+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-innovivas-nuzolvence-could-reshape-sti-care-and-resistance-strategy/ 2025-12-13T18:28:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-mitochondrial-stress-be-weaponized-in-cancer-bantam-starts-btm-3566-dosing/ 2025-12-13T18:32:05+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-the-cosette-mayne-pharma-breakdown-signals-for-future-pharma-ma-in-australia/ 2025-12-13T18:34:20+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-sterile-drug-manufacturers-should-expect-from-ast-and-marchesini-in-2026/ 2025-12-13T18:36:42+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/exact-sciences-unveils-key-oncodetect-results-in-tnbc-is-this-a-reimbursement-turning-point/ 2025-12-13T18:40:14+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-eclinical-solutions-is-embedding-agentic-ai-into-trial-data-workflows-for-2026/ 2025-12-13T18:42:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/spiderwort-biotechnologies-cellulose-scaffolds-show-promise-in-spinal-cord-repair/ 2025-12-13T18:45:38+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/waskyra-approved-for-wiskott-aldrich-syndrome-what-it-means-for-stem-cell-alternatives/ 2025-12-13T18:48:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-zegen-15-the-breakthrough-diabetic-foot-ulcer-therapy-insurers-will-finally-cover/ 2025-12-13T18:50:11+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-aidabreasts-multi-omic-insights-may-reduce-overtreatment-in-breast-cancer-care/ 2025-12-13T18:53:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-the-nanoparticle-bci-model-reveals-about-the-future-of-brain-interfaces/ 2025-12-13T18:57:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-the-bendit17-microcatheter-fda-clearance-signals-for-catheter-innovation/ 2025-12-13T19:02:38+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Bendit_Technologies_Microcatheter-e1765652532288.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/Bendit_Technologies_Microcatheter-e1765652532288.webp https://pharmadevicenews.com/what-the-tracerx-study-reveals-about-personalis-mrd-technology-in-nsclc/ 2025-12-13T19:05:31+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-negative-pressure-therapy-disrupt-renal-support-in-heart-failure-inside-juxtaflows-new-approach/ 2025-12-14T02:44:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/heart-failure-patient.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/heart-failure-patient.webp https://pharmadevicenews.com/can-chinese-biopharma-finally-break-the-innovation-ceiling-in-autoimmune-disease-inside-the-ibi3011-playbook/ 2025-12-14T02:55:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Chinese-biopharma-autoimmune-disease.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/Chinese-biopharma-autoimmune-disease.webp https://pharmadevicenews.com/sobi-bets-950m-on-arthrosi-to-reshape-chronic-gout-treatment-with-pozdeutinurad/ 2025-12-14T03:12:19+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Sobi_HQ_office_facade_0-e1765681682689.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/Sobi_HQ_office_facade_0-e1765681682689.webp https://pharmadevicenews.com/could-novartis-change-the-itp-playbook-with-just-four-doses-of-ianalumab/ 2025-12-14T03:26:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/novartis-logo-banting-1-close-up-e1765682425463.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/novartis-logo-banting-1-close-up-e1765682425463.webp https://pharmadevicenews.com/is-avenzos-avzo-021-the-next-big-player-in-hr-her2-metastatic-breast-cancer/ 2025-12-14T03:38:06+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-baxters-connected-infusion-pumps-are-transforming-hospital-bedside-care/ 2025-12-14T03:44:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-makes-prilenias-prevails-trial-different-from-past-als-failures/ 2025-12-14T03:53:14+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/nikang-therapeutics-unveils-nkt5097-as-dual-cdk2-4-degrader-for-solid-tumor-strategy/ 2025-12-14T04:51:10+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-ide574-reshape-breast-and-lung-cancer-treatment-by-targeting-kat6-and-kat7/ 2025-12-14T04:53:24+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-provee-change-how-bph-is-treated-fda-nod-gives-proverum-its-biggest-win-yet/ 2025-12-14T05:13:43+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/from-arpa-h-to-basilea-what-phare-bios-new-deal-reveals-about-biotech-partnerships/ 2025-12-14T05:22:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-embedded-ai-help-philips-challenge-ge-and-siemens-in-imaging-software/ 2025-12-14T07:05:43+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/header-philips-advanced-visualization-workspace-16-cardiovascular-suite-e1765695793459.avif https://pharmadevicenews.com/wp-content/uploads/2025/12/header-philips-advanced-visualization-workspace-16-cardiovascular-suite-e1765695793459.avif https://pharmadevicenews.com/majestec-3-results-put-johnson-johnsons-bispecific-combo-at-center-of-myeloma-care-debate/ 2025-12-14T07:12:10+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/lillys-40m-commitment-to-iu-aims-to-transform-alzheimers-research-and-trials/ 2025-12-14T13:40:30+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/philips-bets-on-ai-automation-to-solve-cardiac-mr-access-and-staffing-gaps/ 2025-12-14T13:57:26+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/header-philips-mr-workspace-smartheart-e1765720552969.avif https://pharmadevicenews.com/wp-content/uploads/2025/12/header-philips-mr-workspace-smartheart-e1765720552969.avif https://pharmadevicenews.com/ivonescimab-delivers-80-percent-response-in-tnbc-is-akeso-redefining-pd-1-treatment/ 2025-12-14T14:00:42+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-novo-nordisks-semaglutide-7-2-mg-set-a-new-standard-in-obesity-treatment/ 2025-12-14T14:00:52+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Semaglutide-in-a-pill.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/Semaglutide-in-a-pill.webp https://pharmadevicenews.com/can-nivolumab-plus-avd-become-the-new-frontline-treatment-in-classical-hodgkin-lymphoma/ 2025-12-14T14:01:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/will-veradermics-non-hormonal-oral-pill-become-the-first-fda-approved-hair-loss-therapy-in-decades/ 2025-12-14T14:01:52+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/VERADERMICS_PR_Photos_Oct15_V3_3500px-scaled-e1765688933799.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/VERADERMICS_PR_Photos_Oct15_V3_3500px-scaled-e1765688933799.webp https://pharmadevicenews.com/can-medras-ai-powered-lab-scientists-finally-close-the-feedback-loop-in-drug-discovery/ 2025-12-14T14:02:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Medra_robotic_arm-e1765688358293.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/Medra_robotic_arm-e1765688358293.webp https://pharmadevicenews.com/fda-re-approves-usantibiotics-augmentin-xr-reviving-domestic-antibiotic-access-and-setting-cnpv-precedent/ 2025-12-14T14:02:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-guardant-health-and-trial-library-fix-the-clinical-trial-inclusion-gap-with-ai-and-genomics/ 2025-12-14T14:02:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-pfizer-reposition-tukysa-as-a-first-line-maintenance-option-after-her2climb-05/ 2025-12-14T14:02:35+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-ge-healthcare-and-tribun-health-are-rethinking-oncology-workflows/ 2025-12-14T14:02:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-ascletis-denifanstat-reshape-acne-treatment-by-targeting-fatty-acid-synthesis/ 2025-12-14T14:03:03+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/novo-nordisk-finalizes-5-2bn-akero-deal-to-expand-in-advanced-mash-care/ 2025-12-14T14:03:12+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Novo-Nordisk-headquarters-Denmark.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/Novo-Nordisk-headquarters-Denmark.webp https://pharmadevicenews.com/can-trilliumbio-and-oncobit-make-mrd-monitoring-standard-for-uveal-melanoma-in-the-u-s/ 2025-12-14T14:03:21+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/guardant-and-gemelli-bring-precision-oncology-in-house-what-it-means-for-eu-care-delivery/ 2025-12-14T14:03:30+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-eli-lillys-jaypirca-now-the-most-compelling-single-agent-therapy-in-untreated-cll/ 2025-12-14T14:03:40+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/eli-lillys-6bn-api-plant-in-alabama-signals-new-era-in-u-s-peptide-drug-manufacturing/ 2025-12-14T14:03:49+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Eli_Lilly_and_Company_new_plant_rendering-e1765689510692.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/Eli_Lilly_and_Company_new_plant_rendering-e1765689510692.webp https://pharmadevicenews.com/eli-lilly-targets-first-line-cll-with-jaypirca-as-bruin-cll-314-trends-toward-pfs-benefit/ 2025-12-14T14:03:59+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/johnson-johnson-targets-earlier-line-myeloma-with-carvykti-expansion/ 2025-12-14T14:04:10+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-medtronics-surgical-robotics-push-could-reshape-operating-rooms-nationwide/ 2025-12-14T14:04:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Medtronic_Hugo_RAS_System_FDA_clearance-e1765694072790.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/Medtronic_Hugo_RAS_System_FDA_clearance-e1765694072790.webp https://pharmadevicenews.com/can-medtronic-and-abbott-redefine-insulin-delivery-with-the-instinct-integrated-minimed-780g/ 2025-12-14T14:04:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/MiniMed_medtronic.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/MiniMed_medtronic.webp https://pharmadevicenews.com/why-philips-lumiguide-could-disrupt-image-guided-therapy-with-real-time-light-based-3d-navigation/ 2025-12-14T14:04:32+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/header-lumiguide-3d-device-guidance-in-use-e1765694564198.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/header-lumiguide-3d-device-guidance-in-use-e1765694564198.webp https://pharmadevicenews.com/philips-launches-verida-is-ai-finally-delivering-clinical-grade-spectral-ct/ 2025-12-14T14:04:38+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/header-philips-verida-ct-angle-view-e1765695431687.avif https://pharmadevicenews.com/wp-content/uploads/2025/12/header-philips-verida-ct-angle-view-e1765695431687.avif https://pharmadevicenews.com/can-higher-dose-wegovy-reshape-the-obesity-treatment-curve-for-novo-nordisk/ 2025-12-14T14:04:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Wegovy-package-with-FlexTouch%C2%AE-pen-e1765686753397.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/Wegovy-package-with-FlexTouch%C2%AE-pen-e1765686753397.webp https://pharmadevicenews.com/vaxxas-earns-gmp-licence-for-hd-map-production-what-this-unlocks-for-clinical-trials/ 2025-12-14T18:10:40+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/vaxxas-biomedical-facility.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/vaxxas-biomedical-facility.webp https://pharmadevicenews.com/milestone-pharmaceuticals-cardamyst-nasal-spray-wins-fda-approval-a-new-chapter-for-self-administered-psvt-treatment/ 2025-12-15T03:05:59+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/cardamyst-case-product-incase-e1765767903658.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/cardamyst-case-product-incase-e1765767903658.webp https://pharmadevicenews.com/immunomes-phase-3-varegacestat-data-could-redefine-gamma-secretase-inhibition-in-desmoid-tumors/ 2025-12-15T07:06:06+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/lifenet-health-acquires-tissue-testing-technologies-to-scale-biopreservation-in-regenerative-medicine/ 2025-12-15T18:18:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-cosette-pharmaceuticals-first-generic-ciprofloxacin-hydrocortisone-launch-reveals-about-fda-cgt-incentives/ 2025-12-16T13:17:50+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Cosette-Pharmaceuticals-Inc.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/Cosette-Pharmaceuticals-Inc.webp https://pharmadevicenews.com/what-orsobios-phase-1b-2a-tlc-6740-results-reveal-about-the-limits-of-glp-1-monotherapy/ 2025-12-16T13:32:30+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-personalized-ctdna-finally-solve-the-risk-stratification-gap-in-therapy-resistant-early-breast-cancer/ 2025-12-16T13:35:16+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/bioretec-secures-fda-breakthrough-status-for-remeos-drillpin-sharpening-focus-on-pediatric-fracture-repair/ 2025-12-16T13:36:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/detect-ion-mayo-clinic-join-forces-to-develop-non-invasive-pneumonia-breath-test/ 2025-12-16T13:36:41+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/non-invasive-pneumonia-breath-test.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/non-invasive-pneumonia-breath-test.webp https://pharmadevicenews.com/why-bluewind-medicals-latest-fda-clearance-matters-for-long-term-urgency-urinary-incontinence-care/ 2025-12-16T13:36:52+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/may-healths-anavi-system-ce-mark-highlights-a-new-middle-ground-in-pcos-infertility-treatment/ 2025-12-16T13:37:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/astrazeneca-gains-eu-approval-for-saphnelo-self-injection-pen-in-lupus-treatment/ 2025-12-16T16:22:13+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/AstraZeneca.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/AstraZeneca.webp https://pharmadevicenews.com/enhertu-plus-pertuzumab-receives-fda-approval-for-1st-line-her2-positive-metastatic-breast-cancer-is-the-new-standard-of-care-here/ 2025-12-16T17:21:28+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/sanofis-tau-focused-alzheimers-deal-highlights-growing-confidence-in-non-amyloid-targets/ 2025-12-16T17:32:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-harbour-biomeds-deal-with-bristol-myers-squibb-redefine-the-future-of-multispecific-antibodies/ 2025-12-17T00:34:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/gsks-exdensur-wins-fda-nod-for-severe-asthma-can-twice-yearly-dosing-reset-the-biologics-playbook/ 2025-12-17T06:45:17+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/indiviors-sublocade-shows-stronger-outcomes-in-high-frequency-fentanyl-users-what-this-changes-for-opioid-use-disorder-treatment-in-2026/ 2025-12-17T17:11:17+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Indiviors-SUBLOCADE-300-mg-dose.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/Indiviors-SUBLOCADE-300-mg-dose.webp https://pharmadevicenews.com/can-prism-biolab-and-talus-bio-finally-drug-the-undruggable-with-ai-and-ppi-chemistry/ 2025-12-17T18:02:37+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/transcription-factor-and-protein%E2%80%93protein-interaction-drug-discovery.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/transcription-factor-and-protein%E2%80%93protein-interaction-drug-discovery.webp https://pharmadevicenews.com/innovents-mazdutide-earns-nature-spotlight-are-dual-gcg-glp-1-agonists-set-to-reshape-diabetes-and-obesity-care/ 2025-12-18T00:26:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/fda-clears-subcutaneous-rybrevant-faspro-for-first-line-egfr-nsclc-what-this-changes-for-patients-and-providers/ 2025-12-18T01:39:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/oncologist-discusses-subcutaneous-lung-cancer-treatment.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/oncologist-discusses-subcutaneous-lung-cancer-treatment.webp https://pharmadevicenews.com/padcev-plus-keytruda-meets-survival-endpoints-in-cisplatin-eligible-bladder-cancer-patients/ 2025-12-18T15:47:37+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/bladder-cancer-treatment.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/bladder-cancer-treatment.webp https://pharmadevicenews.com/takedas-zasocitinib-hits-key-phase-3-psoriasis-goals-challenging-oral-and-biologic-rivals/ 2025-12-18T17:43:54+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/once-daily-oral-TYK2-inhibitors.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/once-daily-oral-TYK2-inhibitors.webp https://pharmadevicenews.com/meiji-seika-pharmas-alliance-with-mbc-biolabs-signals-a-bold-shift-in-global-rd-sourcing-strategy/ 2025-12-19T03:58:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/hardy-diagnostics-bets-on-chemiluminescent-testing-with-nemiss-n-light-platform/ 2025-12-20T00:37:11+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/on-site-pathogen-detection.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/on-site-pathogen-detection.webp https://pharmadevicenews.com/can-ai-and-chemistry-finally-converge-to-drug-transcription-factors-the-race-to-target-the-cells-command-center/ 2025-12-22T13:42:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/advanced-drug-discovery.webp https://pharmadevicenews.com/how-hansa-biopharma-is-targeting-a-transplant-blind-spot-with-imlifidase/ 2025-12-20T02:19:11+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/kidney-prepared-for-transplant-in-a-sterile-surgical-setting.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/kidney-prepared-for-transplant-in-a-sterile-surgical-setting.webp https://pharmadevicenews.com/the-undruggable-no-more-inside-the-new-wave-of-ppi-inhibitors-in-cancer-and-fibrosis/ 2025-12-24T03:13:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/advanced-research-into-protein%E2%80%93protein-interaction-inhibitors.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/advanced-research-into-protein%E2%80%93protein-interaction-inhibitors.webp https://pharmadevicenews.com/why-boehringers-10bn-u-s-investment-and-trumprx-deal-may-reshape-pharma-cost-dynamics/ 2025-12-20T05:45:10+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Boehringer-Ingelheims-10B-U.S.-expansion.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/Boehringer-Ingelheims-10B-U.S.-expansion.webp https://pharmadevicenews.com/amgen-adds-aimovig-and-amjevita-to-trumprx-platform-in-latest-move-to-defuse-u-s-pricing-pressure/ 2025-12-20T08:56:19+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Amgens-discounted-pricing.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/Amgens-discounted-pricing.webp https://pharmadevicenews.com/will-ai-native-drug-discovery-platforms-create-a-new-biotech-category-in-2026/ 2025-12-25T10:02:53+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/AI-native-drug-discovery-platforms.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/AI-native-drug-discovery-platforms.webp https://pharmadevicenews.com/beyond-biologics-can-structure-guided-small-molecules-replace-antibodies-in-intracellular-targets/ 2025-12-26T13:53:14+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/advanced-drug-discovery-two.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/advanced-drug-discovery-two.webp https://pharmadevicenews.com/wasatch-biolabs-agilent-to-scale-native-read-targeted-sequencing-for-precision-multi-omics/ 2025-12-20T14:10:12+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/targeted-sequencing-technologies.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/targeted-sequencing-technologies.webp https://pharmadevicenews.com/tolmar-secures-fda-nod-for-pre-chemo-rubraca-use-in-brca-mutated-prostate-cancer/ 2025-12-20T16:06:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/prostate-cancer-research-and-testing.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/prostate-cancer-research-and-testing.webp https://pharmadevicenews.com/what-is-the-regulome-and-why-is-it-becoming-biotechs-new-battleground/ 2025-12-27T03:08:33+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/advanced-gene-regulation-research.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/advanced-gene-regulation-research.webp https://pharmadevicenews.com/can-oral-glp-1s-maintain-weight-loss-after-injectables-lillys-orforglipron-may-prove-it-can/ 2025-12-21T04:52:42+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/oral-weight-loss-medication.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/oral-weight-loss-medication.webp https://pharmadevicenews.com/is-brca-the-new-egfr-why-germline-mutations-are-reshaping-prostate-cancer-treatment-strategies/ 2025-12-28T10:49:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/prostate-cancer-genomics-research.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/prostate-cancer-genomics-research.webp https://pharmadevicenews.com/meta-flux-and-mercury-bio-team-up-to-target-intracellular-cns-pathways-with-precision/ 2025-12-21T11:22:52+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/intracellular-drug-delivery-into-neurons.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/intracellular-drug-delivery-into-neurons.webp https://pharmadevicenews.com/what-biotroniks-partnership-with-soin-neuroscience-reveals-about-the-future-of-neuromodulation/ 2025-12-21T12:36:57+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/spinal-cord-stimulation.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/spinal-cord-stimulation.webp https://pharmadevicenews.com/oral-complement-therapy-for-myasthenia-gravis-novartis-iptacopan-enters-the-neurology-arena/ 2025-12-22T13:34:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-pictors-virascreen-core-is-reshaping-clinical-lab-workflows-for-infectious-disease-testing/ 2025-12-21T14:37:32+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-brca-the-new-egfr-why-germline-mutations-are-reshaping-prostate-cancer-treatment-strategies-2/ 2025-12-21T14:40:03+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/hansa-biopharma-files-bla-for-imlifidase-in-kidney-transplant-desensitization-what-this-changes-for-u-s-patients/ 2025-12-21T14:42:37+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-hardy-diagnostics-nemis-partnership-reveals-about-microbiologys-shift-to-the-plant-floor/ 2025-12-21T14:46:57+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/beyond-ovarian-and-breast-cancer-are-parp-inhibitors-finally-proving-their-worth-in-urologic-oncology/ 2025-12-24T14:45:42+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/PARP-inhibitor-research-and-formulation.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/PARP-inhibitor-research-and-formulation.webp https://pharmadevicenews.com/astrazeneca-secures-global-rights-to-jacobio-pharmas-pan%e2%80%91kras-jab%e2%80%9123e73-in-high%e2%80%91stakes-kras-market-expansion/ 2025-12-21T14:51:10+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/t-maximums-mt027-clears-fda-hurdle-for-glioblastoma-in-major-step-for-solid-tumor-car-t/ 2025-12-21T14:54:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-genentechs-lunsumio-velo-approval-means-for-relapsed-follicular-lymphoma-treatment/ 2025-12-22T06:49:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-gensight-biologics-french-cua-decision-means-for-lhon-gene-therapy/ 2025-12-22T06:52:32+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/rhythm-biosciences-and-datma-join-forces-to-validate-cancer-risk-tools-with-federated-data/ 2025-12-22T13:41:35+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/real%E2%80%91world-healthcare-data.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/real%E2%80%91world-healthcare-data.webp https://pharmadevicenews.com/can-tcr-bispecifics-unlock-prostate-cancer-immunotherapy-why-pfizer-is-backing-flagship-and-repertoire/ 2025-12-22T13:47:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/immunotherapy-research.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/immunotherapy-research.webp https://pharmadevicenews.com/ptc-therapeutics-receives-japanese-approval-for-sephience-in-full-spectrum-pku/ 2025-12-22T14:33:50+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/phenylketonuria-treatment.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/phenylketonuria-treatment.webp https://pharmadevicenews.com/boehringer-ingelheim-expands-jascayd-label-to-ppf-following-pivotal-trial-success/ 2025-12-22T14:42:31+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/progressive-pulmonary-fibrosis.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/progressive-pulmonary-fibrosis.webp https://pharmadevicenews.com/ausperbios-ahb%e2%80%91137-enters-final-testing-phase-in-hbeag-negative-chronic-hepatitis-b-patients/ 2025-12-22T14:51:50+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/chronic-hepatitis-B-infection.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/chronic-hepatitis-B-infection.webp https://pharmadevicenews.com/pace-trial-what-menarinis-biomarker-data-reveals-about-escalating-treatment-in-metastatic-breast-cancer/ 2025-12-22T15:02:59+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/circulating-tumor-cell-analysis.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/circulating-tumor-cell-analysis.webp https://pharmadevicenews.com/biohaven-ends-psychiatric-push-for-bhv-7000-after-phase-2-trial-in-depression-fails-to-show-efficacy/ 2025-12-25T01:58:11+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/neuropharmaceutical-research.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/neuropharmaceutical-research.webp https://pharmadevicenews.com/mabwells-anti-st2-antibody-9mw1911-cleared-for-u-s-phase-iia-trial-could-this-reshape-copd-biologics/ 2025-12-25T02:21:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Chronic-obstructive-pulmonary-disease.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/Chronic-obstructive-pulmonary-disease.webp https://pharmadevicenews.com/why-sanofis-2-2bn-dynavax-deal-is-a-high-stakes-bet-on-adult-vaccines/ 2025-12-26T00:28:41+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/adult-hepatitis-B-and-shingles-vaccines.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/adult-hepatitis-B-and-shingles-vaccines.webp https://pharmadevicenews.com/co-diagnostics-secures-australian-patent-for-co-dx-pcr-platform-marking-global-ip-expansion-milestone/ 2025-12-29T16:49:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/point-of-care-PCR-testing-device.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/point-of-care-PCR-testing-device.webp https://pharmadevicenews.com/hai-solutions-earns-fda-de-novo-clearance-for-qikcap-uvc-iv-disinfection-device/ 2025-12-30T16:27:10+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/UVC-disinfection-device.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/UVC-disinfection-device.webp https://pharmadevicenews.com/gsk-strikes-deal-with-u-s-to-lower-asthma-and-copd-drug-prices-and-avoid-tariffs/ 2025-12-31T16:56:05+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/U.S.-drug-pricing-reform.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/U.S.-drug-pricing-reform.webp https://pharmadevicenews.com/can-mabwells-anti-il-11-antibody-redefine-scarring-treatment-through-fibrosis-reversal/ 2025-12-31T06:48:17+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Hypertrophic-scar-and-fibrosis-research-e1767163655884.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/Hypertrophic-scar-and-fibrosis-research-e1767163655884.webp https://pharmadevicenews.com/what-lumos-infinitas-ces-showcase-reveals-about-the-next-wave-of-physiological-sensing/ 2025-12-31T06:54:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Silicon-photonics-demonstrates-breadth-at-CES-but-faces-headwinds-in-regulated-health-markets-e1767164037427.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/Silicon-photonics-demonstrates-breadth-at-CES-but-faces-headwinds-in-regulated-health-markets-e1767164037427.webp https://pharmadevicenews.com/overtures-titanium-implant-sees-rising-use-in-patients-too-young-for-total-knee-replacement/ 2025-12-31T07:01:55+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/Overtures-knee-resurfacing-system-gains-attention-amid-biologic-repair-fatigue.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/Overtures-knee-resurfacing-system-gains-attention-amid-biologic-repair-fatigue.webp https://pharmadevicenews.com/could-vandas-success-with-nereus-revive-interest-in-neurokinin-1-pathways/ 2025-12-31T07:06:43+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-purity-products-urox-formula-reveals-about-the-future-of-urological-wellness/ 2025-12-31T07:22:38+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/MyBladder_Product_Image.webp https://pharmadevicenews.com/wp-content/uploads/2025/12/MyBladder_Product_Image.webp https://pharmadevicenews.com/can-delcaths-hepzato-redefine-the-treatment-window-for-metastatic-uveal-melanoma/ 2026-01-01T06:09:17+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-a-global-trials-map-help-fix-spondyloarthritiss-fragmented-development-landscape/ 2026-01-01T06:13:24+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/corcepts-relacorilant-crl-leaves-endocrinology-ambitions-in-limbo-as-oncology-pivot-takes-center-stage/ 2026-01-01T06:22:54+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/koru-medical-seeks-fda-clearance-to-expand-freedomedge-into-her2-breast-cancer-treatment/ 2026-01-01T06:28:41+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/from-parkinsons-to-platform-scalability-whats-next-for-sinopias-leads-technology/ 2026-01-01T06:36:12+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/elanco-wins-usda-approval-for-befrena-expanding-mab-options-in-canine-dermatitis/ 2026-01-01T14:17:48+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/astrazeneca-daiichi-sankyo-push-enhertu-into-early-breast-cancer-with-new-fda-nod/ 2026-01-01T14:17:57+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/FDA-Breakthrough-Therapy-designation.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/FDA-Breakthrough-Therapy-designation.webp https://pharmadevicenews.com/how-sanofis-cpg-1018-platform-could-reshape-vaccine-formulation-in-2026/ 2026-01-01T14:22:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/adult-vaccine-development.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/adult-vaccine-development.webp https://pharmadevicenews.com/delcath-subgroup-data-links-survival-to-tumor-burden-and-ldh-in-uveal-melanoma/ 2026-01-01T14:27:51+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/will-biobeats-wearable-bp-patch-become-the-new-standard-in-hypertension-diagnosis/ 2026-01-01T14:32:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/Biobeat_2-e1767277685293.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/Biobeat_2-e1767277685293.webp https://pharmadevicenews.com/neoimmunetech-takes-over-endaris-u-s-rights-from-emmaus-what-this-signals-for-the-future-of-sickle-cell-treatment/ 2026-01-01T14:37:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/sickle-cell-disease-research-and-treatment.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/sickle-cell-disease-research-and-treatment.webp https://pharmadevicenews.com/can-subcutaneous-infusion-disrupt-oncology-workflows-inside-koru-medicals-510k-strategy-for-freedomedge/ 2026-01-01T14:45:50+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/vicarious-surgical-bets-on-outsourced-software-execution-to-control-costs-and-advance-clinical-timelines/ 2026-01-01T14:49:43+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-verastem-oncologys-kras-g12c-trial-exit-reveals-a-calculated-pivot-to-next-generation-lung-cancer-targets/ 2026-01-01T14:53:06+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-pathocares-1-75bn-tender-offer-reprice-the-future-of-ai-driven-diagnostics/ 2026-01-01T14:58:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/genmab-ends-acasunlimab-trials-what-it-signals-about-bispecific-immunotherapy-risk/ 2026-01-01T15:02:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-establishment-labs-shift-the-breast-reconstruction-standard-in-the-u-s-with-motiva/ 2026-01-01T15:06:41+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-johnson-johnsons-riptac-bet-deliver-the-next-wave-of-targeted-oral-cancer-drugs/ 2026-01-01T15:10:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/quralis-links-qrl-101-to-motor-nerve-excitability-shift-in-als-is-target-validation-finally-here/ 2026-01-01T15:14:24+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/neurological-basis-of-amyotrophic-lateral-sclerosis.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/neurological-basis-of-amyotrophic-lateral-sclerosis.webp https://pharmadevicenews.com/can-epigenome-editing-bypass-gene-size-limits-modalis-lama1-data-revives-hope-in-congenital-muscular-dystrophy/ 2026-01-01T15:18:39+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/omeros-secures-fda-approval-for-yartemlea-the-first-therapy-for-transplant-associated-ta-tma/ 2026-01-01T15:49:16+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/transplant%E2%80%91associated-thrombotic-microangiopathy.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/transplant%E2%80%91associated-thrombotic-microangiopathy.webp https://pharmadevicenews.com/gilead-sciences-acquires-rp-3467-from-repare-therapeutics-in-30m-synthetic-lethality-deal/ 2026-01-01T15:53:39+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/janux-therapeutics-advances-masked-egfr-t-cell-engager-janx008-into-phase-1-expansion/ 2026-01-01T16:33:28+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-cataltheias-deseyne-lens-replace-multifocal-optics-in-age-related-vision-correction/ 2026-01-01T16:36:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-vyriads-vv169-redefine-car-t-therapy-with-single-dose-in-vivo-delivery/ 2026-01-01T16:40:09+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/edwards-lifesciences-sapien-m3-fda-approval-marks-a-turning-point-for-transseptal-mitral-valve-therapy/ 2026-01-01T16:50:17+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/SAPIEN_M3_Dock_and_Valve_HERO-scaled-e1767285296160.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/SAPIEN_M3_Dock_and_Valve_HERO-scaled-e1767285296160.webp https://pharmadevicenews.com/envedas-env-6946-enters-phase-1-can-a-multi-biologic-in-a-pill-reshape-the-future-of-ibd-therapy/ 2026-01-01T16:56:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/coya-therapeutics-expands-als-trial-into-canada-as-coya-302-gains-health-canada-clearance/ 2026-01-01T16:58:37+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-kashiv-biosciences-gujarat-plant-expansion-could-redefine-biomanufacturing-in-india/ 2026-01-01T17:04:14+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/ustekinumab-biosimilar-approved-in-japan-can-samsung-bioepis-expand-its-global-autoimmune-footprint/ 2026-01-01T17:09:17+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-xortx-is-linking-gout-to-genetics-and-reshaping-the-future-of-precision-uric-acid-therapies/ 2026-01-01T17:18:44+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/goldentree-backs-alvotech-with-100m-financing-to-accelerate-pipeline-execution/ 2026-01-01T17:26:51+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/outlooks-bevacizumab-for-wet-amd-rejected-again-whats-holding-back-fda-approval/ 2026-01-01T17:34:08+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/intelligent-bio-solutions-taps-syrma-johari-to-cut-drug-reader-costs-and-prep-for-u-s-launch/ 2026-01-01T17:42:32+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-bioatlas-oz-v-set-a-new-standard-in-ror2-targeted-therapy-for-head-and-neck-cancer/ 2026-01-01T17:46:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-gut-restricted-pde4-inhibitors-transform-treatment-for-ulcerative-colitis-and-crohns/ 2026-01-02T00:18:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-positron-corporations-2m-raise-unlock-growth-in-cardiac-pet-ct-imaging/ 2026-01-02T00:18:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/serum-institute-exits-ixchiq-rollout-as-valneva-resets-lmic-strategy/ 2026-01-02T00:18:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/fulgent-genetics-acquires-bako-diagnostics-and-stratadx-to-expand-ai-pathology-strategy/ 2026-01-02T00:18:42+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/nmpa-clears-zai-labs-cobenfy-rewriting-the-schizophrenia-treatment-playbook/ 2026-01-02T00:18:48+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-agenus-is-taking-aim-at-cold-tumors-with-fc-enhanced-anti-ctla-4-therapy/ 2026-01-02T00:18:53+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-givinostats-entry-into-japan-a-turning-point-for-dmd-care-and-for-jcr-pharmaceuticals-rare-disease-strategy/ 2026-01-02T00:18:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/hoth-therapeutics-makes-strategic-ip-move-to-tackle-radiation-and-targeted-therapy-skin-toxicities/ 2026-01-02T16:38:20+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/radiation-induced-skin-toxicity.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/radiation-induced-skin-toxicity.webp https://pharmadevicenews.com/brainspace-wins-fda-nod-for-automated-brain-fluid-system-what-this-means-for-icus/ 2026-01-03T03:14:33+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/ICU-environment.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/ICU-environment.webp https://pharmadevicenews.com/is-bebirds-earsight-ultra-x-a-glimpse-into-the-future-of-consumer-grade-otoscopy/ 2026-01-03T03:38:28+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/Bebirds-EarSight-Ultra-X-e1767411469587.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/Bebirds-EarSight-Ultra-X-e1767411469587.webp https://pharmadevicenews.com/samsung-bioepis-takes-over-byooviz-commercialization-in-europe-after-biogen-exit/ 2026-01-03T05:57:13+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/pre-filled-syringe-and-vial.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/pre-filled-syringe-and-vial.webp https://pharmadevicenews.com/incytes-minjuvi-combo-gets-japan-approval-for-relapsed-follicular-lymphoma/ 2026-01-03T14:53:48+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/antibody-targeted-therapy-in-lymphoma-treatment.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/antibody-targeted-therapy-in-lymphoma-treatment.webp https://pharmadevicenews.com/revbio-wins-fda-nod-to-begin-dental-trial-of-tetranite-bone-adhesive/ 2026-01-03T15:47:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/dental-bone-graft-procedure.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/dental-bone-graft-procedure.webp https://pharmadevicenews.com/gensight-biologics-gets-green-light-for-gs010-in-israel-what-this-means-for-lhon-patients-and-regulators/ 2026-01-03T16:34:33+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/ophthalmic-gene-therapy-research.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/ophthalmic-gene-therapy-research.webp https://pharmadevicenews.com/kallisios-stentra-system-enters-clinical-use-at-stanford-expanding-precision-radiation-toolkit-for-head-and-neck-cancer/ 2026-01-03T17:58:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/Stentra-radiation-e1767463060251.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/Stentra-radiation-e1767463060251.webp https://pharmadevicenews.com/diamyd-medical-fast-tracks-type-1-diabetes-phase-3-trial-after-fda-alignment-on-earlier-efficacy-readout/ 2026-01-04T05:49:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/diabetes-clinical-research.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/diabetes-clinical-research.webp https://pharmadevicenews.com/chmp-backs-vueway-pediatric-expansion-signaling-a-cautious-but-meaningful-shift-in-neonatal-mri-contrast-use/ 2026-01-04T06:57:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/neonatal-magnetic-resonance-imaging-scan.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/neonatal-magnetic-resonance-imaging-scan.webp https://pharmadevicenews.com/fda-clears-mabxience-amneal-denosumab-biosimilars-opening-a-new-front-in-osteoporosis-and-oncology-pricing/ 2026-01-04T10:36:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/biosimilar-injectable-medicines.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/biosimilar-injectable-medicines.webp https://pharmadevicenews.com/curasight-begins-phase-1-trial-of-utreat-in-glioblastoma-marking-shift-to-clinical-stage-radiopharma-development/ 2026-01-04T11:17:19+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/targeted-radiopharmaceutical-therapy.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/targeted-radiopharmaceutical-therapy.webp https://pharmadevicenews.com/hutchmeds-fanregratinib-wins-priority-review-in-china-for-intrahepatic-cholangiocarcinoma/ 2026-01-04T13:21:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/FGFR-related-tumor-activity-in-liver-cells.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/FGFR-related-tumor-activity-in-liver-cells.webp https://pharmadevicenews.com/jj-ends-jnj-5939-trial-early-in-atopic-dermatitis-after-missing-efficacy-mark/ 2026-01-04T16:42:14+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/severe-atopic-dermatitis-symptoms.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/severe-atopic-dermatitis-symptoms.webp https://pharmadevicenews.com/can-early-access-programs-reshape-the-approval-arc-for-rare-disease-gene-therapies/ 2026-01-05T05:16:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/ophthalmic-gene-therapy-research-and-regulatory-review-environments.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/ophthalmic-gene-therapy-research-and-regulatory-review-environments.webp https://pharmadevicenews.com/is-bilateral-delivery-becoming-the-new-standard-in-retinal-gene-therapy/ 2026-01-06T05:23:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-dental-bone-glue-the-new-frontier-in-graft-free-implantology-what-revbios-tetranite-trial-could-mean-for-chairside-workflows/ 2026-01-05T02:34:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/dental-ridge-augmentation-procedure.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/dental-ridge-augmentation-procedure.webp https://pharmadevicenews.com/from-orthopedic-cement-to-smart-scaffolds-is-the-next-generation-of-bone-adhesives-finally-viable-in-human-use/ 2026-01-06T02:43:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/orthopedic-fracture-repair.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/orthopedic-fracture-repair.webp https://pharmadevicenews.com/fda-maintains-constructive-stance-as-island-pharmaceuticals-progresses-galidesivir-clinical-development/ 2026-01-05T01:02:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/fda-gives-go-ahead-to-geneditbios-first-genome-editing-trial-for-tgfbi-corneal-dystrophy/ 2026-01-05T16:28:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/early-stage-genome%E2%80%91editing-development.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/early-stage-genome%E2%80%91editing-development.webp https://pharmadevicenews.com/gsk-secures-china-nmpa-approval-for-nucala-in-eosinophilic-copd-targeting-hospitalisation-risk/ 2026-01-05T18:03:13+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/COPD-patient.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/COPD-patient.webp https://pharmadevicenews.com/xrlabs-taps-nvidias-jetson-thor-and-isaac-platform-to-rewire-real-time-intelligence-in-surgical-scopes/ 2026-01-06T01:02:11+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/XRlabs_Surgeons-scaled-e1767661272384.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/XRlabs_Surgeons-scaled-e1767661272384.webp https://pharmadevicenews.com/can-avatar-medicals-glasses-free-3d-imaging-shift-patient-communication-from-confusion-to-clarity/ 2026-01-06T01:17:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/incytes-tafasitamab-clears-pivotal-trial-in-high-risk-dlbcl-will-it-shift-front-line-treatment/ 2026-01-06T01:37:20+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/lymphoma-research.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/lymphoma-research.webp https://pharmadevicenews.com/amgen-acquires-dark-blue-therapeutics-to-expand-targeted-aml-degradation-strategy/ 2026-01-07T00:37:28+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/acute-myeloid-leukemia-research.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/acute-myeloid-leukemia-research.webp https://pharmadevicenews.com/illumina-expands-ai-powered-multiomic-strategy-with-launch-of-connected-multiomics-software-platform/ 2026-01-07T00:53:23+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/Illumina_Connected_Multiomics-e1767747121566.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/Illumina_Connected_Multiomics-e1767747121566.webp https://pharmadevicenews.com/sepsis-breakthrough-what-the-embrace-trial-reveals-about-sobis-emapalumab-strategy/ 2026-01-07T18:11:24+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/sepsis-care-and-immune-pathway-monitoring.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/sepsis-care-and-immune-pathway-monitoring.webp https://pharmadevicenews.com/ventyx-to-give-lilly-an-oral-inflammation-pipeline-whats-the-real-upside/ 2026-01-08T14:54:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/cornerloc-transloc-3d-system-hits-key-milestones-in-spartan-trial/ 2026-01-08T01:18:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-biofrontera-inc-s-dual-database-locks-mark-a-critical-step-toward-validated-clinical-and-regulatory-data/ 2026-01-08T20:15:44+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/polyrizon-names-pl-14-allergy-blocker-nasarix-positioning-polymer-based-nasal-barrier-for-market-readiness/ 2026-01-08T21:30:06+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/Nasal-spray-creating-a-protective-barrier-e1767906523953.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/Nasal-spray-creating-a-protective-barrier-e1767906523953.webp https://pharmadevicenews.com/innovent-ollins-bispecific-antibody-oln324-delivers-superior-retinal-drying-in-dme/ 2026-01-09T01:35:28+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/kaon-automation-acquisition-expands-automated-industrial-robotics-inc-s-aseptic-filling-and-pharmaceutical-manufacturing-automation-capabilities/ 2026-01-11T16:41:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/Kaon-Automation-Jan-9-2026-e1767978129570.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/Kaon-Automation-Jan-9-2026-e1767978129570.webp https://pharmadevicenews.com/how-leons-fr-jet-modular-mixer-achieved-stable-high-concentration-mrna-lnps-in-a-peer-reviewed-study/ 2026-01-09T19:55:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/mRNA-LNPs-Mixer-e1767988144102.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/mRNA-LNPs-Mixer-e1767988144102.webp https://pharmadevicenews.com/how-madrigal-pharmaceuticals-is-building-a-multi-mechanism-mash-pipeline-with-the-phase-2-dgat-2-inhibitor-ervogastat/ 2026-01-09T20:24:53+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/amazon-adds-oral-wegovy-to-pharmacy-platform-will-this-reshape-obesity-care-logistics/ 2026-01-10T13:50:42+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-amneals-parkinsons-strategy-evolve-beyond-symptoms-keiferx-tie-up-may-signal-shift/ 2026-01-10T13:54:26+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/pharmajets-needle-free-system-to-power-scancells-melanoma-phase-3-after-strong-dna-therapy-data/ 2026-01-10T13:58:41+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/mrm-3379-enters-patient-testing-for-fragile-x-syndrome-in-mirums-bloom-phase-2-trial/ 2026-01-10T14:10:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-assertio-win-market-traction-with-convenience-led-g-csf-dosing-schedules/ 2026-01-10T14:14:50+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/eli-lilly-taps-chai-discovery-to-accelerate-biologics-with-ai-generated-candidates/ 2026-01-10T14:25:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/medipost-raises-140m-to-fund-u-s-phase-iii-trial-of-stem-cell-therapy-for-knee-osteoarthritis/ 2026-01-10T14:32:08+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-revvitys-signals-xynthetica-integration-with-lilly-tunelab-could-reshape-biotech-ai/ 2026-01-10T14:47:33+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-naveriss-navdx-performance-outcomes-could-alter-hpv-cancer-follow%e2%80%91up-standards/ 2026-01-10T14:54:12+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/airnexis-launches-with-200m-and-phase-2-dual-pde3-4-copd-drug-licensed-from-haisco/ 2026-01-10T14:58:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-clarametyxs-cmtx-101-reshape-cystic-fibrosis-care-by-targeting-biofilms/ 2026-01-10T15:06:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-biocytogen-and-acepodia-are-betting-on-bsad2cs-for-next-gen-cancer-therapy/ 2026-01-10T15:11:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-zetomipzomib-move-the-needle-in-autoimmune-hepatitis-what-kezars-fda-meeting-signals/ 2026-01-10T15:19:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-aurora-therapeutics-believes-the-fda-is-ready-for-grouped-crispr-approvals/ 2026-01-10T15:25:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/mh002-enters-phase-2b-can-mrm-healths-live-biotherapeutic-consortium-redefine-ulcerative-colitis-treatment-standards/ 2026-01-10T15:31:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-kalvistas-refill-led-ekterly-growth-signal-a-new-standard-in-on-demand-hae-care/ 2026-01-10T15:41:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/savara-selects-pantherx-as-exclusive-pharmacy-for-molbreevi-amid-pap-bla-review/ 2026-01-10T15:44:59+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-ossium-health-redefining-bone-marrow-transplants-with-off-the-shelf-cryopreservation/ 2026-01-10T15:49:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-alessas-enolen-implant-change-how-early-stage-prostate-cancer-is-treated/ 2026-01-10T15:52:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/enyo-pharmas-vonafexor-reverses-kidney-decline-in-alport-syndrome-with-sustained-benefit/ 2026-01-10T15:56:35+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-enodias-sec61-targeting-platform-redefine-druggability-in-secreted-and-membrane-proteins/ 2026-01-10T16:12:16+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-aetnas-pediatric-telehealth-play-with-blueberry-could-redefine-medicaid-access/ 2026-01-10T16:18:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/will-surfs-sustain-platform-bring-at-home-neuromodulation-to-mainstream-rheumatology/ 2026-01-10T16:24:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/ollins-next-gen-vegf-ang2-antibody-shows-superiority-over-faricimab-in-phase-1b-trial/ 2026-01-10T16:32:12+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-sonotheras-ripple-platform-redefine-nonviral-delivery-in-oversized-genetic-payloads/ 2026-01-10T16:34:37+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/jjs-amivantamab-shows-strong-first-line-response-in-metastatic-colorectal-cancer/ 2026-01-10T17:48:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/bispecific-antibody-targeting-a-colorectal-tumor.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/bispecific-antibody-targeting-a-colorectal-tumor.webp https://pharmadevicenews.com/camuruss-fda-review-restart-for-oclaiz-puts-long-acting-octreotide-on-track-for-a-potential-u-s-launch-in-mid-2026/ 2026-01-11T06:39:42+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/injectable-drug-delivery-devices.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/injectable-drug-delivery-devices.webp https://pharmadevicenews.com/can-kinasets-inhaled-jak-inhibitor-finally-bring-relief-to-all-severe-asthma-patients/ 2026-01-11T14:24:20+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/pfizers-braftovi-triplet-shows-64-response-in-first-line-braf-mutant-colorectal-cancer/ 2026-01-11T14:28:20+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-functional-logic-beat-genetic-drift-mindwalks-bet-on-influenza-physics/ 2026-01-11T14:33:32+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/aktis-oncology-raises-318m-ipo-what-this-means-for-alpha-radiotherapy-biotech-bets/ 2026-01-11T14:37:20+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/welldoc-seeks-fda-nod-for-ai-based-glucose-prediction-in-non-insulin-type-2-diabetes/ 2026-01-11T14:40:33+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-mri-body-scans-redefine-preventive-care-amra-expands-into-dutch-market-with-prescan/ 2026-01-11T14:53:44+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/labcorp-and-quest-partner-with-visby-to-expand-access-to-rapid-at-home-pcr-sti-test/ 2026-01-11T14:56:57+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-princeton-radiology-is-betting-on-whole-body-mri-and-breast-screening-growth/ 2026-01-11T15:08:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/phanes-spevatamig-shows-40-response-rate-in-mpdac-how-it-compares-to-gnp-standard/ 2026-01-11T15:16:09+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-the-nanodropper-bedo-viseon-merger-could-reset-the-rules-of-personalized-eyecare/ 2026-01-11T16:24:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-ventaris-surgicals-30m-backed-system-solve-the-biggest-gap-in-kidney-stone-treatment/ 2026-01-11T16:30:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/mg-backs-bit-bio-with-50m-series-c-to-accelerate-nams-and-ai-ready-cell-models/ 2026-01-11T16:35:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/treatment-beyond-progression-zenocutuzumab-data-could-shift-standards-in-nrg1-pancreatic-cancer/ 2026-01-11T16:40:08+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/pierre-fabre-and-iktos-partner-on-ai-designed-small-molecule-cancer-therapies/ 2026-01-11T17:34:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-10x-genomics-is-betting-on-clia-lab-certification-to-advance-spatial-diagnostics-in-oncology/ 2026-01-12T14:45:05+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/medtronics-minimed-go-cleared-by-fda-can-smart-mdi-finally-close-the-algorithm-gap-in-diabetes-care/ 2026-01-12T14:51:54+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/Medtronics-MiniMed-Go-cleared-by-FDA-e1768229465810.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/Medtronics-MiniMed-Go-cleared-by-FDA-e1768229465810.webp https://pharmadevicenews.com/can-dataseas-acoustic-bci-tech-unlock-real-world-stroke-rehab-and-assistive-device-control/ 2026-01-12T14:56:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-theradaptives-osteoadapt-could-disrupt-the-2bn-spinal-biologics-market-in-2026/ 2026-01-12T15:00:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-10x-genomics-is-betting-on-peripheral-blood-to-decode-complex-immune-disorders/ 2026-01-12T15:06:48+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-the-first-use-of-yorlabs-ice-device-tells-us-about-cardiology-imaging-disruption/ 2026-01-12T15:15:41+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-does-zyus-life-sciences-c15-million-life-offering-signal-about-its-cannabinoid-pharmaceutical-strategy/ 2026-01-12T15:54:38+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/Pharma-Research-ZYUS-e1768233038321.webp https://pharmadevicenews.com/a-rare-survival-signal-in-pancreatic-cancer-actuate-therapeutics-elraglusib-data-at-asco-gi-2026-reignites-first-line-treatment-hopes/ 2026-01-12T16:19:17+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-oncolytics-biotechs-new-goblet-cohort-4-data-matters-for-third-line-anal-cancer-immunotherapy-strategies/ 2026-01-12T16:26:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-insitros-therml-platform-finally-delivering-on-the-ai-native-promise-for-biologics-and-small-molecules/ 2026-01-12T17:27:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/fda-accepts-pimicotinib-nda-for-tgct-what-this-signals-for-rare-tumor-drug-development-and-the-csf-1r-inhibitor-class/ 2026-01-13T01:30:42+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/knee-joint-affected-by-tenosynovial-giant-cell-tumor.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/knee-joint-affected-by-tenosynovial-giant-cell-tumor.webp https://pharmadevicenews.com/fda-clears-3dicom-md-cloud-what-this-means-for-singular-healths-u-s-expansion-and-diagnostic-imaging-disruption/ 2026-01-13T03:11:51+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/cloud-based-medical-imaging-system.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/cloud-based-medical-imaging-system.webp https://pharmadevicenews.com/smithnephew-bets-on-lower-failure-rates-in-shoulder-surgery-with-450m-integrity-orthopaedics-acquisition/ 2026-01-13T03:33:40+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/Tendon-Seam-Construct.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/Tendon-Seam-Construct.webp https://pharmadevicenews.com/can-abcl635-redefine-non-hormonal-menopause-treatment-inside-abcelleras-phase-2-push/ 2026-01-13T04:06:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/bionpharma-wins-fda-approval-for-etravirine-as-steerlifes-fragmelt-proves-regulatory-ready/ 2026-01-13T17:58:35+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-thryvs-sgk1-inhibitor-become-the-first-disease-modifying-therapy-for-long-qt-syndrome-type-2/ 2026-01-13T18:05:05+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/cardiac-monitoring-and-medication.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/cardiac-monitoring-and-medication.webp https://pharmadevicenews.com/illuminas-billion-cell-atlas-marks-inflection-point-for-ai-enabled-drug-discovery-in-2026/ 2026-01-13T18:10:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/advanced-single-cell-analysis.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/advanced-single-cell-analysis.webp https://pharmadevicenews.com/standard-process-launches-cultivate-symposium-to-advance-whole-food-nutrition-strategies-for-healthy-aging-practitioners/ 2026-01-13T20:56:28+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-creative-medical-technology-holdings-adapt-interim-results-may-mark-a-turning-point-for-cell-based-chronic-pain-treatments/ 2026-01-13T21:14:06+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/Chronic-back-pain-CMT-e1768338652851.webp https://pharmadevicenews.com/how-annamycins-clean-cardiac-safety-profile-may-strengthen-moleculins-oncology-development-strategy/ 2026-01-13T21:31:23+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/vista-ai-raises-29-5m-to-expand-automated-mri-scanning-beyond-cardiology/ 2026-01-14T15:03:16+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/MRI-scanner-in-a-hospital.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/MRI-scanner-in-a-hospital.webp https://pharmadevicenews.com/cereno-scientifics-cs014-shows-antithrombotic-effect-without-bleeding-risk-in-new-hdac-study/ 2026-01-14T15:11:57+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/Preclinical-cardiovascular-research.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/Preclinical-cardiovascular-research.webp https://pharmadevicenews.com/robotic-cochlear-implants-approved-for-kids-is-iotasoft-reshaping-pediatric-ent-standards/ 2026-01-14T16:03:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/iotaMotion_Robotic_Assisted_Cochlear_Implant_Insertion_System-scaled-e1768406534354.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/iotaMotion_Robotic_Assisted_Cochlear_Implant_Insertion_System-scaled-e1768406534354.webp https://pharmadevicenews.com/gt-medical-technologies-bridges-trial-begins-enrollment-testing-gammatile-in-newly-diagnosed-glioblastoma-patients/ 2026-01-14T16:10:48+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/GammaTile-being-implanted.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/GammaTile-being-implanted.webp https://pharmadevicenews.com/can-lynx-analytics-lumen-framework-reshape-ai-driven-decision-making-in-life-sciences/ 2026-01-14T16:24:38+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/agentic-artificial-intelligence-platforms.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/agentic-artificial-intelligence-platforms.webp https://pharmadevicenews.com/ficlatuzumab-joins-beat-aml-trial-is-aveos-c-met-inhibitor-ready-for-broader-testing/ 2026-01-15T13:23:19+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-airos-medicals-extended-warranty-could-reshape-buyer-expectations-in-lymphedema-care/ 2026-01-15T13:31:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/AIROS-Medical-raises-the-bar-on-durability-with-five-year-warranty-for-pneumatic-compression-devices.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/AIROS-Medical-raises-the-bar-on-durability-with-five-year-warranty-for-pneumatic-compression-devices.webp https://pharmadevicenews.com/how-biocorneums-new-bruise-kit-reflects-a-wider-shift-in-aesthetic-medicine-aftercare/ 2026-01-15T13:44:53+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/Biocorneum-launches-new-dual-formula-bruise-system-to-reduce-recovery-time-after-cosmetic-procedures-scaled-e1768484523227.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/Biocorneum-launches-new-dual-formula-bruise-system-to-reduce-recovery-time-after-cosmetic-procedures-scaled-e1768484523227.webp https://pharmadevicenews.com/theratears-expands-into-digital-eye-strain-relief-what-the-launch-signals-for-otc-eye-care/ 2026-01-15T13:59:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/TheraTears-targets-screen-fatigue-with-two-new-launches-e1768485502495.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/TheraTears-targets-screen-fatigue-with-two-new-launches-e1768485502495.webp https://pharmadevicenews.com/can-ab-1009-reshape-treatment-for-late-onset-pompe-askbio-prepares-for-first-patient-in-u-s/ 2026-01-15T14:11:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/hyundai-bioscience-begins-u-s-phase-2-trial-of-xafty-for-covid-flu-and-rsv/ 2026-01-15T14:15:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-tn-001-avoid-hallucinogenic-pitfalls-while-delivering-rapid-antidepressant-effects/ 2026-01-15T14:24:40+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-ut-health-san-antonios-grk2-inhibitor-reduce-opioid-use-in-burn-trauma-care/ 2026-01-15T14:29:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/johnson-johnsons-tecvayli-may-redefine-second-line-myeloma-care-after-majestec-9/ 2026-01-15T14:36:12+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-does-swissmedic-approval-of-santheras-agamree-mean-for-long-term-steroid-treatment-in-duchenne-muscular-dystrophy/ 2026-01-15T19:11:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharma-1.png https://pharmadevicenews.com/luce-1-phase-1-2-study-fully-enrolled-as-aavantgarde-evaluates-aavb-081-gene-therapy-in-usher-syndrome-type-b-retinitis-pigmentosa/ 2026-01-15T19:21:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/clinical-data-show-vaxart-oral-norovirus-vaccine-induces-maternal-and-infant-immunity/ 2026-01-15T19:30:43+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharma-2.png https://pharmadevicenews.com/ocugens-ocu410-shows-early-phase-2-promise-as-a-modifier-gene-therapy-for-geographic-atrophy-in-dry-amd/ 2026-01-16T01:41:10+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/hmnc-brain-health-reports-phase-2b-efficacy-signals-for-bh-200-in-genetically-defined-depression-patients-at-acnp/ 2026-01-16T01:57:55+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/lilly-and-nvidia-commit-1bn-to-ai-co-innovation-lab-for-next-gen-drug-discovery/ 2026-01-16T15:45:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/AI-powered-drug-discovery-lab.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/AI-powered-drug-discovery-lab.webp https://pharmadevicenews.com/strive-finalizes-semler-scientific-acquisition-to-strengthen-diagnostic-and-patient-monitoring-capabilities/ 2026-01-16T19:46:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/gt-biopharma-submits-ind-for-gtb-5550-trike-targeting-b7-h3-expressing-solid-tumors-with-nk-cell-activation/ 2026-01-16T20:33:52+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharma-2.png https://pharmadevicenews.com/akesos-cadonilimab-outperforms-pd-1-inhibitors-in-real-world-gastric-cancer-study/ 2026-01-17T04:31:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-celltrions-her2-cd3-bispecific-could-compete-in-the-t-cell-engager-arena/ 2026-01-17T04:36:28+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/with-allojoin-phase-3-in-motion-fosun-kairos-takes-lead-on-stem-cell-therapy-rollout-in-china/ 2026-01-17T04:43:52+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-rakuten-medicals-deal-with-lotte-biologics-signals-for-photoimmunotherapy-scale-up/ 2026-01-17T04:47:54+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-fda-breakthrough-status-for-the-amplifi-vein-dilation-system-means-for-dialysis-care-in-2026/ 2026-01-17T04:53:13+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/fda-clears-vizmarks-vm1-tumor-marker-is-this-the-fix-for-mri-artifact-in-breast-imaging/ 2026-01-17T05:12:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/fda-clears-bear-implant-label-for-lower-osteoarthritis-risk-what-this-changes-in-acl-surgery/ 2026-01-17T05:17:40+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-wearable-ultrasound-reinvent-breast-imaging-what-the-isono-health-atusa-launch-really-signals/ 2026-01-17T07:02:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/allergy-relief-shake-up-dr-reddys-launches-generic-pataday-0-7-eye-drops/ 2026-01-17T07:07:41+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/saudi-fda-approves-immunitybios-anktiva-in-nsclc-what-this-means-for-immunotherapy-2-0/ 2026-01-17T07:12:57+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/fda-grants-orphan-drug-designation-to-atossas-z-endoxifen-for-duchenne-whats-next/ 2026-01-17T14:32:23+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/pharmaceutical-compounds-and-clinical-tools.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/pharmaceutical-compounds-and-clinical-tools.webp https://pharmadevicenews.com/elunetirom-shows-synaptogenic-promise-as-autobahn-eyes-pivotal-trials-in-depression/ 2026-01-17T15:23:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-epcoritamab-reshape-salvage-dlbcl-care-genmabs-phase-3-data-brings-regulatory-momentum/ 2026-01-17T15:26:20+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-agc-biologics-role-in-waskyra-tells-us-about-the-future-of-ethical-cell-therapy-scale-up/ 2026-01-17T15:35:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/xenotherapeutics-takeover-of-repare-wins-near-unanimous-vote-whats-at-stake-for-the-pipeline/ 2026-01-17T15:39:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/organons-nexplanon-earns-five-year-approval-how-this-changes-the-larc-landscape/ 2026-01-17T15:43:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-provations-ipro-lite-could-signal-the-end-of-paper-based-anesthesia-workflows/ 2026-01-17T15:53:55+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-endoquests-paradigm-trial-approval-reveals-about-robotic-esd-innovation-in-gi-surgery/ 2026-01-17T15:56:46+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/will-cartridge-based-cbc-systems-replace-central-labs-henry-schein-bets-on-it-with-citocbc/ 2026-01-17T16:00:08+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/immunitybios-car-nk-cell-therapy-achieves-15-month-remission-in-waldenstrom-lymphoma/ 2026-01-17T16:34:39+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/organons-nexplanon-gains-fda-nod-for-five-year-use-but-rems-adds-new-provider-hurdles/ 2026-01-18T01:50:49+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/contraceptive-implant-applicator.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/contraceptive-implant-applicator.webp https://pharmadevicenews.com/what-d3-bios-dual-kras-ind-clearances-reveal-about-the-next-wave-of-targeted-oncology/ 2026-01-19T04:26:35+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-astrazenecas-c-car031-deal-reveals-about-the-future-of-car-t-in-liver-cancer/ 2026-01-19T04:29:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/harbour-biomed-converts-spr202-partnership-into-strategic-stake-in-spruce-biosciences/ 2026-01-19T04:32:16+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-abbvies-epcoritamab-reshapes-the-competitive-calculus-in-relapsed-diffuse-large-b-cell-lymphoma/ 2026-01-19T04:48:31+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/iregenes-nouvneu001-becomes-first-ipsc-therapy-with-rmat-and-fast-track-designations/ 2026-01-19T13:26:20+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/akesos-gumokimab-advances-to-nmpa-review-in-ankylosing-spondylitis-is-chinas-il-17-race-entering-a-new-phase/ 2026-01-19T13:30:20+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/guardant-health-and-merck-sign-global-deal-to-co-develop-cancer-companion-diagnostics/ 2026-01-19T13:34:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-enhertu-plus-pertuzumab-on-track-to-redefine-first-line-treatment-in-her2-positive-metastatic-breast-cancer/ 2026-01-19T13:37:16+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-ketamine-treatment-clinics-like-serenity-redefine-psychiatric-care-delivery-in-suburban-america/ 2026-01-20T04:07:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/naturmegas-ruby-o-shows-bioavailability-edge-over-standard-fish-oil-in-peer-reviewed-trial/ 2026-01-20T04:11:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-gsks-2-2bn-acquisition-of-rapt-therapeutics-reshape-the-food-allergy-treatment-landscape-with-ozureprubart/ 2026-01-20T16:21:57+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/GSK-to-acquire-RAPT-Therapeutics.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/GSK-to-acquire-RAPT-Therapeutics.webp https://pharmadevicenews.com/lillys-sofetabart-mipitecan-gets-fda-breakthrough-therapy-designation-for-ovarian-cancer/ 2026-01-20T16:35:53+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/ovarian-cancer-research-and-drug-development.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/ovarian-cancer-research-and-drug-development.webp https://pharmadevicenews.com/what-boston-scientifics-14-5bn-penumbra-buyout-means-for-stroke-and-clot-intervention-markets/ 2026-01-20T17:00:10+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/mechanical-thrombectomy-procedure.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/mechanical-thrombectomy-procedure.webp https://pharmadevicenews.com/maia-biotechnology-advances-ateganosine-cancer-program-with-phase-3-thio-104-trial-and-2026-catalyst-timeline/ 2026-01-21T01:42:24+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharma-1.png https://pharmadevicenews.com/adaptin-bio-prepares-phase-1-glioblastoma-trial-following-preclinical-progress-in-brain-cancer-candidate/ 2026-01-21T02:24:46+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharma-1.png https://pharmadevicenews.com/insilico-hygtia-therapeutics-to-co-develop-brain-penetrant-nlrp3-inhibitor-ism8969-for-cns-diseases/ 2026-01-21T03:07:59+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/brain-targeted-drug-discovery.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/brain-targeted-drug-discovery.webp https://pharmadevicenews.com/intent-biologics-secures-fda-pediatric-waiver-clears-path-to-late-stage-dfu-trial-for-pep-biologic/ 2026-01-21T17:58:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/lucid-diagnostics-gains-strategic-va-partnership-to-deploy-esoguard-across-veteran-programs/ 2026-01-21T21:16:06+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/biotissue-divests-surgical-and-wound-care-business-to-biostem-sharpening-focus-on-ocular-regeneration/ 2026-01-22T00:22:21+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-60-degrees-pharmaceuticals-is-betting-on-runway-health-to-reshape-malaria-prevention-access/ 2026-01-22T19:29:17+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-pds0101-patent-coverage-reshapes-competitive-risk-in-hpv16-positive-head-and-neck-cancer-development/ 2026-01-22T20:38:17+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-amlitelimabs-dosing-flexibility-could-disrupt-biologic-treatment-patterns-in-atopic-dermatitis/ 2026-01-23T15:46:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/vaxcyte-advances-vax-31-as-phase-3-trial-design-choices-highlight-regulatory-and-adoption-priorities/ 2026-01-23T15:53:54+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/brazil-rollout-puts-bavarian-nordics-chikungunya-vaccine-under-regulatory-and-execution-scrutiny/ 2026-01-23T18:05:32+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-crispr-editing-of-nrf2-reverse-resistance-in-head-and-neck-squamous-cell-carcinoma/ 2026-01-24T04:35:20+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-deceased-donor-marrow-a-viable-backup-graft-first-human-data-from-ossium-says-yes/ 2026-01-24T04:40:32+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/Cryopreserved-marrow-transplant-feasibility-from-Ossium-enters-spotlight-at-Tandem-2026-e1769229603682.webp https://pharmadevicenews.com/how-immunitybios-anktiva-combo-is-challenging-glioblastomas-immune-collapse-model/ 2026-01-24T05:10:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-agilents-new-slide-scanner-system-shift-digital-pathology-from-pilot-to-mainstream-in-europe/ 2026-01-24T06:47:39+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/nalu-medicals-wearable-powered-pns-shows-strong-24-month-durability-in-comfort-rct/ 2026-01-24T06:53:12+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/red-c-setback-for-bausch-health-what-this-failed-phase-3-trial-reveals-about-cirrhosis-care-gaps/ 2026-01-24T07:00:49+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/medtronic-expands-affera-platform-with-sphere-360-catheter-ce-mark-and-ide-trial-kickoff/ 2026-01-24T07:05:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-myriad-setting-a-new-performance-and-pricing-benchmark-in-bioscaffold-trauma-use/ 2026-01-24T07:09:19+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/jama-validates-nalbuphine-ers-efficacy-in-ipf-chronic-cough-as-trevi-eyes-next-steps/ 2026-01-24T07:16:50+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-elevidys-meet-its-promise-sareptas-pivotal-duchenne-gene-therapy-trial-nears-major-milestone/ 2026-01-24T07:25:39+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-fdas-clearance-of-acons-flowflex-plus-test-marks-a-turning-point-in-home-diagnostics/ 2026-01-24T07:32:37+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/alcrestas-relizorb-shows-bmi-and-weight-gains-in-pediatric-tube-fed-patients/ 2026-01-24T07:35:57+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-insilico-medicines-ism8969-could-unlock-a-new-class-of-neuroinflammatory-drugs/ 2026-01-24T07:40:43+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-the-trinity-tube-reveals-about-the-future-of-multifunctional-devices-in-nicu-care/ 2026-01-24T07:45:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/avacta-therapeutics-lse-avct-advances-fap-targeting-drug-conjugate-ava6103-into-phase-1-whats-at-stake/ 2026-01-24T14:31:13+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-episwitch-pse-become-more-than-a-diagnostic-tool-in-prostate-disease-management/ 2026-01-25T14:51:26+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-this-the-end-of-emface-lookalikes-inside-btls-cross-border-ip-enforcement-playbook/ 2026-01-25T14:54:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-philanthropic-capital-succeed-where-pharma-failed-in-gram-negative-antibiotic-discovery/ 2026-01-25T14:58:08+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/resolve-m-therapeutics-exits-stealth-with-johnson-johnson-innovation-support-to-pursue-ms1-driven-immune-resolution/ 2026-01-25T15:02:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/biostem-acquires-neox-and-clarix-as-biotissue-refocuses-on-eye-care-therapies/ 2026-01-25T15:06:49+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-prorxs-needle-free-trt-could-reshape-hormone-therapy-for-med-spas-and-dtc-providers/ 2026-01-25T15:19:28+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-zepto-life-technology-redefining-fungal-diagnostics-with-cell-free-dna-technology/ 2026-01-25T15:22:14+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/aidoc-secures-fda-clearance-for-first-ai-triage-system-covering-14-acute-conditions-in-ct/ 2026-01-25T15:26:11+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/veloxis-pharmaceuticals-pegrizeprument-gets-orphan-status-will-fda-incentives-accelerate-clinical-momentum/ 2026-01-25T15:30:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/far-biotech-expands-to-madison-what-this-means-for-ai-based-drug-development/ 2026-01-25T15:37:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-q-care-plus-is-blending-prep-birth-control-and-sexual-health-in-one-telehealth-platform/ 2026-01-25T16:26:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-mdlifespans-plasma-exchange-expansion-reveals-about-toxin-burden-and-aging-medicine/ 2026-01-25T16:29:23+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-legacys-vasectomy-solution-setting-a-new-standard-for-post-procedure-patient-management/ 2026-01-25T16:51:31+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/Legacy.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/Legacy.webp https://pharmadevicenews.com/replacing-microbiota-rejuvenates-aging-gut-tissue-what-new-mouse-data-means-for-regenerative-gi-therapies/ 2026-01-25T16:59:41+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/ai-in-clinical-operations-can-phasevs-real-time-site-optimization-reshape-ibd-trial-efficiency/ 2026-01-25T17:02:03+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-mabwells-adc-7mw4911-overcome-drug-resistance-in-late-stage-gi-cancers/ 2026-01-25T17:26:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/paq-therapeutics-initiates-phase-1-for-pt0511-pan-kras-degrader-raises-77m-in-series-b/ 2026-01-25T17:30:49+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-hoth-therapeuticss-topical-ht-001-redefine-egfr-therapy-adherence-in-cancer-supportive-care/ 2026-01-25T17:36:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/thailand-approves-nerlynx-for-her2-breast-cancer-will-it-change-relapse-prevention/ 2026-01-25T17:41:28+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-brazils-gmp-approval-for-pembrolizumab-biosimilar-changes-global-biosimilar-dynamics/ 2026-01-25T17:46:04+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-makes-break-wave-different-sonomotions-fda-clearance-puts-ultrasound-lithotripsy-in-the-spotlight/ 2026-01-25T18:04:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/SonoMotion__imaging_therapy_probes-scaled-e1769364199197.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/SonoMotion__imaging_therapy_probes-scaled-e1769364199197.webp https://pharmadevicenews.com/how-urcosimods-fda-compassionate-use-authorization-reshapes-development-risk-in-ocular-neuropathic-pain/ 2026-01-26T01:09:14+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-biocrysts-astria-acquisition-reshapes-long-acting-competition-in-hereditary-angioedema-prophylaxis/ 2026-01-26T01:17:09+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/brello-rise-enters-the-obesity-care-landscape-as-a-digital-wellness-adjunct-to-medical-weight-loss/ 2026-01-26T04:03:14+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-trisols-ttvr-platform-solve-the-right-heart-puzzle-in-tricuspid-regurgitation-care/ 2026-01-26T04:09:09+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/Trisols-valve-trial-shows-strong-early-outcomes-in-patients-deemed-too-high-risk-for-surgery-e1769400477279.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/Trisols-valve-trial-shows-strong-early-outcomes-in-patients-deemed-too-high-risk-for-surgery-e1769400477279.webp https://pharmadevicenews.com/gores-tips-expansion-device-wins-ce-mark-could-6-10-mm-range-reshape-portal-hypertension-shunt-strategies/ 2026-01-26T04:17:46+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/WL_Gore_TIPS_Endoprosthesis-scaled-e1769400957897.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/WL_Gore_TIPS_Endoprosthesis-scaled-e1769400957897.webp https://pharmadevicenews.com/neurosense-expands-alzheimers-ip-with-u-s-patent-but-all-eyes-are-on-road-trial-results/ 2026-01-26T04:26:32+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/could-cerevascs-eshunt-replace-vp-shunts-in-post-aneurysmal-hydrocephalus-treatment/ 2026-01-26T04:30:32+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-vitasmarts-fda-nod-could-shift-transplant-strategies-for-extended-criteria-grafts/ 2026-01-26T04:35:09+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/gsks-trelegy-ellipta-becomes-chinas-first-approved-triple-therapy-for-both-asthma-and-copd/ 2026-01-26T04:35:35+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/asthma-and-COPD-treatment.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/asthma-and-COPD-treatment.webp https://pharmadevicenews.com/can-targeting-neuropathy-reverse-tissue-death-what-the-rapid-nexus-study-means-for-chronic-wound-care/ 2026-01-26T04:39:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-jjs-lumateperone-raise-the-bar-for-mdd-remission-new-caplyta-data-fuels-fresh-hope/ 2026-01-26T04:49:59+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/pharmaceutical-tablets-and-clinical-tools.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/pharmaceutical-tablets-and-clinical-tools.webp https://pharmadevicenews.com/syracuse-orthopedic-specialists-and-three-affiliates-join-evolve-orthopedic-partners-platform/ 2026-01-26T04:53:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/moderna-and-mercks-mrna-4157-combo-shows-durable-benefit-in-resected-high-risk-melanoma/ 2026-01-26T05:01:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/suspicious-melanoma-lesion.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/suspicious-melanoma-lesion.webp https://pharmadevicenews.com/can-edge-ai-help-redefine-acute-care-what-ge-healthcare-and-nxps-anesthesia-and-nicu-concepts-reveal/ 2026-01-26T05:06:59+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/edge-AI-integration-in-acute-care.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/edge-AI-integration-in-acute-care.webp https://pharmadevicenews.com/fda-priority-review-for-leqembi-iqlik-could-transform-alzheimers-drug-initiation-at-home/ 2026-01-26T06:33:32+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-oral-glp-1-finally-viable-inside-ascletis-pharmas-u-s-trial-for-asc30/ 2026-01-26T06:39:59+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/argo-biopharmas-rnai-therapy-targets-lpa-what-phase-2b-with-novartis-could-prove/ 2026-01-26T06:46:04+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/landmark-fda-nod-gives-msc-developers-long-awaited-quality-benchmark-for-clinical-use/ 2026-01-26T06:49:46+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/eisai-and-biogen-advance-injectable-alzheimers-therapy-with-fda-fast-track-decision/ 2026-01-26T07:09:33+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/genethon-advances-duchenne-gene-therapy-trial-while-licensing-pompe-tech-to-bayers-askbio/ 2026-01-26T11:47:16+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/nateras-lung-transplant-biomarker-study-validates-noninvasive-dd-cfdna-surveillance-model/ 2026-01-26T11:57:03+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/ozelles-100b-image-diagnostic-ai-platform-puts-scale-and-precision-at-the-center-of-care/ 2026-01-26T12:04:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/bd-research-cloud-7-0-introduces-horizon-panel-maker-to-automate-complex-experiment-setup/ 2026-01-26T12:08:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/from-dript-to-vitaline-a-new-phase-for-clinical-hydration-in-the-u-s-eldercare-system/ 2026-01-26T12:14:43+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-smart-dental-devices-redefine-sleep-disorder-treatment-aesyras-trial-says-yes/ 2026-01-26T13:20:52+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/AesyBite-Active-shows-strong-safety-efficacy-in-sleep-bruxism-treatment-study-e1769433612375.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/AesyBite-Active-shows-strong-safety-efficacy-in-sleep-bruxism-treatment-study-e1769433612375.webp https://pharmadevicenews.com/why-aviva-bios-deuterated-testosterone-may-change-hormone-therapy-for-women/ 2026-01-26T13:29:04+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/AVA%E2%80%91291-shows-1000x-lower-breast-cancer-risk-in-preclinical-data-e1769433979275.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/AVA%E2%80%91291-shows-1000x-lower-breast-cancer-risk-in-preclinical-data-e1769433979275.webp https://pharmadevicenews.com/merz-therapeutics-files-xeomin-pediatric-spasticity-indication-with-ema-following-phase-3-success/ 2026-01-26T13:33:33+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-united-therapeutics-is-betting-on-scaffold-based-liver-support-in-high-mortality-alf/ 2026-01-26T13:37:13+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/novaliq-targets-uveitis-with-eyesol-based-nov05-can-topical-tacrolimus-go-intraocular/ 2026-01-26T13:42:40+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/nocion-therapeutics-reveals-new-pain-data-is-a-platform-pivot-underway/ 2026-01-26T13:53:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-sareptas-elevidys-redefine-duchenne-therapy-inside-the-3-year-embark-data/ 2026-01-26T13:57:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/fortitude-biomedicines-enters-the-degradation-race-with-catalytic-adc-platform-glue-dactm/ 2026-01-26T14:05:05+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-mirums-bluejay-acquisition-reveals-about-its-long-term-liver-disease-strategy/ 2026-01-26T14:13:03+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-indiviors-delaware-redomiciliation-matters-more-than-a-corporate-address-change/ 2026-01-26T19:25:33+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/scancells-late-stage-push-for-iscib1-reframes-the-risk-calculus-in-advanced-melanoma-trials/ 2026-01-26T19:32:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-arcutis-biotherapeutics-control-of-zoryve-promotion-could-influence-real-world-dermatology-and-pediatric-use/ 2026-01-26T19:48:49+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-genentechs-ct-388-challenge-obesity-drug-giants-with-22-5-weight-loss-and-%ce%b2-arrestin-bias/ 2026-01-27T07:18:30+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/abanza-gains-510k-for-quadlock-acl-system-but-is-this-a-clinical-leap-or-an-engineering-refinement/ 2026-01-27T18:29:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/Abanza_Inc___QuadLock-e1769538531787.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/Abanza_Inc___QuadLock-e1769538531787.webp https://pharmadevicenews.com/imviva-biotech-secures-fda-orphan-designation-as-cd7-car-t-development-faces-execution-challenges/ 2026-01-27T19:52:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-cloudbreak-pharmas-phase-2-fda-meeting-reveals-about-late-stage-risk-in-ophthalmic-drug-development/ 2026-01-27T20:01:38+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/cognition-therapeutics-advances-regulatory-strategy-for-zervimesine-in-an-underserved-neurodegenerative-disease/ 2026-01-27T20:20:49+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/tinlarebant-moves-closer-to-fda-review-after-belite-bio-finishes-dragon-ii-trial-enrollment/ 2026-01-27T20:24:24+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-skyhawks-sky-0515-the-first-disease-modifying-breakthrough-in-huntingtons-disease/ 2026-01-28T07:00:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-the-usdtl-courtfact-deal-reveals-about-techs-role-in-court-managed-care/ 2026-01-28T07:03:35+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/could-fujirebios-ptau-217-csf-assay-become-a-new-standard-in-alzheimers-research/ 2026-01-28T07:06:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-sets-hanmis-glp-1-strategy-apart-as-efpeglenatide-heads-into-latin-america/ 2026-01-28T07:11:06+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/will-tetrapharms-tpc-026-unlock-the-chronic-care-gap-in-metabolic-disorders/ 2026-01-28T07:14:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-boehringers-tl1a-il23-bispecific-bet-could-reshape-ibd-drug-development/ 2026-01-28T07:17:57+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/johnson-johnson-expands-darzalex-faspro-label-with-new-d-vrd-approval-in-newly-diagnosed-myeloma/ 2026-01-28T07:23:35+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/sixty-degrees-pharmaceuticals-bets-on-purification-science-to-unlock-castanospermine-commercialization/ 2026-01-28T20:30:19+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/parkinsons-disease-research-shifts-toward-proteoform-level-resolution-with-nautilus-biotechnologys-platform/ 2026-01-28T21:12:19+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/sinorda-bets-on-bispecifics-with-wuxi-biologics-for-ibd-and-autoimmune-expansion/ 2026-01-29T07:49:55+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/Dr_Chris_Chen__right__CEO_WuXi_Biologics_Dr_Pingsheng_Hu-e1769672963566.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/Dr_Chris_Chen__right__CEO_WuXi_Biologics_Dr_Pingsheng_Hu-e1769672963566.webp https://pharmadevicenews.com/what-hera-biolabs-absorption-into-demeetra-reveals-about-ip-bottlenecks-in-gene-editing-rd/ 2026-01-30T05:16:26+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/sinomune-to-launch-almiralls-seysara-in-china-can-it-reshape-acne-treatment-models/ 2026-01-30T05:23:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/tenpoints-yuvezzi-sets-new-benchmark-in-presbyopia-eye-drop-efficacy-and-safety/ 2026-01-30T05:32:24+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/Tenpoints-YUVEZZI-sets-new-benchmark-in-presbyopia-eye-drop-efficacy-and-safety-e1769751078353.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/Tenpoints-YUVEZZI-sets-new-benchmark-in-presbyopia-eye-drop-efficacy-and-safety-e1769751078353.webp https://pharmadevicenews.com/how-galdermas-wake-up-to-restylane-campaign-reflects-evolving-aesthetics-patient-preferences/ 2026-01-30T05:49:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/galderma-e1769752148189.webp https://pharmadevicenews.com/is-biocodexs-fullify-the-first-probiotic-to-challenge-glp-1-drugs-in-the-consumer-weight-loss-space/ 2026-01-30T06:06:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/01/Biocodex-launches-Fullify-a-first-of-its-kind-probiotic-targeting-appetite-via-gut-brain-pathway-e1769753121797.webp https://pharmadevicenews.com/wp-content/uploads/2026/01/Biocodex-launches-Fullify-a-first-of-its-kind-probiotic-targeting-appetite-via-gut-brain-pathway-e1769753121797.webp https://pharmadevicenews.com/what-koru-medicals-rystiggo-delivery-clearance-means-for-subcutaneous-infusion-models/ 2026-01-30T06:10:38+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-quinces-failed-neat-trial-reveals-about-rare-pediatric-trial-design-risks/ 2026-01-30T06:15:33+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-vetter-pharmas-saarland-project-reveals-about-long-cycle-cdmo-investment-strategies/ 2026-01-30T06:22:04+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-uvdis-new-v-mix-air-disinfection-system-could-reshape-hvac-pathogen-control/ 2026-01-30T06:26:03+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-scilex-holding-company-sees-strategic-optionality-in-diagnostic-platforms-beyond-traditional-therapeutics/ 2026-01-30T22:44:33+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-alx-oncologys-new-cd47-findings-suggest-about-biomarker-driven-immuno-oncology-strategies/ 2026-01-30T22:55:33+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/lillys-3-5bn-pennsylvania-site-will-anchor-u-s-manufacturing-for-next-gen-injectables-including-retatrutide/ 2026-02-01T06:00:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/LILLY_Lehigh_Valley_new_facility-e1769925583628.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/LILLY_Lehigh_Valley_new_facility-e1769925583628.webp https://pharmadevicenews.com/tenacias-ztalmy-launch-shows-new-blueprint-for-orphan-neurology-drugs-in-china/ 2026-02-02T04:15:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/frontage-expands-us-china-clinical-footprint-to-meet-demand-for-early-phase-integration/ 2026-02-02T04:21:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Frontage-targets-patent-cliff-opportunities-with-US-clinical-trial-expansion-e1770006051229.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Frontage-targets-patent-cliff-opportunities-with-US-clinical-trial-expansion-e1770006051229.webp https://pharmadevicenews.com/cynosure-lutronic-sets-stage-for-global-mosaic-3d-rollout-with-imcas-2026-momentum/ 2026-02-02T04:27:35+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Cynosure-Lutronic-pushes-Mosaic-3D-global-adoption-strategy-after-CE-mark-milestone-scaled-e1770006393351.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Cynosure-Lutronic-pushes-Mosaic-3D-global-adoption-strategy-after-CE-mark-milestone-scaled-e1770006393351.webp https://pharmadevicenews.com/trace-biosciences-lgw16-03-ind-approval-opens-new-chapter-in-nerve-targeted-surgical-imaging/ 2026-02-02T04:33:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Trace-Biosciences-moves-toward-first-in-human-trials-with-breakthrough-nerve-imaging-agent-e1770006747885.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Trace-Biosciences-moves-toward-first-in-human-trials-with-breakthrough-nerve-imaging-agent-e1770006747885.webp https://pharmadevicenews.com/why-sixty-degrees-pharmaceuticals-is-betting-on-retail-channels-for-tafenoquine-adoption/ 2026-02-02T21:28:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-alk-abellos-eurneffy-launch-shift-real-world-adoption-of-non-injectable-adrenaline-in-eu-schools/ 2026-02-02T21:49:31+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-aquestive-therapeutics-anaphylm-crl-reveals-about-human-factors-scrutiny-in-emergency-use-drug-approvals/ 2026-02-02T22:07:43+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/creates-in-vivo-car-t-achieves-full-b-cell-depletion-and-repeat-dosing-in-primates/ 2026-02-03T04:11:37+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-fugos-integrated-printing-cycle-could-shift-dental-manufacturing-economics/ 2026-02-03T04:16:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/FUGOs-centrifugal-3D-printing-debut-could-signal-a-shift-in-dental-manufacturing-economics-e1770092151556.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/FUGOs-centrifugal-3D-printing-debut-could-signal-a-shift-in-dental-manufacturing-economics-e1770092151556.webp https://pharmadevicenews.com/nmpa-greenlights-zeiss-artevo-750-and-850-boosting-chinas-surgical-visualization-tech/ 2026-02-03T04:23:37+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/ZEISS-brings-3D-digital-ophthalmic-microscopy-to-China-with-ARTEVO-850-launch-e1770092556783.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/ZEISS-brings-3D-digital-ophthalmic-microscopy-to-China-with-ARTEVO-850-launch-e1770092556783.webp https://pharmadevicenews.com/why-the-srs-lenke-aubin-3d-classification-could-reshape-adolescent-scoliosis-research/ 2026-02-03T04:27:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-avidity-is-spinning-off-atrium-therapeutics-before-the-novartis-acquisition-closes/ 2026-02-03T04:30:37+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/wuxi-biologics-to-support-vertexs-autoimmune-tce-rd-with-full-crdmo-integration/ 2026-02-03T04:35:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/could-invivyds-vyd2311-offer-a-safer-alternative-to-mrna-covid-vaccines-for-vulnerable-groups/ 2026-02-03T15:47:12+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-theriva-biologics-apao-2026-presentation-signals-for-intravitreal-oncology-treatments/ 2026-02-03T15:55:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-prelude-therapeutics-is-advancing-a-jak2-jh2-strategy-into-the-clinic-after-fda-ind-clearance/ 2026-02-03T16:10:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/relay-therapeutics-secures-fda-breakthrough-designation-for-zovegalisib-in-pik3ca-mutant-hr-her2-advanced-breast-cancer/ 2026-02-03T16:24:52+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-gt-biopharmas-b7-h3-trike-could-reshape-immunotherapy-for-solid-tumors/ 2026-02-03T16:33:24+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-mira-pharmaceuticals-is-targeting-chemotherapy-induced-nerve-pain-with-ketamir-2/ 2026-02-03T19:10:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-jcr-unlocking-the-cns-for-lysosomal-storage-diseases-before-gene-therapy-gets-there/ 2026-02-05T04:09:48+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-leydens-cr9114-nasal-spray-could-disrupt-traditional-flu-vaccination-models/ 2026-02-05T04:17:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-brightseeds-glycemic-control-data-could-reshape-how-glp-1-companion-products-are-evaluated/ 2026-02-05T04:28:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Brightseeds-BioMetaControl-trial-raises-the-bar-for-AI-discovered-nutraceuticals-in-prediabetes-care-e1770265660826.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Brightseeds-BioMetaControl-trial-raises-the-bar-for-AI-discovered-nutraceuticals-in-prediabetes-care-e1770265660826.webp https://pharmadevicenews.com/bioselective-capitals-cdmo-acquisition-reshapes-domestic-pharma-manufacturing-landscape/ 2026-02-05T04:36:23+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-propanc-biopharmas-prp-signals-about-alternative-mechanisms-in-the-crowded-pancreatic-cancer-pipeline/ 2026-02-05T19:05:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-ampligen-plus-durvalumab-finally-overcome-immunotherapy-resistance-in-metastatic-pancreatic-cancer/ 2026-02-05T19:13:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-priovants-brepocitinib-advances-a-long-overlooked-inflammatory-skin-disease-toward-approval/ 2026-02-06T16:39:30+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-pulmovants-phocus-study-design-matters-for-regulatory-confidence-in-pulmonary-hypertension-associated-with-interstitial-lung-disease/ 2026-02-06T16:55:03+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-idorsia-pharmaceuticals-ltds-lucerastat-redefine-fabry-disease-treatment-beyond-enzyme-replacement-therapy/ 2026-02-06T16:58:54+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-johnson-johnsons-akeega-opinion-means-for-parp-inhibitors-beyond-castration-resistance/ 2026-02-06T21:39:12+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/anathapindika-health-expands-retail-footprint-testing-detox-first-nutraceutical-demand-in-specialty-stores/ 2026-02-06T21:55:50+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/clearmind-medicine-inc-and-polyrizon-ltd-target-formulation-risk-in-meais-addiction-program/ 2026-02-06T22:24:43+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-tg-therapeutics-actrims-strategy-signals-about-the-next-competitive-phase-in-anti-cd20-multiple-sclerosis-therapy/ 2026-02-06T22:53:17+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/genentechs-fenebrutinib-challenges-the-ppms-treatment-ceiling-but-does-not-yet-reset-it/ 2026-02-08T12:53:12+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/primary-progressive-multiple-sclerosis.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/primary-progressive-multiple-sclerosis.webp https://pharmadevicenews.com/johnson-johnsons-early-omnypulse-data-show-promise-but-the-real-test-lies-ahead/ 2026-02-08T12:59:57+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/pulsed-field-ablation-catheter.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/pulsed-field-ablation-catheter.webp https://pharmadevicenews.com/rapid-medicals-distals-trial-signals-a-structural-shift-in-how-medium-vessel-stroke-may-finally-be-treated/ 2026-02-08T14:18:03+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/endovascular-thrombectomy-procedure.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/endovascular-thrombectomy-procedure.webp https://pharmadevicenews.com/true-metrix-labeling-change-puts-focus-on-how-glucose-meters-communicate-extreme-risk-events/ 2026-02-08T14:26:12+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/TMX_Meters_E5-Recall_All.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/TMX_Meters_E5-Recall_All.webp https://pharmadevicenews.com/fda-removes-cns-limitation-for-yescarta-reshaping-the-regulatory-boundary-for-car-t-therapy-in-primary-cns-lymphoma/ 2026-02-09T01:53:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/CAR-T-cell-therapy-research.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/CAR-T-cell-therapy-research.webp https://pharmadevicenews.com/what-biofronteras-phase-3-results-mean-for-non-facial-actinic-keratosis-treatment-strategies/ 2026-02-10T01:42:09+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/could-carterra-inc-s-vega-ht-spr-accelerate-fragment-and-small-molecule-discovery-without-compromising-rigor/ 2026-02-10T01:50:05+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/inside-the-fresenius-kabi-and-phlow-corp-epinephrine-deal-and-why-regulators-will-scrutinise-what-comes-next/ 2026-02-10T04:10:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-evecxias-evx-301-trial-reveals-about-the-future-of-serotonin-based-psychiatry/ 2026-02-10T04:15:06+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-sciexs-echo-ms-compatibility-with-zenotof-8600-signals-for-modern-drug-discovery-labs/ 2026-02-10T04:22:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/SCIEX-strengthens-its-discovery-platform-strategy-through-Echo-MS-and-ZenoTOF-8600-pairing-e1770697268678.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/SCIEX-strengthens-its-discovery-platform-strategy-through-Echo-MS-and-ZenoTOF-8600-pairing-e1770697268678.webp https://pharmadevicenews.com/what-agenus-bot-and-bal-biomarker-work-reveals-about-rescuing-immunologically-cold-tumors/ 2026-02-10T04:26:55+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-immune-status-the-next-wellness-frontier-inside-kirin-and-immunosenss-strategy/ 2026-02-10T04:31:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-nicox-sas-ncx-470-presentations-signal-for-nitric-oxide-based-eye-therapies/ 2026-02-10T22:24:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-kainova-therapeutics-latest-financing-reveals-about-the-future-of-ccr8-targeted-cancer-therapies/ 2026-02-10T22:38:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-regeneron-pharmaceuticals-redefine-allergy-treatment-with-phase-3-allergen-blocking-antibodies-and-dupilumab-expansion/ 2026-02-10T22:51:08+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-kailera-therapeutics-and-hengrui-pharmas-phase-2-ribupatide-results-reveal-about-oral-glp-1-viability/ 2026-02-10T22:58:50+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-lillys-orna-therapeutics-deal-means-for-immune-reset-strategies/ 2026-02-11T17:55:30+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-galdermas-we-are-all-sculptra-program-reframes-collagen-biostimulation-in-aesthetic-medicine/ 2026-02-12T07:18:41+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/does-whoops-biomarker-integration-move-wearables-closer-to-regulated-healthcare/ 2026-02-12T07:26:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-carsgen-therapeutics-rmb370m-manufacturing-plan-reveals-about-car-t-execution-risk/ 2026-02-13T04:28:28+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-innovents-ibi354-replace-chemotherapy-in-first-line-her2-positive-metastatic-breast-cancer/ 2026-02-13T04:33:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-hurricane-ventures-investment-in-bioreact-highlights-the-next-phase-of-digital-bioprocessing/ 2026-02-13T04:38:59+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-the-fda-decision-on-ptc-therapeutics-translarna-reveals-about-duchenne-muscular-dystrophy-drug-approvals/ 2026-02-13T04:50:46+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-online-therapy-finally-close-new-mexicos-mental-health-gap-skymd-bets-big-on-statewide-virtual-care/ 2026-02-13T04:56:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/medtronic-secures-fda-clearance-for-stealth-axis-surgical-system-in-spine-robotics/ 2026-02-13T17:05:55+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-novartis-pharma-ag-positioned-to-convert-accelerated-approval-for-vanrafia-in-2026/ 2026-02-13T17:52:11+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-alto-neurosciences-alto-101-finally-move-the-needle-on-cognitive-impairment-in-schizophrenia/ 2026-02-13T18:29:43+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-astrazenecas-kalos-and-logos-data-reveal-about-triple-inhaler-therapy-in-asthma/ 2026-02-13T18:38:06+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-kandus-ipsihand-brain-computer-interface-reopen-the-recovery-window-after-stroke/ 2026-02-14T03:58:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-biolife-solutions-qkine-deal-could-reshape-how-cytokines-are-sourced-in-cell-and-gene-therapy/ 2026-02-14T04:03:41+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/new-england-biolabs-strengthens-liquid-biopsy-foundations-with-scalable-cfdna-extraction-launch/ 2026-02-14T04:08:50+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-stimlabs-dermaform-approval-reveals-about-the-future-of-regenerative-wound-care/ 2026-02-14T04:14:09+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-hoth-therapeutics-exon-skipping-patent-matters-more-for-strategy-than-near-term-value/ 2026-02-14T04:18:51+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-purehealth-research-llcs-venease-highlights-gaps-between-compression-therapy-and-clinical-intervention/ 2026-02-14T04:31:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-universal-influenza-vaccines-finally-move-beyond-theory-centivax-begins-phase-1-testing/ 2026-02-14T04:50:42+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/diamond-lake-clinics-exomind-rollout-signals-shifting-priorities-in-noninvasive-depression-treatment/ 2026-02-14T04:54:09+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-applied-medical-technologys-explant-express-fda-clearance-reveals-about-breast-implant-explantation-workflows/ 2026-02-14T05:04:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Explant-Express-FDA-clearance-signals-rising-focus-on-standardising-ruptured-breast-implant-removal-e1771045382825.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Explant-Express-FDA-clearance-signals-rising-focus-on-standardising-ruptured-breast-implant-removal-e1771045382825.webp https://pharmadevicenews.com/difgen-pharmaceuticals-expands-complex-generics-footprint-with-fluorometholone-ophthalmic-suspension-approval/ 2026-02-14T05:10:49+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-lillys-libretto-432-results-matter-beyond-selpercatinibs-event-free-survival-win/ 2026-02-17T00:56:11+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/genentech-advances-gazyva-toward-first-approval-in-primary-membranous-nephropathy-after-phase-iii-win/ 2026-02-17T04:03:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-subcutaneous-infliximab-change-how-clinicians-manage-drug-holidays-in-crohns-disease-and-ulcerative-colitis/ 2026-02-17T04:07:08+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/delphi-diagnostics-data-challenges-one-size-fits-all-use-of-extended-endocrine-therapy-in-breast-cancer/ 2026-02-17T04:10:55+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-compass-pathways-upcoming-comp360-data-could-redefine-late-stage-psychedelic-drug-development/ 2026-02-17T04:14:10+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-newrons-eur-38m-financing-matters-for-phase-iii-evenamide-development-in-treatment-resistant-schizophrenia/ 2026-02-17T04:17:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-dialed-moods-make-biohacking-sustainable-beyond-niche-wellness-communities/ 2026-02-17T04:22:59+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/biofrontera-targets-u-s-label-expansion-for-ameluz-in-trunk-and-extremities/ 2026-02-17T19:06:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/novo-nordisk-secures-eu-nod-for-higher-wegovy-dose-amid-intensifying-glp-1-competition/ 2026-02-17T19:14:04+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/fda-ind-clearance-propels-viromissiles-idov-immune-into-major-u-s-cancer-centers/ 2026-02-17T19:28:54+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/moleculin-biotech-inc-secures-japanese-ip-boost-as-annamycin-enters-pivotal-phase-3/ 2026-02-17T19:36:49+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-janux-therapeutics-janx011-trial-could-redefine-immune-reset-in-autoimmune-disease/ 2026-02-18T03:59:35+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-the-invenra-b-body-licensing-deal-changes-for-twist-bioscience-and-antibody-discovery-services/ 2026-02-18T04:03:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-deciphera-pharmaceuticals-tirabrutinib-nda-matters-for-the-future-of-cns-lymphoma-therapy/ 2026-02-18T04:06:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/bristol-myers-squibb-pushes-celmod-frontier-as-fda-accepts-iberdomide-nda-in-relapsed-multiple-myeloma/ 2026-02-18T04:10:52+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-pfizers-braftovi-results-could-reshape-first-line-treatment-for-braf-mutant-mcrc/ 2026-02-18T04:15:21+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/henry-schein-one-and-align-technology-deepen-digital-dentistry-integration-as-workflow-platforms-take-center-stage/ 2026-02-18T04:20:04+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/nimbus-therapeutics-tests-a-dual-inflammation-and-repair-thesis-with-sik2-inhibitors/ 2026-02-18T04:29:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/from-lung-scans-to-heart-risk-signals-what-mclaren-health-cares-ai-rollout-reveals-about-preventive-care/ 2026-02-18T04:34:39+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/nim-1324-enters-phase-2-as-nimmune-biopharma-tests-immunometabolism-as-the-next-frontier-in-inflammatory-bowel-disease/ 2026-02-18T04:40:14+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/rallybio-validates-durable-complement-suppression-with-rlyb116-in-phase-1-study/ 2026-02-18T04:44:03+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/scribe-therapeutics-deepens-in-vivo-crispr-validation-with-second-eli-lilly-collaboration-milestone/ 2026-02-18T06:35:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-watchmaker-genomics-is-repurposing-crispr-cas9-to-reshape-ngs-library-normalization-at-scale/ 2026-02-18T06:42:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-the-prostate-cancer-foundations-6-3m-bet-on-young-investigators-could-shape-the-next-decade-of-prostate-cancer-innovation/ 2026-02-19T03:46:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-harmony-biosciences-pitolisant-approval-changes-the-risk-calculus-in-pediatric-narcolepsy/ 2026-02-19T03:55:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-alcons-total30-multifocal-for-astigmatism-targets-the-toughest-segment-in-contact-lens-care/ 2026-02-19T04:02:24+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-bioemtech-and-northstar-medical-radioisotopes-actinium-225-agreement-matters-for-preclinical-alpha-therapy-development/ 2026-02-19T04:07:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/bioaffinity-technologies-positions-cypath-lung-as-a-confidence-tool-rather-than-a-diagnostic-replacement/ 2026-02-19T04:11:14+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/viiv-healthcares-cabenuva-and-dovato-strategy-looks-like-an-ecosystem-play-as-ultra-long-acting-candidates-advance/ 2026-02-19T04:18:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/instanosis-secures-fda-breakthrough-status-for-xylazine-urine-test-as-overdose-care-faces-new-diagnostic-gaps/ 2026-02-19T04:26:42+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-unc-healths-mevion-deployment-reflects-a-reset-in-proton-therapy-economics/ 2026-02-19T04:31:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-ge-healthcares-35m-barda-expansion-reveals-about-the-future-of-trauma-imaging/ 2026-02-19T04:35:53+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-omeros-corporations-oncotox-aml-study-reveals-about-mutation-agnostic-aml-therapies/ 2026-02-19T04:40:42+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/gilead-expands-its-hiv-playbook-as-lenacapavir-moves-from-niche-drug-to-platform-strategy/ 2026-02-19T04:45:05+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-avidity-biosciences-phase-1-2-marina-results-reveal-about-the-future-of-dm1-drug-development/ 2026-02-19T07:04:10+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/staar-surgical-advances-evo-icl-adoption-as-fda-approval-reframes-high-myopia-treatment-economics/ 2026-02-19T07:10:49+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/starton-therapeutics-advances-star-lld-as-delivery-innovation-in-multiple-myeloma/ 2026-02-19T19:01:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/profusa-lumee-oxygen-gains-pre-approval-orders-as-eu-mdr-decision-looms/ 2026-02-19T19:09:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/dror-ortho-design-advances-u-s-commercialization-with-next-generation-zsmile-platform/ 2026-02-19T19:45:35+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/next-generation-signa-mri-gains-fda-nod-sharpening-ge-healthcares-imaging-strategy/ 2026-02-19T19:53:26+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-project-santa-fe-foundation-and-virchow-medical-are-testing-a-proactive-future-for-oncology-diagnostics/ 2026-02-20T03:26:10+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/life-spine-strengthens-prolifts-long-term-viability-as-mri-compatibility-becomes-a-procurement-baseline/ 2026-02-20T03:30:52+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-seek-labs-crispr-platform-could-change-the-economics-of-avian-influenza-outbreaks/ 2026-02-20T03:36:21+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/ambient-temperature-rna-ish-enters-mainstream-pathology-as-molecular-instruments-expands-hcr-pro-automation/ 2026-02-20T03:40:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/menopause-specific-hair-loss-enters-the-clinical-spotlight-after-kilgourmd-trial-data/ 2026-02-20T03:56:13+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/KilgourMD-phase-II-data-forces-a-rethink-of-menopause-related-hair-loss-treatment-timelines-e1771559712751.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/KilgourMD-phase-II-data-forces-a-rethink-of-menopause-related-hair-loss-treatment-timelines-e1771559712751.webp https://pharmadevicenews.com/from-ingredients-to-devices-what-bon-natural-life-limiteds-apple-mask-means-for-medical-aesthetics-innovation/ 2026-02-20T04:04:49+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/BON-Natural-Life-Limited-tests-bio-electronic-aesthetics-bet-as-apple-polyphenol-mask-enters-clinical-validation-phase-e1771560227545.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/BON-Natural-Life-Limited-tests-bio-electronic-aesthetics-bet-as-apple-polyphenol-mask-enters-clinical-validation-phase-e1771560227545.webp https://pharmadevicenews.com/devonian-health-group-advances-thykamine-with-human-liver-on-a-chip-data-targeting-fibrosis-in-mash/ 2026-02-20T04:10:48+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Devonian-Health-Groups-MASH-strategy-leans-on-human-relevant-fibrosis-evidence-e1771560592541.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Devonian-Health-Groups-MASH-strategy-leans-on-human-relevant-fibrosis-evidence-e1771560592541.webp https://pharmadevicenews.com/bimini-health-tech-strengthens-puregraft-franchise-with-sync-as-fat-grafting-scales-globally/ 2026-02-20T04:20:54+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Bimini-Health-Tech-expands-Puregraft-platform-as-fat-grafting-shifts-toward-efficiency-first-devices.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Bimini-Health-Tech-expands-Puregraft-platform-as-fat-grafting-shifts-toward-efficiency-first-devices.webp https://pharmadevicenews.com/merlin-cp-gep-becomes-first-nccn-endorsed-molecular-test-for-early-stage-melanoma-risk-assessment/ 2026-02-20T04:28:35+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Merlin-CP-GEP-becomes-first-NCCN-endorsed-molecular-test-for-early-stage-melanoma-risk-assessment-e1771561661941.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Merlin-CP-GEP-becomes-first-NCCN-endorsed-molecular-test-for-early-stage-melanoma-risk-assessment-e1771561661941.webp https://pharmadevicenews.com/why-sibel-healths-aria-sensor-could-change-endpoint-design-in-chronic-refractory-cough-trials/ 2026-02-20T04:34:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Sibel-Healths-FDA-acceptance-signals-a-potential-shift-in-how-chronic-cough-drugs-are-measured-in-trials-e1771561997431.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Sibel-Healths-FDA-acceptance-signals-a-potential-shift-in-how-chronic-cough-drugs-are-measured-in-trials-e1771561997431.webp https://pharmadevicenews.com/what-belay-diagnostics-summit-2-0-results-reveal-about-the-future-of-cns-molecular-diagnostics/ 2026-02-20T04:44:59+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Belay-Diagnostics-validates-Summit-2.0-CSF-genomic-assay-raising-the-evidentiary-bar-for-CNS-liquid-biopsy-e1771562653610.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Belay-Diagnostics-validates-Summit-2.0-CSF-genomic-assay-raising-the-evidentiary-bar-for-CNS-liquid-biopsy-e1771562653610.webp https://pharmadevicenews.com/why-immunitybios-anktiva-european-launch-could-reshape-bcg-unresponsive-bladder-cancer-care/ 2026-02-20T04:50:26+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/ImmunityBio-bets-on-Accord-Healthcare-to-unlock-ANKTIVA-adoption-across-Europe-e1771562974520.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/ImmunityBio-bets-on-Accord-Healthcare-to-unlock-ANKTIVA-adoption-across-Europe-e1771562974520.webp https://pharmadevicenews.com/why-ge-healthcares-fda-cleared-signa-mri-update-is-more-about-operations-than-image-quality/ 2026-02-20T04:56:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/GE-HealthCare-expands-SIGNA-MRI-platform-with-FDA-cleared-helium-free-systems-and-AI-workflow-layer-e1771563329842.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/GE-HealthCare-expands-SIGNA-MRI-platform-with-FDA-cleared-helium-free-systems-and-AI-workflow-layer-e1771563329842.webp https://pharmadevicenews.com/can-targeting-cd36-reshape-hepatocellular-carcinoma-immunotherapy-pilatus-biosciences-takes-first-step/ 2026-02-20T05:01:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Pilatus-Biosciences-moves-beyond-PD-1-with-FDA-backed-Fast-Track-pathway-for-PLT012-e1771563630276.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Pilatus-Biosciences-moves-beyond-PD-1-with-FDA-backed-Fast-Track-pathway-for-PLT012-e1771563630276.webp https://pharmadevicenews.com/what-enveric-biosciences-eb-003-data-reveal-about-separating-benefit-from-hallucinations/ 2026-02-20T05:06:40+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Enveric-Biosciences-EB-003-data-deepen-the-case-for-non-hallucinogenic-5-HT2A-antidepressants-e1771563949536.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Enveric-Biosciences-EB-003-data-deepen-the-case-for-non-hallucinogenic-5-HT2A-antidepressants-e1771563949536.webp https://pharmadevicenews.com/why-yoltech-therapeutics-yolt-202-data-matters-for-the-future-of-gene-editing-in-alpha-1-antitrypsin-deficiency/ 2026-02-20T05:45:01+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/YolTech-Therapeutics-interim-YOLT-202-data-reshapes-expectations-for-curative-Alpha-1-Antitrypsin-Deficiency-therapies-e1771566240490.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/YolTech-Therapeutics-interim-YOLT-202-data-reshapes-expectations-for-curative-Alpha-1-Antitrypsin-Deficiency-therapies-e1771566240490.webp https://pharmadevicenews.com/johnson-johnsons-three-year-tremfya-data-sharpen-the-durability-debate-in-ulcerative-colitis-care/ 2026-02-21T16:16:21+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Johnson-Johnson-strengthens-its-ulcerative-colitis-position-with-extended-guselkumab-outcomes-e1771690533972.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Johnson-Johnson-strengthens-its-ulcerative-colitis-position-with-extended-guselkumab-outcomes-e1771690533972.webp https://pharmadevicenews.com/fda-approval-of-milsaperidone-puts-vanda-pharmaceuticals-into-crowded-bipolar-i-disorder-and-schizophrenia-markets/ 2026-02-21T16:23:37+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Vanda-Pharmaceuticals-secures-milsaperidone-approval-but-bipolar-I-disorder-and-schizophrenia-uptake-remains-uncertain-e1771690963360.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Vanda-Pharmaceuticals-secures-milsaperidone-approval-but-bipolar-I-disorder-and-schizophrenia-uptake-remains-uncertain-e1771690963360.webp https://pharmadevicenews.com/what-lake-forest-regenesiss-emsculpt-neo-launch-reveals-about-the-future-of-device-led-metabolic-care/ 2026-02-21T17:10:30+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-altapointes-ketamine-assisted-protocol-could-reshape-opioid-withdrawal-management/ 2026-02-21T17:17:50+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/AltaPointe-ketamine-protocol-may-change-how-buprenorphine-is-started-in-fentanyl-dependence-e1771694216818.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/AltaPointe-ketamine-protocol-may-change-how-buprenorphine-is-started-in-fentanyl-dependence-e1771694216818.webp https://pharmadevicenews.com/are-lymphatic-system-supplements-moving-from-folklore-to-functional-claims-a-look-at-purehealth-research/ 2026-02-21T17:28:40+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-edwards-lifesciences-is-betting-on-transcatheter-replacement-to-solve-tricuspid-regurgitation/ 2026-02-22T03:52:09+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Edwards-Lifesciences-advances-structural-heart-care-with-EVOQUE-tricuspid-valve-replacement-e1771732257475.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Edwards-Lifesciences-advances-structural-heart-care-with-EVOQUE-tricuspid-valve-replacement-e1771732257475.webp https://pharmadevicenews.com/partner-therapeutics-zenocutuzumab-data-adds-nuance-to-progression-driven-treatment-decisions-in-nrg1-positive-lung-cancer/ 2026-02-22T05:14:05+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Partner-Therapeutics-zenocutuzumab-data-adds-nuance-to-progression-driven-treatment-decisions-in-NRG1-positive-lung-cancer-e1771737192697.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Partner-Therapeutics-zenocutuzumab-data-adds-nuance-to-progression-driven-treatment-decisions-in-NRG1-positive-lung-cancer-e1771737192697.webp https://pharmadevicenews.com/what-guerbets-pediatric-gadopiclenol-label-expansion-reveals-about-the-future-of-mri-contrast-agents/ 2026-02-22T05:27:17+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Guerbet-expands-gadopiclenol-into-neonates-as-FDA-backs-half-dose-MRI-contrast-strategy-e1771737990986.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Guerbet-expands-gadopiclenol-into-neonates-as-FDA-backs-half-dose-MRI-contrast-strategy-e1771737990986.webp https://pharmadevicenews.com/how-solaria-bio-is-positioning-bondia-for-credibility-in-a-crowded-bone-health-market/ 2026-02-22T05:31:43+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Solaria-Bio-microbiome-study-on-Bondia-shifts-focus-from-bone-claims-to-strain-level-control-e1771738260112.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Solaria-Bio-microbiome-study-on-Bondia-shifts-focus-from-bone-claims-to-strain-level-control-e1771738260112.webp https://pharmadevicenews.com/what-inventhelps-heat-therapy-mitten-reveals-about-the-limits-of-consumer-pain-devices/ 2026-02-22T05:37:55+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Hand-and-wrist-heat-therapy-devices-still-face-a-credibility-gap-and-InventHelps-mitten-illustrates-why-e1771738623698.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Hand-and-wrist-heat-therapy-devices-still-face-a-credibility-gap-and-InventHelps-mitten-illustrates-why-e1771738623698.webp https://pharmadevicenews.com/novo-nordisks-cagrisema-misses-non-inferiority-against-tirzepatide-why-a-23-weight-loss-still-reshapes-the-obesity-pipeline/ 2026-02-23T15:24:19+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/injectable-obesity-drug-research.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/injectable-obesity-drug-research.webp https://pharmadevicenews.com/recursion-pharmaceuticals-to-spotlight-self-driving-lab-model-at-nvidia-gtc-2026/ 2026-02-23T19:47:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-pharmalas-three-year-stability-program-de-risk-mdma-distribution-challenges/ 2026-02-23T21:02:01+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-subcutaneous-amivantamab-approval-in-europe-could-reshape-egfr-mutated-nsclc-treatment-workflows/ 2026-02-23T21:37:24+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-daiichi-sankyo-is-betting-early-on-sylamorebios-sylec-delivery-platform-for-cns-programs/ 2026-02-24T07:01:10+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/SylamoreBio-and-Daiichi-Sankyo-collaboration-highlights-why-CNS-drug-delivery-is-back-in-pharma-focus-e1771916447470.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/SylamoreBio-and-Daiichi-Sankyo-collaboration-highlights-why-CNS-drug-delivery-is-back-in-pharma-focus-e1771916447470.webp https://pharmadevicenews.com/why-gilead-sciences-arcellx-acquisition-reshapes-the-competitive-dynamics-of-bcma-car-t-therapy/ 2026-02-24T07:05:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/How-anito-cel-could-redefine-Gilead-Sciences-long-term-strategy-in-multiple-myeloma-cell-therapy-e1771916704100.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/How-anito-cel-could-redefine-Gilead-Sciences-long-term-strategy-in-multiple-myeloma-cell-therapy-e1771916704100.webp https://pharmadevicenews.com/what-arcus-biosciences-casdatifan-data-reveal-about-durability-limits-in-late-line-renal-cell-carcinoma/ 2026-02-24T07:10:40+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Arcus-Biosciences-casdatifan-data-test-whether-next-generation-HIF-2%CE%B1-inhibition-can-outperform-late-line-kidney-cancer-expectations-e1771916981796.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Arcus-Biosciences-casdatifan-data-test-whether-next-generation-HIF-2%CE%B1-inhibition-can-outperform-late-line-kidney-cancer-expectations-e1771916981796.webp https://pharmadevicenews.com/vir-biotechnologys-vir-5500-tests-whether-dual-masked-t-cell-engagers-can-finally-work-in-metastatic-prostate-cancer/ 2026-02-25T07:14:53+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/20-20-biolabs-and-ibm-collaboration-signals-new-direction-in-preventive-diagnostics/ 2026-02-26T02:16:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-longeveron-inc-s-phase-2b-results-mean-for-regenerative-medicine-in-aging-populations/ 2026-02-26T02:23:37+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/eton-pharmaceuticals-expands-rare-endocrine-portfolio-with-fda-backed-liquid-desmopressin/ 2026-02-26T02:40:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/aicuris-pritelivir-shows-superior-lesion-healing-in-hiv-associated-refractory-hsv/ 2026-02-26T02:49:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/gsk-plc-and-35pharma-inc-what-the-950m-hs235-deal-changes-in-pulmonary-hypertension-therapy/ 2026-02-26T06:51:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-bristol-myers-squibbs-luspatercept-results-reveal-about-the-future-of-alpha-thalassemia-care/ 2026-02-26T06:55:49+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-beren-therapeutics-adrabetadex-nda-could-redefine-approval-standards-in-ultra-rare-pediatric-disease/ 2026-02-26T07:03:23+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/quiver-bioscience-deal-shows-how-angelini-pharma-is-rethinking-genetic-epilepsy-innovation/ 2026-02-26T07:06:57+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-clearnote-healths-avantect-test-finally-close-the-early-detection-gap-in-pancreatic-cancer/ 2026-02-26T07:11:11+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/gossamer-bio-phase-3-prosera-results-what-seralutinibs-near-miss-means-for-pulmonary-arterial-hypertension/ 2026-02-26T07:15:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/biomericas-responder-data-raises-new-questions-about-diet-driven-ibs-management/ 2026-02-26T20:34:52+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/scynexis-expands-scy-247-program-with-iv-sad-and-mad-trial-launch/ 2026-02-26T20:49:04+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/avacta-aim-avct-fap-exd-data-challenges-enhertu-on-tumor-selectivity-ahead-of-phase-1-start/ 2026-02-27T15:27:08+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-x4-pharmaceuticals-and-norgine-unlock-eu-access-to-the-first-targeted-whim-therapy/ 2026-02-27T20:31:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/ipsen-moves-closer-to-eu-approval-for-ojemda-in-braf-driven-childhood-brain-tumors/ 2026-02-27T20:52:38+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/tscan-therapeutics-strengthens-heme-pipeline-with-dual-ind-clearances/ 2026-02-27T21:04:04+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/organon-co-strengthens-larc-strategy-with-miudella-license-from-sebela-pharmaceuticals/ 2026-02-28T04:45:39+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Organon-Co.-licenses-MIUDELLA-copper-IUD-what-this-changes-in-the-U.S.-hormone-free-contraception-market-e1772253865376.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Organon-Co.-licenses-MIUDELLA-copper-IUD-what-this-changes-in-the-U.S.-hormone-free-contraception-market-e1772253865376.webp https://pharmadevicenews.com/why-gsks-expanded-bora-pharmaceuticals-partnership-reflects-new-cdmo-selection-logic/ 2026-02-28T15:55:17+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/real-world-data-meets-legal-limits-as-bayer-targets-erleada-claims-in-prostate-cancer/ 2026-02-28T16:10:14+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-stathmin-2-restoration-succeed-where-als-therapies-have-failed-quralis-data-examined/ 2026-02-28T16:14:57+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/sciwind-biosciences-and-pfizer-china-bet-on-ecnoglutide-as-chinas-glp-1-market-enters-its-most-competitive-phase/ 2026-02-28T16:18:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-ossiofiber-metal-free-bunion-fixation-redefine-minimally-invasive-hallux-valgus-surgery/ 2026-02-28T16:27:33+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/02/Ossio-Inc.-expands-bio-integrative-fixation-into-bunion-surgery-with-metal-free-MIA-system-e1772295984258.webp https://pharmadevicenews.com/wp-content/uploads/2026/02/Ossio-Inc.-expands-bio-integrative-fixation-into-bunion-surgery-with-metal-free-MIA-system-e1772295984258.webp https://pharmadevicenews.com/why-merck-and-eisais-belzutifan-lenvatinib-combo-could-reset-treatment-sequencing-in-advanced-renal-cell-carcinoma/ 2026-03-01T13:26:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Belzutifan-gives-Merck-and-Eisai-a-new-lever-in-advanced-renal-cell-carcinoma-after-immunotherapy-e1772368594697.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Belzutifan-gives-Merck-and-Eisai-a-new-lever-in-advanced-renal-cell-carcinoma-after-immunotherapy-e1772368594697.webp https://pharmadevicenews.com/mercks-keytruda-plus-welireg-cuts-recurrence-risk-in-phase-3-litespark-022-trial-for-adjuvant-clear-cell-renal-cell-carcinoma/ 2026-03-01T13:43:44+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/KEYTRUDA-and-WELIREG-deliver-Phase-3-LITESPARK-022-win-in-adjuvant-clear-cell-renal-cell-carcinoma-reshaping-post-nephrectomy-care-e1772372559762.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/KEYTRUDA-and-WELIREG-deliver-Phase-3-LITESPARK-022-win-in-adjuvant-clear-cell-renal-cell-carcinoma-reshaping-post-nephrectomy-care-e1772372559762.webp https://pharmadevicenews.com/biocytogen-and-ideaya-biosciences-push-ide034-into-the-clinic-as-dual-antigen-adc-strategies-mature/ 2026-03-01T13:50:33+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/IDEAYA-Biosciences-moves-IDE034-into-Phase-1-testing-whether-bispecific-ADCs-can-outperform-conventional-TOP1-conjugates-e1772372981761.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/IDEAYA-Biosciences-moves-IDE034-into-Phase-1-testing-whether-bispecific-ADCs-can-outperform-conventional-TOP1-conjugates-e1772372981761.webp https://pharmadevicenews.com/can-ctdna-guided-bladder-preservation-become-viable-after-signateras-asco-gu-data/ 2026-03-01T14:02:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Signatera-MRD-data-at-ASCO-GU-raises-new-questions-about-who-really-needs-cystectomy-e1772373660512.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Signatera-MRD-data-at-ASCO-GU-raises-new-questions-about-who-really-needs-cystectomy-e1772373660512.webp https://pharmadevicenews.com/merck-strengthens-its-womens-oncology-position-with-keynote-b96-overall-survival-results/ 2026-03-01T14:09:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/KEYNOTE-B96-overall-survival-data-reframes-immunotherapys-role-in-platinum-resistant-ovarian-cancer-e1772374125919.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/KEYNOTE-B96-overall-survival-data-reframes-immunotherapys-role-in-platinum-resistant-ovarian-cancer-e1772374125919.webp https://pharmadevicenews.com/lrs-wins-fda-clearance-to-test-thermosuit-cooling-device-in-pivotal-ischemic-stroke-trial/ 2026-03-02T15:41:50+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/takeda-and-protagonist-near-fda-decision-on-novel-pv-therapy-rusfertide/ 2026-03-03T02:29:41+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-bioxytrans-prolectin-m-accelerate-viral-clearance-in-mild-covid-19/ 2026-03-03T02:36:06+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/meiji-seika-pharma-wins-eu-orphan-drug-status-for-morcamilast-in-palmoplantar-pustulosis/ 2026-03-03T04:20:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Meiji-Seika-Pharma-advances-morcamilast-with-EU-orphan-backing-in-rare-dermatology-e1772511554877.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Meiji-Seika-Pharma-advances-morcamilast-with-EU-orphan-backing-in-rare-dermatology-e1772511554877.webp https://pharmadevicenews.com/ono-pharmaceutical-strengthens-early-stage-pipeline-with-congruence-platform-deal/ 2026-03-03T04:27:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Congruence-Revenir-platform-moves-into-neurology-and-immunology-under-Ono-agreement-e1772511958923.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Congruence-Revenir-platform-moves-into-neurology-and-immunology-under-Ono-agreement-e1772511958923.webp https://pharmadevicenews.com/can-acadia-overturn-emas-negative-opinion-on-trofinetide-for-rett-syndrome/ 2026-03-03T04:35:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Acadia-faces-EU-setback-as-trofinetide-Rett-data-questioned-by-CHMP-e1772512457873.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Acadia-faces-EU-setback-as-trofinetide-Rett-data-questioned-by-CHMP-e1772512457873.webp https://pharmadevicenews.com/new-hss-data-question-bleeding-risks-of-nsaids-in-anticoagulated-hip-replacement-patients/ 2026-03-03T04:41:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/ChatGPT-Image-Mar-3-2026-10_10_06-AM-e1772512846264.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/ChatGPT-Image-Mar-3-2026-10_10_06-AM-e1772512846264.webp https://pharmadevicenews.com/faster-candida-auris-identification-thermo-fisher-scientific-unveils-new-agar/ 2026-03-03T06:05:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Thermo-Fisher-Scientific-targets-Candida-auris-with-new-chromogenic-media-scaled-e1772517891299.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Thermo-Fisher-Scientific-targets-Candida-auris-with-new-chromogenic-media-scaled-e1772517891299.webp https://pharmadevicenews.com/lucent-diagnostics-expands-cognitive-biomarker-reach-through-life-line-screening/ 2026-03-03T06:15:39+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Will-blood-based-Alzheimers-tests-reshape-preventive-health-screening-models-e1772518500105.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Will-blood-based-Alzheimers-tests-reshape-preventive-health-screening-models-e1772518500105.webp https://pharmadevicenews.com/what-fda-clearance-means-for-median-technologies-eyonis-lcs-in-a-crowded-ai-radiology-market/ 2026-03-03T06:21:57+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Can-eyonis-LCS-deliver-real-world-impact-beyond-regulatory-milestones-in-lung-cancer-screening-e1772518876183.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Can-eyonis-LCS-deliver-real-world-impact-beyond-regulatory-milestones-in-lung-cancer-screening-e1772518876183.webp https://pharmadevicenews.com/pharmaessentia-corporation-secures-japan-approval-for-high-dose-besremi-regimen-in-polycythemia-vera/ 2026-03-03T06:26:06+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-propanc-biopharmas-prp-proenzyme-platform-a-credible-challenger-in-the-pancreatic-oncology-market/ 2026-03-03T21:36:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/insight-molecular-diagnostics-builds-regulatory-case-for-graftassuredx-kidney-transplant-test/ 2026-03-03T21:41:01+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/psyence-biomedical-ltd-advances-natural-psilocybin-development-with-phase-iib-cancer-distress-trial/ 2026-03-03T22:05:21+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-persevere-therapeutics-plans-to-reposition-misetionamide-in-a-crowded-ovarian-cancer-pipeline/ 2026-03-03T22:13:08+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/affinia-therapeutics-aftx-201-fast-track-decision-highlights-rising-interest-in-cardiac-gene-therapy/ 2026-03-04T17:36:10+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/FDA-Fast-Track-for-AFTX-201-raises-new-expectations-for-gene-therapy-in-BAG3-cardiomyopathy-e1772645705876.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/FDA-Fast-Track-for-AFTX-201-raises-new-expectations-for-gene-therapy-in-BAG3-cardiomyopathy-e1772645705876.webp https://pharmadevicenews.com/what-seaport-therapeutics-glyph-platform-reveals-about-the-emerging-science-of-gut-lymphatic-targeting/ 2026-03-04T17:41:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Why-ARPA-H-funding-for-Seaport-Therapeutics-could-accelerate-a-new-class-of-lymphatic-targeted-medicines-e1772646057454.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Why-ARPA-H-funding-for-Seaport-Therapeutics-could-accelerate-a-new-class-of-lymphatic-targeted-medicines-e1772646057454.webp https://pharmadevicenews.com/can-an2-therapeutics-reposition-epetraborole-for-polycythemia-vera-and-reshape-hematocrit-control-strategies/ 2026-03-04T17:47:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/What-epetraboroles-hematocrit-effects-could-mean-for-the-future-treatment-landscape-in-polycythemia-vera-e1772646366928.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/What-epetraboroles-hematocrit-effects-could-mean-for-the-future-treatment-landscape-in-polycythemia-vera-e1772646366928.webp https://pharmadevicenews.com/why-forma-life-sciences-u-s-cdmo-launch-signals-renewed-momentum-in-domestic-oral-solid-drug-manufacturing/ 2026-03-04T17:54:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Forma-Life-Sciences-bets-on-oral-solid-dosage-manufacturing-as-pharmaceutical-supply-chains-rebalance-e1772646832253.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Forma-Life-Sciences-bets-on-oral-solid-dosage-manufacturing-as-pharmaceutical-supply-chains-rebalance-e1772646832253.webp https://pharmadevicenews.com/what-the-akeso-inovio-immunotherapy-collaboration-signals-for-the-future-of-glioblastoma-clinical-research/ 2026-03-05T03:36:16+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/intrinsic-therapeutics-introduces-barricaid-narrow-anchor-as-surgeons-seek-better-reherniation-prevention-tools/ 2026-03-05T03:43:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Intrinsic-Therapeutics-updates-Barricaid-platform-as-reimbursement-momentum-grows-in-spine-surgery-scaled-e1772682159975.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Intrinsic-Therapeutics-updates-Barricaid-platform-as-reimbursement-momentum-grows-in-spine-surgery-scaled-e1772682159975.webp https://pharmadevicenews.com/how-azentas-acquisition-of-uk-biocentre-could-transform-sample-management-services/ 2026-03-05T03:47:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/citius-oncology-tests-lymphir-before-car-t-therapy-in-dlbcl-does-immune-modulation-improve-response-durability/ 2026-03-05T03:52:24+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-airiver-medicals-paclitaxel-drug-coated-balloon-could-reshape-minimally-invasive-airway-treatment/ 2026-03-05T03:58:08+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Airiver-Medical-begins-pivotal-trial-after-FDA-breakthrough-designation-for-airway-stenosis-device-e1772683056741.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Airiver-Medical-begins-pivotal-trial-after-FDA-breakthrough-designation-for-airway-stenosis-device-e1772683056741.webp https://pharmadevicenews.com/vasomune-therapeutics-advances-vascular-leak-therapy-as-fda-allows-pegevongitide-burn-trial-program/ 2026-03-05T04:06:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/boulders-life-sciences-cluster-grows-as-cordenpharma-colorado-expands-peptide-rd-footprint/ 2026-03-05T04:12:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/CordenPharma-Colorado-expands-peptide-development-capacity-with-new-Boulder-lab-lease-e1772683914288.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/CordenPharma-Colorado-expands-peptide-development-capacity-with-new-Boulder-lab-lease-e1772683914288.webp https://pharmadevicenews.com/can-cerevascs-eshunt-system-change-the-future-of-idiopathic-intracranial-hypertension-treatment/ 2026-03-05T04:19:44+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-bayers-mrxperion-510k-clearance-means-for-high-field-mri-workflow-and-contrast-injection-systems/ 2026-03-05T05:47:24+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-3d-printed-medicines-reach-community-pharmacies-pete-pharma-and-atrium24-test-a-new-distribution-model/ 2026-03-05T05:50:14+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/alnylam-pharmaceuticals-taps-tenaya-therapeutics-to-uncover-new-cardiovascular-rnai-drug-targets/ 2026-03-05T20:23:32+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/zealand-pharma-advances-petrelintide-toward-phase-3-as-obesity-treatment-competition-intensifies/ 2026-03-05T20:31:28+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-preservation-focused-implant-systems-reshape-implant-dentistry-nuventus-introduces-nv-c-in-the-united-states/ 2026-03-06T03:11:44+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Nuventus-NV.C-Implant-System-enters-the-U.S.-market-as-clinicians-debate-bone-preservation-strategies-in-implant-dentistry-scaled-e1772766643872.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Nuventus-NV.C-Implant-System-enters-the-U.S.-market-as-clinicians-debate-bone-preservation-strategies-in-implant-dentistry-scaled-e1772766643872.webp https://pharmadevicenews.com/can-francis-medicals-vanquish-system-reshape-minimally-invasive-prostate-cancer-treatment/ 2026-03-06T03:15:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/fda-clears-compact-spry-tms-system-can-soterix-medical-disrupt-the-depression-treatment-market/ 2026-03-06T03:22:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Soterix-Medical-wins-FDA-clearance-for-SPRY-transcranial-magnetic-stimulation-therapy-e1772767264900.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Soterix-Medical-wins-FDA-clearance-for-SPRY-transcranial-magnetic-stimulation-therapy-e1772767264900.webp https://pharmadevicenews.com/how-kenox-pharmaceuticals-is-targeting-the-oindp-cdmo-gap-with-integrated-clinical-manufacturing/ 2026-03-06T03:29:17+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-mitria-medicals-nitinol-spacer-challenges-the-edge-to-edge-repair-model-for-functional-mitral-regurgitation/ 2026-03-06T03:36:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Mitria-Medicals-Subvalvular-Spacer-reaches-U.S.-patients-under-FDA-expanded-access-at-Cleveland-Clinic-e1772768132150.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Mitria-Medicals-Subvalvular-Spacer-reaches-U.S.-patients-under-FDA-expanded-access-at-Cleveland-Clinic-e1772768132150.webp https://pharmadevicenews.com/can-a-postbiotic-ingredient-address-screen-related-eye-fatigue-in-children-kyowa-hakkos-commercial-bet-explained/ 2026-03-06T03:50:50+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Kyowa-Hakkos-postbiotic-eye-ingredient-enters-gummy-format-for-children-and-adults-amid-screen-health-concerns-scaled-e1772768999395.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Kyowa-Hakkos-postbiotic-eye-ingredient-enters-gummy-format-for-children-and-adults-amid-screen-health-concerns-scaled-e1772768999395.webp https://pharmadevicenews.com/can-hemab-therapeutics-sutacimig-finally-deliver-the-first-preventive-therapy-for-glanzmann-thrombasthenia-after-fda-breakthrough-designation/ 2026-03-06T03:55:33+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/jjs-tecvayli-darzalex-faspro-combination-approved-for-myeloma-after-majestec-3-phase-3-results/ 2026-03-06T04:00:23+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-neusperas-12-month-isnm-trial-data-means-for-the-sacral-neuromodulation-competitive-landscape/ 2026-03-06T04:05:41+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/taiwan-biotech-great-novel-therapeutics-launches-phase-i-trial-for-gntbm-38-cancer-therapy/ 2026-03-06T04:10:28+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/bristol-myers-squibb-expands-sotyktu-label-will-tyk2-inhibition-challenge-biologics-in-psoriatic-arthritis/ 2026-03-07T03:51:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Bristol-Myers-Squibb-wins-FDA-approval-for-Sotyktu-in-psoriatic-arthritis.-What-it-means-for-oral-autoimmune-therapies-e1772855416275.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Bristol-Myers-Squibb-wins-FDA-approval-for-Sotyktu-in-psoriatic-arthritis.-What-it-means-for-oral-autoimmune-therapies-e1772855416275.webp https://pharmadevicenews.com/how-incytes-retifanlimab-approval-could-reshape-first-line-therapy-for-advanced-anal-cancer-in-europe/ 2026-03-07T03:57:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Incyte-secures-European-approval-for-retifanlimab-combo-in-advanced-anal-cancer-e1772855767880.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Incyte-secures-European-approval-for-retifanlimab-combo-in-advanced-anal-cancer-e1772855767880.webp https://pharmadevicenews.com/no-fda-advisory-committee-for-molbreevi-what-savaras-day-74-letter-means-for-the-august-pdufa-review/ 2026-03-07T04:05:05+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Savaras-molgramostim-clears-FDA-advisory-committee-hurdle-but-the-harder-regulatory-work-is-just-beginning-e1772856214829.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Savaras-molgramostim-clears-FDA-advisory-committee-hurdle-but-the-harder-regulatory-work-is-just-beginning-e1772856214829.webp https://pharmadevicenews.com/mindwalk-adds-vhh-capability-as-nanobodies-gain-ground-in-car-t-and-multispecific-design/ 2026-03-07T04:15:14+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/B-Cell-Llama-platform-positions-MindWalk-for-partnership-deals-in-bispecific-drug-discovery-e1772856842454.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/B-Cell-Llama-platform-positions-MindWalk-for-partnership-deals-in-bispecific-drug-discovery-e1772856842454.webp https://pharmadevicenews.com/lonza-sells-capsules-and-health-ingredients-unit-to-lone-star-funds-retains-40-stake/ 2026-03-07T04:22:41+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Lonza-Group-divests-capsules-and-nutraceuticals-division-to-Lone-Star-in-strategic-portfolio-narrowing-e1772857295641.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Lonza-Group-divests-capsules-and-nutraceuticals-division-to-Lone-Star-in-strategic-portfolio-narrowing-e1772857295641.webp https://pharmadevicenews.com/johnson-johnson-strengthens-its-multiple-myeloma-franchise-with-tecvayli-and-darzalex-faspro-approval-what-clinicians-are-watching-next/ 2026-03-09T01:09:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-hr-healthcares-ez-protect-catheter-reshape-infection-prevention-expectations-in-intermittent-catheter-care/ 2026-03-08T04:05:55+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/HR-HealthCare-expands-EZ-Series-with-EZ-Protect-hydrophilic-catheter-as-home-based-urology-care-accelerates-e1772942694152.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/HR-HealthCare-expands-EZ-Series-with-EZ-Protect-hydrophilic-catheter-as-home-based-urology-care-accelerates-e1772942694152.webp https://pharmadevicenews.com/aisa-pharmas-aisa-021-shows-mixed-but-promising-signals-in-systemic-sclerosis-associated-raynauds-phenomenon/ 2026-03-08T04:12:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/could-lifevac-redefine-emergency-choking-response-after-failed-basic-life-support-protocols/ 2026-03-08T04:19:41+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/FDA-De-Novo-decision-on-LifeVac-could-reshape-the-regulatory-future-of-anti-choking-airway-clearance-devices-scaled-e1772943530510.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/FDA-De-Novo-decision-on-LifeVac-could-reshape-the-regulatory-future-of-anti-choking-airway-clearance-devices-scaled-e1772943530510.webp https://pharmadevicenews.com/gazyvas-allegory-data-what-the-sri-4-and-doris-remission-outcomes-mean-for-lupus-care/ 2026-03-08T04:42:04+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/insightecs-focused-ultrasound-therapy-secures-french-reimbursement-could-incisionless-brain-procedures-expand-across-europe/ 2026-03-08T10:36:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/France-approves-national-reimbursement-for-MR-guided-focused-ultrasound-in-essential-tremor.-What-this-means-for-neurosurgery-adoption-e1772966139537.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/France-approves-national-reimbursement-for-MR-guided-focused-ultrasound-in-essential-tremor.-What-this-means-for-neurosurgery-adoption-e1772966139537.webp https://pharmadevicenews.com/how-adelas-tissue-free-ctdna-methylation-test-could-reshape-monitoring-of-immunotherapy-outcomes/ 2026-03-08T10:43:33+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-lightweight-ai-models-replace-massive-drug-discovery-systems-insilico-medicine-and-liquid-ai-think-so/ 2026-03-08T10:51:08+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-creatv-bios-lifetracdx-may-change-immune-biomarker-tracking-in-colorectal-cancer-studies/ 2026-03-08T10:56:40+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/pillar-biosciences-launches-rapid-aml-sequencing-panel-while-creatv-bio-liquid-biopsy-enters-colorectal-cancer-trial-biomarker-role/ 2026-03-08T11:02:38+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-the-fda-hearing-on-vanda-pharmaceuticals-hetlioz-could-reshape-drug-approval-challenges/ 2026-03-08T11:17:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-dariohealth-aims-to-strengthen-oral-glp-1-effectiveness-through-precision-behavioral-health-tools/ 2026-03-08T11:23:14+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-pierre-fabre-pharmaceuticals-regulatory-strategy-for-tabelecleucel-matters-for-rare-oncology-approvals/ 2026-03-08T11:27:48+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-matricelfs-parkinsons-spinout-reveals-about-the-future-of-cell-based-neurodegeneration-therapies/ 2026-03-08T11:32:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/asieris-pharmaceuticals-launches-cevira-in-china-challenging-surgical-dominance-in-cin2-therapy/ 2026-03-08T11:37:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-the-vizient-innovative-technology-contract-means-for-cresilon-and-the-future-of-trauma-hemostatic-gels/ 2026-03-08T12:18:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-the-peli-biothermal-and-polar-group-alliance-reveals-about-global-pharma-supply-chains/ 2026-03-08T12:25:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-the-us-biotek-laboratories-and-nutripath-pathology-merger-could-reshape-integrative-diagnostics-testing/ 2026-03-08T12:31:30+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/hua-medicines-dorzagliatin-wins-hong-kong-approval-what-the-glucokinase-activator-milestone-means-for-diabetes-treatment/ 2026-03-08T12:37:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-the-senhwa-biosciences-and-celltype-collaboration-reveals-about-ais-role-in-oncology-pipelines/ 2026-03-08T12:42:48+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-tag1s-lead-212-supply-deal-with-dana-farber-reveals-about-the-future-of-radiopharmaceutical-oncology/ 2026-03-08T12:53:21+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-precision-biologics-is-betting-on-tumor-specific-neoepitopes-to-reshape-monoclonal-antibody-cancer-therapy/ 2026-03-08T12:58:12+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-the-pincell-acquisition-option-reveals-about-scinai-immunotherapeutics-pipeline-strategy/ 2026-03-08T13:13:08+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-the-fda-ide-approval-for-thermosuit-means-for-the-future-of-neuroprotective-stroke-therapy/ 2026-03-08T13:42:39+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/xtalpi-and-revir-therapeutics-push-ai-designed-rtx-117-into-human-trials-for-rare-neurological-disorders/ 2026-03-08T13:47:17+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-xellsmarts-expanding-ind-portfolio-is-shaping-the-emerging-market-for-cns-cell-therapies/ 2026-03-08T14:08:43+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-innoblatives-sira-cpt-code-approval-signals-for-reimbursement-evidence-generation-and-surgical-adoption/ 2026-03-08T14:19:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/AMA-Category-III-CPT-code-for-SIRA-device-signals-early-reimbursement-pathway-for-intraoperative-breast-cancer-ablation-scaled-e1772979489337.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/AMA-Category-III-CPT-code-for-SIRA-device-signals-early-reimbursement-pathway-for-intraoperative-breast-cancer-ablation-scaled-e1772979489337.webp https://pharmadevicenews.com/phase-3-cypress-miss-forces-theravance-biopharma-to-rethink-pipeline-and-accelerate-strategic-alternatives/ 2026-03-08T14:24:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-artificial-intelligence-predict-delivery-timing-ultrasound-ais-fda-clearance-tests-the-idea/ 2026-03-08T14:34:20+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Ultrasound-AI-wins-FDA-De-Novo-clearance-for-Delivery-Date-AI-and-advances-predictive-obstetric-imaging-e1772980385108.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Ultrasound-AI-wins-FDA-De-Novo-clearance-for-Delivery-Date-AI-and-advances-predictive-obstetric-imaging-e1772980385108.webp https://pharmadevicenews.com/how-glenmark-pharmaceuticals-fluticasone-inhaler-approval-could-reshape-the-u-s-asthma-inhaler-market/ 2026-03-08T14:53:26+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Glenmark-Pharmaceuticals-secures-U.S.-FDA-approval-for-fluticasone-inhalation-aerosol-generic-with-180-day-exclusivity-e1772981532155.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Glenmark-Pharmaceuticals-secures-U.S.-FDA-approval-for-fluticasone-inhalation-aerosol-generic-with-180-day-exclusivity-e1772981532155.webp https://pharmadevicenews.com/abbvies-affirm-trial-what-clinicians-should-watch-next-for-risankizumab-in-crohns-disease/ 2026-03-08T15:02:32+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/AbbVie-Phase-3-AFFIRM-data-what-subcutaneous-risankizumab-induction-could-change-in-Crohns-disease-treatment-e1772982099801.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/AbbVie-Phase-3-AFFIRM-data-what-subcutaneous-risankizumab-induction-could-change-in-Crohns-disease-treatment-e1772982099801.webp https://pharmadevicenews.com/ananda-pharmas-endocan-study-explores-whether-pharmaceutical-grade-cbd-can-address-unmet-needs-in-endometriosis-care/ 2026-03-08T15:07:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Endometriosis-drug-development-enters-cannabinoid-territory-as-Ananda-Pharma-tests-MRX1-CBD-therapy-e1772982399232.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Endometriosis-drug-development-enters-cannabinoid-territory-as-Ananda-Pharma-tests-MRX1-CBD-therapy-e1772982399232.webp https://pharmadevicenews.com/revalesios-rns60-program-signals-renewed-momentum-in-adjunctive-stroke-therapeutics/ 2026-03-08T15:15:53+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Revalesio-highlights-RNS60-stroke-trial-insights-as-imaging-biomarkers-reshape-neuroprotection-research-e1772982891737.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Revalesio-highlights-RNS60-stroke-trial-insights-as-imaging-biomarkers-reshape-neuroprotection-research-e1772982891737.webp https://pharmadevicenews.com/foresee-pharmaceuticals-wins-chmp-backing-for-camcevi-21-mg-expanding-prostate-cancer-treatment-options-in-europe/ 2026-03-08T15:21:16+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-serviers-2-5bn-acquisition-of-day-one-biopharmaceuticals-could-reshape-the-pediatric-glioma-treatment-landscape/ 2026-03-08T15:49:41+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-ecg-based-monitoring-reshape-virtual-gi-care-models-lohman-technologies-and-salvo-health-deepen-alliance/ 2026-03-08T15:57:23+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Lohman-Technologies%E2%80%93Salvo-Health-partnership-expansion-signals-new-phase-for-remote-monitoring-in-GI-care-e1772985386548.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Lohman-Technologies%E2%80%93Salvo-Health-partnership-expansion-signals-new-phase-for-remote-monitoring-in-GI-care-e1772985386548.webp https://pharmadevicenews.com/ce-mark-clearance-for-bd-revello-stent-highlights-growing-competition-in-endovascular-pad-therapies/ 2026-03-08T16:03:53+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/BD-secures-EU-CE-Mark-for-Revello-vascular-covered-stent-as-iliac-artery-treatment-competition-intensifies.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/BD-secures-EU-CE-Mark-for-Revello-vascular-covered-stent-as-iliac-artery-treatment-competition-intensifies.webp https://pharmadevicenews.com/insilico-medicines-ai-designed-anemia-therapy-begins-phase-i-testing-in-collaboration-with-taigen/ 2026-03-08T16:44:32+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-sciwind-biosciences-ecnoglutide-challenge-conventional-glp-1-drugs-in-the-expanding-obesity-market/ 2026-03-08T16:55:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/immunitybio-resubmits-fda-application-for-anktiva-in-bladder-cancer-after-agency-requests-updated-efficacy-data/ 2026-03-09T17:48:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-novelmed-therapeutics-challenge-established-pnh-drugs-with-its-bb-targeting-antibody-ruxoprubart/ 2026-03-09T18:45:09+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/junshi-biosciences-pushes-subcutaneous-pd-1-therapy-as-chinas-oncology-system-strains/ 2026-03-09T19:14:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-veru-inc-s-phase-2b-plateau-trial-signals-about-the-evolution-of-combination-obesity-drugs/ 2026-03-09T19:25:54+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-the-eus-elfabrio-dosing-update-means-for-fabry-disease-treatment-burden/ 2026-03-09T19:31:12+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/novo-nordisk-prothena-coramitug-program-reaches-key-phase-3-milestone-in-attr-cardiomyopathy/ 2026-03-10T07:28:20+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-citius-oncologys-lymphir-program-reflects-a-broader-shift-in-immuno-oncology-strategy/ 2026-03-10T19:38:28+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/connect-biopharma-advances-rademikibart-data-as-global-competition-grows-in-eczema-biologics/ 2026-03-10T19:48:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-qt-imagings-latest-fda-clearance-reveals-about-the-future-of-radiation-free-breast-imaging/ 2026-03-10T20:02:09+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/oragenics-launches-phase-iia-trial-of-onp-002-as-drug-developers-revisit-traumatic-brain-injury-therapies/ 2026-03-10T20:08:01+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-medtronics-550m-scientia-vascular-deal-improve-catheter-and-guidewire-technology-for-stroke-treatment/ 2026-03-11T04:03:11+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Medtronics-550-million-Scientia-Vascular-purchase-signals-a-strategic-shift-in-neurovascular-procedure-access-e1773201700773.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Medtronics-550-million-Scientia-Vascular-purchase-signals-a-strategic-shift-in-neurovascular-procedure-access-e1773201700773.webp https://pharmadevicenews.com/how-qiagens-qiastat-dx-rise-gi-panel-clearance-could-reshape-multiplex-pathogen-testing-in-clinical-labs/ 2026-03-11T04:13:31+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/QIAGEN-wins-FDA-clearance-for-gastrointestinal-panels-on-QIAstat-Dx-Rise-as-syndromic-testing-platforms-expand-in-U.S.-labs-e1773202353947.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/QIAGEN-wins-FDA-clearance-for-gastrointestinal-panels-on-QIAstat-Dx-Rise-as-syndromic-testing-platforms-expand-in-U.S.-labs-e1773202353947.webp https://pharmadevicenews.com/can-single-use-bronchoscopes-reshape-icu-airway-management-karl-storz-secures-fda-clearance-for-five-s-6-5/ 2026-03-11T04:33:14+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/KARL-STORZ-expands-airway-portfolio-with-FDA-cleared-FIVE-S-6.5-single-use-bronchoscope-e1773203548199.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/KARL-STORZ-expands-airway-portfolio-with-FDA-cleared-FIVE-S-6.5-single-use-bronchoscope-e1773203548199.webp https://pharmadevicenews.com/why-tiximeds-tix100-data-highlights-a-growing-therapeutic-gap-after-glp-1-weight-loss-treatment/ 2026-03-11T04:37:16+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-toro-neurovasculars-fda-cleared-toro-88-catheter-means-for-the-neurovascular-device-market/ 2026-03-11T18:51:30+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/could-io-therapeutics-irx4204-reshape-the-science-of-breast-cancer-prevention/ 2026-03-11T19:22:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/bridgebio-pharma-advances-bbp-418-toward-fda-filing-after-phase-3-muscular-dystrophy-trial-data/ 2026-03-11T19:32:33+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-poltreg-t1d-reveals-about-the-future-of-cell-therapy-in-autoimmune-diseases/ 2026-03-12T03:35:08+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-pretzel-therapeutics-px578-finally-address-the-root-cause-of-polg-disease-in-mitochondrial-dna-depletion-syndromes/ 2026-03-12T03:47:24+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Pretzel-Therapeutics-advances-PX578-as-a-potential-disease-modifying-therapy-for-POLG-disease-e1773287190926.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Pretzel-Therapeutics-advances-PX578-as-a-potential-disease-modifying-therapy-for-POLG-disease-e1773287190926.webp https://pharmadevicenews.com/what-insulets-evolution-2-data-means-for-automated-insulin-delivery-in-type-2-diabetes/ 2026-03-12T03:53:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Insulet-EVOLUTION-2-study-hits-68-time-in-range-without-boluses-in-type-2-diabetes-e1773287569788.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Insulet-EVOLUTION-2-study-hits-68-time-in-range-without-boluses-in-type-2-diabetes-e1773287569788.webp https://pharmadevicenews.com/can-blood-based-alzheimers-diagnostics-change-clinical-practice-c2n-diagnostics-enters-south-korea-with-precivityad2/ 2026-03-12T04:00:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/C2N-Diagnostics-expands-PrecivityAD2-blood-test-into-South-Korea-as-Alzheimers-diagnostics-market-shifts-toward-earlier-detection-e1773288002592.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/C2N-Diagnostics-expands-PrecivityAD2-blood-test-into-South-Korea-as-Alzheimers-diagnostics-market-shifts-toward-earlier-detection-e1773288002592.webp https://pharmadevicenews.com/united-therapeutics-targets-2026-fda-submission-for-tyvaso-ipf-indication-after-teton-2-success/ 2026-03-12T04:09:08+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Tyvaso-TETON-2-data-marks-first-inhaled-therapy-to-slow-IPF-fibrosis-in-phase-3-trial-e1773288482155.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Tyvaso-TETON-2-data-marks-first-inhaled-therapy-to-slow-IPF-fibrosis-in-phase-3-trial-e1773288482155.webp https://pharmadevicenews.com/why-tersera-therapeutics-divestiture-signals-strategic-realignment-in-niche-infusion-therapies-and-hospital-medicines/ 2026-03-12T04:17:32+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/ESTEVE-deepens-specialty-hospital-portfolio-as-Prialt-and-Quzyttir-acquisition-reshapes-non-opioid-pain-and-acute-allergy-treatment-markets-e1773288995152.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/ESTEVE-deepens-specialty-hospital-portfolio-as-Prialt-and-Quzyttir-acquisition-reshapes-non-opioid-pain-and-acute-allergy-treatment-markets-e1773288995152.webp https://pharmadevicenews.com/curatis-licenses-corticorelin-to-neupharma-in-chf-83-5m-japan-deal/ 2026-03-12T04:24:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Curatis-and-Neupharma-agree-Japan-licensing-deal-for-corticorelin-in-peritumoral-brain-edema-e1773289430686.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Curatis-and-Neupharma-agree-Japan-licensing-deal-for-corticorelin-in-peritumoral-brain-edema-e1773289430686.webp https://pharmadevicenews.com/johnson-johnsons-tecnis-puresee-approval-highlights-the-evolving-battle-between-edof-and-multifocal-cataract-lenses/ 2026-03-13T04:24:44+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/TECNIS-PureSee-approval-highlights-how-cataract-surgery-is-increasingly-becoming-a-refractive-vision-procedure-e1773375827112.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/TECNIS-PureSee-approval-highlights-how-cataract-surgery-is-increasingly-becoming-a-refractive-vision-procedure-e1773375827112.webp https://pharmadevicenews.com/why-baseimmunes-ipf-entry-challenges-a-decade-of-single-target-failure-in-pulmonary-fibrosis/ 2026-03-13T05:04:54+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Baseimmune-targets-IPF-with-multi-pathway-immunotherapy-platform-as-single-agent-approaches-stall-e1773378244174.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Baseimmune-targets-IPF-with-multi-pathway-immunotherapy-platform-as-single-agent-approaches-stall-e1773378244174.webp https://pharmadevicenews.com/could-nonthermal-tumor-ablation-replace-surgery-for-low-risk-thyroid-cancer-pulse-biosciences-launches-feasibility-study/ 2026-03-13T05:10:51+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Pulse-Biosciences-begins-human-trial-of-nPulse-Vybrance-system-for-papillary-thyroid-microcarcinoma-treatment-e1773378597654.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Pulse-Biosciences-begins-human-trial-of-nPulse-Vybrance-system-for-papillary-thyroid-microcarcinoma-treatment-e1773378597654.webp https://pharmadevicenews.com/can-herus-pretestpro-replace-multiple-pretesting-devices-in-one-wearable-exam/ 2026-03-13T05:44:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Herus-PretestPro-consolidates-ophthalmic-pretesting-into-a-single-VR-wearable-workflow-e1773380605383.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Herus-PretestPro-consolidates-ophthalmic-pretesting-into-a-single-VR-wearable-workflow-e1773380605383.webp https://pharmadevicenews.com/aptar-pharma-and-covirix-medical-partner-to-develop-inhaled-broad-spectrum-antiviral-treatment/ 2026-03-13T05:51:19+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Aptar-Pharmas-Orbital-DPI-selected-for-COVIRIX-Medical-pandemic-antiviral-development-e1773381012952.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Aptar-Pharmas-Orbital-DPI-selected-for-COVIRIX-Medical-pandemic-antiviral-development-e1773381012952.webp https://pharmadevicenews.com/firefly-neuroscience-explores-ai-analysis-of-brain-waves-for-adhd-subtype-detection/ 2026-03-13T18:38:46+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-the-tacti-004-phase-iii-outcome-challenges-assumptions-about-lag-3-immune-activation/ 2026-03-13T18:50:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/novartis-expands-cosentyx-label-to-adolescents-with-hidradenitis-suppurativa/ 2026-03-13T18:56:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/meiji-seika-pharma-initiates-me3241-phase-i-study-inverting-checkpoint-blockade-logic-for-autoimmune-therapy/ 2026-03-15T04:40:44+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-ultrasensitive-ctdna-monitoring-reshape-how-clinicians-track-neoadjuvant-breast-cancer-therapy-response/ 2026-03-15T04:50:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/sentynl-therapeutics-licenses-progerinin-for-progeria-as-rare-disease-strategy-expands-beyond-zokinvy/ 2026-03-16T12:28:28+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Hutchinson-Gilford-Progeria-Syndrome-e1773664061505.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Hutchinson-Gilford-Progeria-Syndrome-e1773664061505.webp https://pharmadevicenews.com/early-human-trial-of-seger-idea-device-highlights-push-toward-fully-intracorporeal-bowel-surgery/ 2026-03-16T12:39:04+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Seger_Surgical_Solutions-SEGER-IDEA-device-scaled-e1773664698161.webp https://pharmadevicenews.com/alzamend-neuro-moves-al001-into-bipolar-disorder-patients-as-lithium-reformulation-race-intensifies/ 2026-03-16T12:46:44+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/fda-fast-track-for-argo-biopharmas-bw-20805-sirna-puts-haes-next-competitive-battleground-in-focus/ 2026-03-16T13:08:04+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-spontan-reveals-about-aptars-nasal-drug-delivery-platform-and-the-race-for-rapid-acting-erectile-dysfunction-treatments/ 2026-03-17T03:48:06+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Aptar-Pharma-supports-phase-II-development-of-SPONTAN-nasal-spray-as-intranasal-therapies-gain-momentum.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Aptar-Pharma-supports-phase-II-development-of-SPONTAN-nasal-spray-as-intranasal-therapies-gain-momentum.webp https://pharmadevicenews.com/why-convatec-is-expanding-its-esenta-platform-with-the-eakin-freeseal-ostomy-seal-partnership/ 2026-03-17T03:53:38+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Convatec-strengthens-Eakin-Healthcare-partnership-with-co-branded-eakin-freeseal-ostomy-seal-rollout-e1773719574407.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Convatec-strengthens-Eakin-Healthcare-partnership-with-co-branded-eakin-freeseal-ostomy-seal-rollout-e1773719574407.webp https://pharmadevicenews.com/johnson-johnson-expands-pulsed-field-ablation-footprint-as-varipulse-reaches-peru-electrophysiology-centers/ 2026-03-17T04:00:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Johnson-Johnson-introduces-VARIPULSE-pulsed-field-ablation-technology-in-Peru-for-atrial-fibrillation-treatment-e1773719973534.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Johnson-Johnson-introduces-VARIPULSE-pulsed-field-ablation-technology-in-Peru-for-atrial-fibrillation-treatment-e1773719973534.webp https://pharmadevicenews.com/sareptas-sirolimus-gambit-can-enhanced-immunosuppression-rescue-elevidys-for-non-ambulatory-duchenne-patients/ 2026-03-17T04:08:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Sarepta-enrolls-non-ambulatory-Duchenne-patients-in-ELEVIDYS-sirolimus-safety-study-e1773720365540.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Sarepta-enrolls-non-ambulatory-Duchenne-patients-in-ELEVIDYS-sirolimus-safety-study-e1773720365540.webp https://pharmadevicenews.com/guardant-health-brings-shield-multi-cancer-detection-test-to-asia-through-manulife-insurer-deal/ 2026-03-17T04:14:30+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/could-five-year-survival-data-position-kimmtrak-as-a-durable-standard-in-uveal-melanoma-care/ 2026-03-17T20:59:24+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/myriad-genetics-expands-precision-oncology-role-with-zejula-companion-diagnostic-approval/ 2026-03-17T21:10:54+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-alamar-biosciences-neuro-220-panel-could-reshape-biomarker-discovery-in-alzheimers-and-parkinsons-research/ 2026-03-17T21:33:52+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/avactas-precision-exatecan-conjugate-reaches-phase-1-as-competition-in-targeted-topo-i-inhibitors-intensifies/ 2026-03-18T07:59:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/early-stage-biosimilar-deal-between-samsung-bioepis-and-sandoz-covers-vedolizumab-and-four-undisclosed-molecules/ 2026-03-18T08:13:13+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Samsung-Bioepis-and-Sandoz-expand-biosimilar-deal-to-cover-vedolizumab-and-four-early-stage-candidates-scaled-e1773821532400.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Samsung-Bioepis-and-Sandoz-expand-biosimilar-deal-to-cover-vedolizumab-and-four-early-stage-candidates-scaled-e1773821532400.webp https://pharmadevicenews.com/can-synthekines-stk-012-overcome-immunotherapy-resistance-in-first-line-nsclc-patients/ 2026-03-18T08:37:50+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-zai-labs-latest-oncology-data-reveal-about-its-long-term-positioning-in-adc-and-immunotherapy-markets/ 2026-03-19T04:19:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/fulgent-genetics-acquires-bako-diagnostics-and-stratadx-to-offset-precision-diagnostics-headwind/ 2026-03-19T06:19:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-exact-sciences-is-building-a-multi-platform-cancer-diagnostics-case-at-aacr-2026/ 2026-03-19T07:04:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-orum-therapeutics-plans-to-solve-gspt1-toxicity-with-a-dac-approach-in-aml/ 2026-03-19T07:13:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-incytes-54-week-povorcitinib-data-redefine-the-oral-treatment-landscape-in-hidradenitis-suppurativa/ 2026-03-21T07:05:32+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-bristol-myers-squibbs-opdivo-approvals-in-frontline-and-relapsed-classical-hodgkin-lymphoma-reset-treatment-pathways/ 2026-03-21T07:12:39+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-cleerlys-ai-platform-replace-invasive-ivus-invictus-registry-data-suggest-noninvasive-parity/ 2026-03-21T16:26:01+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/macau-clears-immunitybios-anktiva-for-bcg-unresponsive-nmibc-opening-asia-market-amid-commercialization-test/ 2026-03-21T16:35:03+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/curi-bio-and-battelle-commercialise-human-nmj-assay-as-glp-ready-alternative-to-mouse-bioassay-for-botulinum-toxin-testing/ 2026-03-21T16:44:08+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/intrabio-leverages-prior-niemann-pick-approval-to-seek-fda-expansion-of-levacetylleucine-into-ataxia-telangiectasia/ 2026-03-21T17:07:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/will-pediatric-konfident-kid-data-accelerate-kalvistas-sebetralstat-approval-in-hereditary-angioedema/ 2026-03-21T17:14:54+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/aptargroup-enters-phase-ii-posits-study-as-delivery-partner-for-ena-respiratorys-inna-051-nasal-spray/ 2026-03-21T17:26:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/AptarGroups-UDS-powder-nasal-system-selected-for-INNA-051-Phase-II-respiratory-prophylaxis-trial.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/AptarGroups-UDS-powder-nasal-system-selected-for-INNA-051-Phase-II-respiratory-prophylaxis-trial.webp https://pharmadevicenews.com/novartis-acquires-snv4818-from-synnovation-in-3bn-deal-to-reclaim-ground-in-mutant-pi3ka-breast-cancer-space/ 2026-03-21T17:39:53+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/gensight-biologics-begins-lhon-treatment-under-france-compassionate-access-as-revise-phase-ii-moves-forward/ 2026-03-21T17:46:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/oral-pompe-therapy-s-606001-moves-to-phase-2-as-shionogi-expands-rare-disease-focus/ 2026-03-22T04:01:31+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/cathy-ties-origin-genomics-targets-germline-gene-correction-under-us-irb-oversight/ 2026-03-22T04:07:14+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-low-dose-radiotherapy-reshape-osteoarthritis-care-after-siemens-healthineers-fda-clearance/ 2026-03-22T04:14:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Radiotherapy-for-arthritis-moves-closer-to-mainstream-as-Varian-TrueBeam-gains-new-FDA-nod-scaled-e1774152809835.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Radiotherapy-for-arthritis-moves-closer-to-mainstream-as-Varian-TrueBeam-gains-new-FDA-nod-scaled-e1774152809835.webp https://pharmadevicenews.com/ibex-hnl-lab-medicine-deal-signals-shift-from-digital-pathology-to-embedded-ai-decision-support-in-u-s-diagnostics/ 2026-03-22T04:23:43+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/gene-therapy-gains-ground-in-bladder-cancer-as-nccn-strengthens-ferring-pharmaceuticals-adstiladrin-recommendation/ 2026-03-22T04:32:19+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/livanova-plc-expands-sleep-apnea-eligibility-as-aura6000-gains-fda-approval-without-ccc-limits/ 2026-03-22T06:57:54+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/LivaNova-PLC-challenges-screening-barriers-in-sleep-apnea-with-aura6000-approval-e1774162607820.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/LivaNova-PLC-challenges-screening-barriers-in-sleep-apnea-with-aura6000-approval-e1774162607820.webp https://pharmadevicenews.com/triana-biomedicines-tests-degradation-first-approach-in-alk-positive-lung-cancer-with-tri-611/ 2026-03-22T15:20:43+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-culture-free-pneumonia-testing-finally-viable-as-pattern-bioscience-nears-regulatory-submission/ 2026-03-22T15:36:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Rapid-pneumonia-diagnostics-advance-as-Pattern-Bioscience-crosses-1000-samples-in-FDA-bound-study-e1774193709826.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Rapid-pneumonia-diagnostics-advance-as-Pattern-Bioscience-crosses-1000-samples-in-FDA-bound-study-e1774193709826.webp https://pharmadevicenews.com/lgm-pharmas-15m-u-s-manufacturing-expansion-signals-a-deeper-shift-away-from-import-dependence-in-pharma-supply-chains/ 2026-03-22T15:41:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/c2n-diagnostics-advances-precivitytaudx-programme-as-tangle-biomarker-gains-phase-3-evidence/ 2026-03-22T15:51:57+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/C2N-Diagnostics-eMTBR-tau243-enters-Phase-3-evidence-base-as-a-predictor-of-Alzheimers-progression-e1774194657970.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/C2N-Diagnostics-eMTBR-tau243-enters-Phase-3-evidence-base-as-a-predictor-of-Alzheimers-progression-e1774194657970.webp https://pharmadevicenews.com/will-apogee-therapeutics-apex-data-shift-competitive-dynamics-against-dupixent-and-ebglyss/ 2026-03-23T01:18:01+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/could-ideaya-biosciences-challenge-current-standards-in-metastatic-uveal-melanoma-with-darovasertib/ 2026-03-23T01:25:35+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-hutchmed-china-limited-is-positioning-hmpl-760-against-established-btk-therapies-in-lymphoma-care/ 2026-03-23T01:43:37+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-galderma-is-repositioning-restylane-contour-beyond-cheeks-into-full-face-structural-correction/ 2026-03-23T06:34:51+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-roches-phase-iii-bet-on-prasinezumab-is-bigger-than-its-phase-iib-result-suggests/ 2026-03-23T06:38:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-sensorions-sens-501-data-could-reshape-gene-therapy-for-congenital-hearing-loss-treatment/ 2026-03-23T06:59:31+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/dizals-zegfrovy-challenges-chemo-dominance-in-rare-egfr-lung-cancer-mutation/ 2026-03-23T07:04:03+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/harbour-biomed-hbm9378-phase-i-data-does-long-acting-tslp-inhibition-change-asthma-treatment-economics/ 2026-03-23T07:11:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/avalyn-pharma-moves-ap02-into-phase-2-exploring-whether-nebulized-delivery-can-improve-risk-benefit-balance-in-ipf/ 2026-03-24T00:52:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/theriva-biologics-leverages-fda-and-ema-feedback-to-optimize-vcn-01-pivotal-trial/ 2026-03-24T01:39:52+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-prestige-biopharma-turn-hd204-phase-3-data-into-a-credible-avastin-biosimilar-launch/ 2026-03-24T03:52:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/extended-interval-namd-therapy-gets-a-new-contender-as-innovent-biologics-posts-phase-3-star-data/ 2026-03-24T03:57:44+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Innovent-Biologics-Phase-3-win-for-efdamrofusp-alfa-raises-the-bar-for-extended-interval-nAMD-treatment-in-China-e1774324610545.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Innovent-Biologics-Phase-3-win-for-efdamrofusp-alfa-raises-the-bar-for-extended-interval-nAMD-treatment-in-China-e1774324610545.webp https://pharmadevicenews.com/what-celosia-therapeutics-phase-1b-ctx1000-trial-could-reveal-about-tdp-43-targeting-in-als/ 2026-03-24T04:01:39+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/gilead-targets-durable-autoimmune-remission-with-2-18bn-ouro-medicines-acquisition/ 2026-03-24T04:06:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/sesh-products-clears-pmta-filing-threshold-as-fda-substantive-review-begins/ 2026-03-24T04:11:42+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-maat-pharmas-maat013-survival-signal-could-reshape-refractory-gi-agvhd-treatment-debate/ 2026-03-24T04:26:20+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/MaaT-Pharma-tests-microbiome-therapy-limits-as-MaaT013-posts-pivotal-GI-aGvHD-data-e1774326349483.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/MaaT-Pharma-tests-microbiome-therapy-limits-as-MaaT013-posts-pivotal-GI-aGvHD-data-e1774326349483.webp https://pharmadevicenews.com/photonova-spectra-fda-clearance-gives-ge-healthcare-a-stronger-hand-in-advanced-ct-imaging/ 2026-03-24T04:32:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/GE-HealthCare-pushes-deeper-into-spectral-imaging-with-Photonova-Spectra-FDA-clearance-e1774326653726.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/GE-HealthCare-pushes-deeper-into-spectral-imaging-with-Photonova-Spectra-FDA-clearance-e1774326653726.webp https://pharmadevicenews.com/overt-bio-moves-ovt-101-closer-to-clinic-as-solid-tumour-cell-therapy-race-intensifies/ 2026-03-24T04:38:13+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/OverT-Bio-sharpens-OVT-101-clinical-roadmap-in-high-risk-solid-tumour-cell-therapy-push-e1774327038962.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/OverT-Bio-sharpens-OVT-101-clinical-roadmap-in-high-risk-solid-tumour-cell-therapy-push-e1774327038962.webp https://pharmadevicenews.com/wilmington-pharmatech-targets-larger-commercial-api-volumes-with-50m-delaware-expansion/ 2026-03-24T04:45:42+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/bostongene-ai-framework-identifies-actionable-targets-in-65-of-cancer-of-unknown-primary-cases-at-uscap-2026/ 2026-03-24T04:50:12+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-spear-bios-new-ptau-217-assay-reveals-about-where-alzheimers-biomarker-detection-is-heading/ 2026-03-24T04:54:48+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/amani-therapeutics-bets-25m-on-expanding-clozapine-access-in-schizophrenia/ 2026-03-24T05:00:21+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/biocatalysis-integration-deal-between-sk-pharmteco-and-prozomix-highlights-greener-pharma-production-shift/ 2026-03-25T00:08:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/academic-partnerships-signal-propanc-biopharma-inc-push-into-aging-biology-and-tumor-resistance-science/ 2026-03-25T00:18:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/radiopharm-theranostics-builds-clinical-momentum-with-rad-101-data-that-could-influence-neuro-oncology-workflows/ 2026-03-25T00:55:51+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/one-time-gene-therapy-approach-from-ocugen-gains-traction-in-dry-amd-pipeline-race/ 2026-03-25T01:05:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-viz-ais-latest-hypertrophic-cardiomyopathy-studies-reveal-about-the-future-of-cardiac-ai/ 2026-03-25T03:50:46+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Viz.ais-HCM-data-push-shows-why-cardiac-AI-is-shifting-from-detection-to-care-coordination-e1774410600198.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Viz.ais-HCM-data-push-shows-why-cardiac-AI-is-shifting-from-detection-to-care-coordination-e1774410600198.webp https://pharmadevicenews.com/ferring-wins-adstiladrin-label-update-as-operational-efficiency-becomes-a-bigger-oncology-battleground/ 2026-03-25T03:59:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Ferrings-ADSTILADRIN-label-update-could-matter-more-for-clinic-workflow-than-for-bladder-cancer-efficacy-e1774411128455.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Ferrings-ADSTILADRIN-label-update-could-matter-more-for-clinic-workflow-than-for-bladder-cancer-efficacy-e1774411128455.webp https://pharmadevicenews.com/can-sarepta-therapeutics-prove-rna-interference-works-in-fshd1-and-dm1-with-early-phase-1-2-data/ 2026-03-25T04:12:17+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Sarepta-Therapeutics-unveils-first-siRNA-clinical-signals-in-FSHD1-and-DM1-as-the-field-watches-closely-e1774411917303.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Sarepta-Therapeutics-unveils-first-siRNA-clinical-signals-in-FSHD1-and-DM1-as-the-field-watches-closely-e1774411917303.webp https://pharmadevicenews.com/what-roseman-bioventures-could-change-for-biotech-medtech-and-medical-device-startups-in-nevada/ 2026-03-25T05:38:40+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-aeon-biopharma-inc-s-analytical-strategy-reveals-about-the-future-of-botulinum-toxin-biosimilars/ 2026-03-25T17:25:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-veongen-therapeutics-validate-vr-based-endpoints-as-stargardt-trials-move-toward-pivotal-design/ 2026-03-25T17:41:19+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/imunon-advances-phase-3-with-stronger-survival-data-signaling-a-shift-in-ovarian-cancer-immunotherapy/ 2026-03-25T18:08:11+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/nasus-pharma-ltd-expands-intranasal-platform-as-ns002-moves-closer-to-regulatory-pathway/ 2026-03-25T18:35:08+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/luna-trial-2026-spark-biomedical-tests-non-pharmacological-device-for-heavy-menstrual-bleeding/ 2026-03-26T03:34:44+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/corvista-health-expands-machine-learning-diagnostics-to-inoca-with-new-acc-26-poster-data/ 2026-03-26T03:39:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/pixee-medical-receives-ce-mark-for-ar-knee-surgery-system-as-fda-clearance-opens-u-s-ambulatory-market/ 2026-03-26T03:46:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Pixee-Medical-receives-CE-mark-for-AR-knee-surgery-system-as-FDA-clearance-opens-U.S.-ambulatory-market.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Pixee-Medical-receives-CE-mark-for-AR-knee-surgery-system-as-FDA-clearance-opens-U.S.-ambulatory-market.webp https://pharmadevicenews.com/can-mercks-6-7bn-terns-takeover-turn-tern-701-into-a-post-keytruda-oncology-pillar/ 2026-03-26T03:52:13+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-corcepts-lifyorli-become-a-real-new-standard-in-platinum-resistant-ovarian-cancer-after-fda-approval/ 2026-03-26T04:03:35+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Corcept-secures-a-pivotal-ovarian-cancer-win-as-Lifyorli-validates-glucocorticoid-receptor-blockade-in-oncology-scaled-e1774497778127.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Corcept-secures-a-pivotal-ovarian-cancer-win-as-Lifyorli-validates-glucocorticoid-receptor-blockade-in-oncology-scaled-e1774497778127.webp https://pharmadevicenews.com/seaport-therapeutics-glyph-platform-faces-its-real-test-as-glyphallo-advances-in-depression/ 2026-03-26T04:07:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-tempus-ai-and-daiichi-sankyo-are-using-real-world-data-to-reshape-antibody-drug-conjugate-development/ 2026-03-26T04:10:04+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/imperative-care-begins-clear-it-study-as-peripheral-thrombectomy-moves-from-device-adoption-to-evidence-scrutiny/ 2026-03-26T04:13:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-invivoscribes-identiclone-dx-igh-approval-reveals-about-the-new-economics-of-ivdr-ready-hematology-diagnostics/ 2026-03-26T06:12:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-ono-pharmaceutical-bring-clearer-treatment-sequencing-to-advanced-gist-in-japan/ 2026-03-26T06:17:23+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-norgines-pedmarqsi-approval-in-switzerland-could-reshape-cisplatin-ototoxicity-management/ 2026-03-26T06:24:10+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-gc-biopharmas-barycela-approval-in-guatemala-matters-beyond-one-latin-american-market/ 2026-03-26T06:32:18+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-piramal-pharma-solutions-morpeth-tablet-press-upgrade-sharpens-its-play-in-potent-oral-solid-manufacturing/ 2026-03-26T07:01:39+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/What-the-Korsch-X3-installation-at-Morpeth-signals-for-Piramal-Pharma-Solutions-commercial-manufacturing-strategy.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/What-the-Korsch-X3-installation-at-Morpeth-signals-for-Piramal-Pharma-Solutions-commercial-manufacturing-strategy.webp https://pharmadevicenews.com/can-smaller-eyedrops-improve-glaucoma-outcomes-nanodropper-data-make-the-case/ 2026-03-26T07:04:16+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/lupin-limited-moves-closer-to-the-wakix-market-as-pitolisant-tentative-approval-sharpens-future-optionality/ 2026-03-26T07:07:24+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/denterics-gpv381-enters-phase-2-but-can-a-therapeutic-vaccine-really-change-periodontitis-care/ 2026-03-26T07:10:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-abbvies-juvederm-strategy-turn-subtle-aesthetics-into-the-next-growth-engine-for-fillers/ 2026-03-26T07:26:03+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-lunai-bioworks-inc-s-bbb-delivery-platform-unlock-scalable-alzheimers-drug-development-advantages/ 2026-03-26T20:58:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-the-hims-hers-health-inc-and-novo-nordisk-collaboration-reveals-about-the-future-of-obesity-drug-commercialization/ 2026-03-26T21:08:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-the-neok002-ind-milestone-changes-for-biocytogen-neok-bio-and-adc-competition/ 2026-03-27T05:12:54+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/lensone-enters-pivotal-study-as-long-bridge-medical-targets-a-difficult-gap-in-secondary-iol-fixation/ 2026-03-27T05:18:57+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Long-Bridge-Medicals-LensOne-trial-could-test-whether-secondary-IOL-fixation-can-finally-become-more-standardised-e1774588688543.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Long-Bridge-Medicals-LensOne-trial-could-test-whether-secondary-IOL-fixation-can-finally-become-more-standardised-e1774588688543.webp https://pharmadevicenews.com/can-drug-farm-turn-alpk1-inhibition-into-the-first-real-disease-modifying-approach-for-rosah-syndrome/ 2026-03-27T05:23:13+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-agilents-pd-l1-companion-diagnostic-now-shapes-pembrolizumab-access-in-esophageal-carcinoma/ 2026-03-27T05:29:50+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/medtronic-broadens-stealth-axis-reach-as-integrated-surgical-platforms-gain-strategic-importance/ 2026-03-28T04:05:43+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/novo-nordisks-awiqli-approval-could-change-how-basal-insulin-is-used-in-type-2-diabetes/ 2026-03-28T04:10:00+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-anumanas-fda-cleared-pulmonary-hypertension-algorithm-means-for-cardiovascular-ai/ 2026-03-29T04:20:48+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Anumana-wins-FDA-clearance-for-ECG-AI-pulmonary-hypertension-tool-as-early-detection-race-heats-up-e1774758020535.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Anumana-wins-FDA-clearance-for-ECG-AI-pulmonary-hypertension-tool-as-early-detection-race-heats-up-e1774758020535.webp https://pharmadevicenews.com/why-kardigans-phase-2-tonlamarsen-results-matter-more-for-acute-severe-hypertension-than-chronic-blood-pressure-care/ 2026-03-29T04:30:04+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Kardigans-tonlamarsen-data-hint-at-a-new-post-discharge-strategy-for-acute-severe-hypertension-e1774758559453.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Kardigans-tonlamarsen-data-hint-at-a-new-post-discharge-strategy-for-acute-severe-hypertension-e1774758559453.webp https://pharmadevicenews.com/what-galdermas-nemolizumab-phase-ii-data-mean-for-the-competitive-biologic-landscape-in-pediatric-eczema/ 2026-03-29T04:41:16+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/03/Galderma-presents-pediatric-nemolizumab-findings-at-AAD-2026-as-regulatory-case-builds-for-under-12-label-e1774759149703.webp https://pharmadevicenews.com/wp-content/uploads/2026/03/Galderma-presents-pediatric-nemolizumab-findings-at-AAD-2026-as-regulatory-case-builds-for-under-12-label-e1774759149703.webp https://pharmadevicenews.com/arrowhead-pharmaceuticals-strengthens-plozasirans-severe-hypertriglyceridemia-case-with-durable-acc-26-data/ 2026-03-29T04:47:41+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/corcept-therapeutics-expands-hypercortisolism-evidence-base-with-largest-us-resistant-hypertension-screening-trial/ 2026-03-29T04:54:28+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-winrevairs-phase-2-data-matters-beyond-pulmonary-arterial-hypertension/ 2026-03-29T19:54:37+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-takedas-zasocitinib-change-the-plaque-psoriasis-treatment-ladder-after-phase-3-wins/ 2026-03-30T07:13:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-incytes-povorcitinib-54-week-results-matter-for-hidradenitis-suppurativa-treatment/ 2026-03-30T07:16:53+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-merck-expand-winrevair-beyond-pulmonary-arterial-hypertension-after-cadence-data/ 2026-03-30T07:27:23+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-chiesi-global-rare-diseases-is-positioning-lomitapide-for-earlier-lifecycle-management-in-hofh/ 2026-03-30T21:15:42+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-evaxion-a-ss-ai-designed-polio-vaccine-concepts-reshape-the-final-mile-of-eradication/ 2026-03-30T21:25:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-aviadobios-thalamic-delivery-strategy-give-avb-101-an-edge-in-frontotemporal-dementia/ 2026-03-31T06:27:09+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-pepgens-5-mg-kg-freedom2-cohort-reveals-about-the-risk-reward-profile-of-pgn-edodm1/ 2026-03-31T06:35:39+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-alnylam-pharmaceuticals-is-using-new-acc-26-data-to-deepen-the-case-for-vutrisiran-and-zilebesiran/ 2026-03-31T06:42:30+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-mercks-enlicitide-decanoate-become-the-oral-pcsk9-breakthrough-cholesterol-care-has-been-waiting-for/ 2026-03-31T06:45:19+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-certis-oncology-intelligence-reveals-about-the-next-phase-of-ai-in-cancer-rd/ 2026-03-31T06:47:52+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-cogent-biosciences-inc-s-bezuclastinib-filing-could-redefine-the-second-line-treatment-paradigm-in-gastrointestinal-stromal-tumors/ 2026-04-01T18:08:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-ocugen-inc-s-ocu410st-milestone-means-for-the-race-to-treat-inherited-retinal-blindness/ 2026-04-01T18:23:17+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-electrocore-inc-is-strengthening-the-clinical-case-for-bioelectronic-medicine-in-trauma-related-brain-injury/ 2026-04-01T18:40:54+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-calidi-biotherapeutics-inc-s-redtail-platform-solve-the-solid-tumor-t-cell-engager-problem/ 2026-04-01T18:54:44+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/plixorafenib-breakthrough-status-raises-the-stakes-for-fore-biotherapeutics-in-braf-mutant-high-grade-glioma/ 2026-04-02T07:15:24+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-gileads-arcellx-tender-extension-matters-more-for-cell-therapy-execution-than-for-deal-timing/ 2026-04-02T07:18:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/premier-radiology-services-deepens-outpatient-teleradiology-push-with-global-imaging-solutions/ 2026-04-02T07:22:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-alto-neurosciences-alto-101-setback-reveals-about-the-difficulty-of-treating-cognitive-impairment-in-schizophrenia/ 2026-04-02T07:31:31+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/alpha-cognition-expands-alpha-1062-into-traumatic-brain-injury-but-approval-is-still-a-distant-goal/ 2026-04-02T07:34:13+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-insight-health-turn-voice-first-clinical-agents-into-a-durable-healthcare-infrastructure-layer/ 2026-04-03T14:27:52+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Insight-Healths-11m-Series-A-shows-where-patient-facing-AI-may-finally-gain-real-healthcare-traction-e1775226353356.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Insight-Healths-11m-Series-A-shows-where-patient-facing-AI-may-finally-gain-real-healthcare-traction-e1775226353356.webp https://pharmadevicenews.com/what-the-agenus-mink-therapeutics-combination-reveals-about-the-next-phase-of-gi-cancer-immunotherapy/ 2026-04-03T14:41:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Agenus-tests-whether-cell-therapy-can-reopen-the-checkpoint-door-in-refractory-gastroesophageal-cancer-e1775227251883.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Agenus-tests-whether-cell-therapy-can-reopen-the-checkpoint-door-in-refractory-gastroesophageal-cancer-e1775227251883.webp https://pharmadevicenews.com/what-innate-pharmas-kempen-conference-participation-reveals-about-its-2026-biotech-strategy/ 2026-04-03T15:09:11+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Innate-Pharma-heads-to-Kempen-conference-as-investors-weigh-its-next-oncology-catalyst-e1775228896530.webp https://pharmadevicenews.com/vedanta-biosciences-keeps-ve303-phase-3-trial-on-track-as-interim-review-clears-futility-bar/ 2026-04-03T15:20:05+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Vedanta-Biosciences-Phase-3-VE303-momentum-raises-bigger-questions-about-microbiome-drug-readiness-e1775229553874.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Vedanta-Biosciences-Phase-3-VE303-momentum-raises-bigger-questions-about-microbiome-drug-readiness-e1775229553874.webp https://pharmadevicenews.com/why-sv-health-investors-epivax-acquisition-signals-a-bigger-private-equity-push-into-immunogenicity-services/ 2026-04-03T15:24:08+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/ciplas-nintedanib-approval-opens-a-high-stakes-test-in-the-u-s-idiopathic-pulmonary-fibrosis-market/ 2026-04-03T15:38:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Cipla-targets-idiopathic-pulmonary-fibrosis-with-nintedanib-as-U.S.-generic-competition-deepens-e1775230639758.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Cipla-targets-idiopathic-pulmonary-fibrosis-with-nintedanib-as-U.S.-generic-competition-deepens-e1775230639758.webp https://pharmadevicenews.com/why-the-syra-health-and-nora-mental-health-deal-matters-for-telebehavioral-care-in-indiana/ 2026-04-03T15:42:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Syra-Health-and-Nora-Mental-Health-link-AI-triage-with-therapists-in-Indiana-mental-health-push-e1775230920165.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Syra-Health-and-Nora-Mental-Health-link-AI-triage-with-therapists-in-Indiana-mental-health-push-e1775230920165.webp https://pharmadevicenews.com/why-the-ro-and-eli-lilly-kwikpen-move-matters-for-obesity-drug-access-adherence-and-pricing/ 2026-04-03T15:50:29+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Zepbound-KwikPen-arrives-on-Ro-as-Eli-Lilly-tightens-control-over-obesity-drug-distribution-e1775231370485.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Zepbound-KwikPen-arrives-on-Ro-as-Eli-Lilly-tightens-control-over-obesity-drug-distribution-e1775231370485.webp https://pharmadevicenews.com/can-peri-turn-perimenopause-tracking-into-a-credible-new-womens-health-device-category/ 2026-04-03T15:56:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Peris-perimenopause-wearable-could-open-a-new-market-but-proof-will-matter-more-than-novelty-scaled-e1775231732631.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Peris-perimenopause-wearable-could-open-a-new-market-but-proof-will-matter-more-than-novelty-scaled-e1775231732631.webp https://pharmadevicenews.com/eli-lilly-and-companys-foundayo-approval-could-widen-the-obesity-market-faster-than-rivals-expected/ 2026-04-03T16:02:55+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Foundayo-gives-Eli-Lilly-and-Company-a-new-obesity-edge-but-execution-risk-still-matters-e1775232125399.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Foundayo-gives-Eli-Lilly-and-Company-a-new-obesity-edge-but-execution-risk-still-matters-e1775232125399.webp https://pharmadevicenews.com/how-atl-medicals-prevoyance-imaging-system-could-speed-arthroscopy-device-development-with-omnivisions-oh0131-processor/ 2026-04-04T03:53:43+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Why-the-ATL-Medical-and-OMNIVISION-collaboration-signals-growing-demand-for-integrated-medical-imaging-subsystems-scaled-e1775274778636.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Why-the-ATL-Medical-and-OMNIVISION-collaboration-signals-growing-demand-for-integrated-medical-imaging-subsystems-scaled-e1775274778636.webp https://pharmadevicenews.com/spacelabs-healthcare-links-rothman-index-to-depth-health-as-hospitals-chase-faster-safer-bed-movement/ 2026-04-04T03:57:53+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-allevion-medicals-vantage-change-spinal-stenosis-workflows-by-combining-disposable-access-illumination-and-bone-resection-tools/ 2026-04-04T04:04:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Allevion-Medical-Vantage-gets-510k-clearance-but-adoption-will-depend-on-evidence-workflow-fit-and-reimbursement-clarity-e1775275419103.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Allevion-Medical-Vantage-gets-510k-clearance-but-adoption-will-depend-on-evidence-workflow-fit-and-reimbursement-clarity-e1775275419103.webp https://pharmadevicenews.com/can-vr-life-and-h2-global-group-turn-european-medtech-validation-into-real-global-scale/ 2026-04-04T04:10:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/H2-Global-Groups-VR-LIFE-bet-signals-MedTech-ambition-but-can-clinical-traction-support-expansion-e1775275777317.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/H2-Global-Groups-VR-LIFE-bet-signals-MedTech-ambition-but-can-clinical-traction-support-expansion-e1775275777317.webp https://pharmadevicenews.com/openevidence-expands-beyond-search-as-tandem-partnership-pushes-medical-ai-into-prescription-access-workflows/ 2026-04-04T04:15:03+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-aspect-biosystems-turn-government-backed-biomanufacturing-into-a-real-regenerative-medicine-advantage/ 2026-04-04T04:27:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-ctis-is-betting-fdas-e2br3-deadline-will-reshape-pharmacovigilance-software-demand/ 2026-04-04T04:36:04+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/pharmaessentia-expands-beyond-taiwan-with-puerto-rico-plant-as-besremi-growth-plans-widen/ 2026-04-04T05:20:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-earlipoint-health-and-netsmart-reduce-autism-diagnosis-bottlenecks-in-provider-settings/ 2026-04-04T05:41:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/EarliPoint-Health-and-Netsmart-partnership-could-widen-access-to-FDA-cleared-autism-assessment-technology-e1775281225227.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/EarliPoint-Health-and-Netsmart-partnership-could-widen-access-to-FDA-cleared-autism-assessment-technology-e1775281225227.webp https://pharmadevicenews.com/can-tenpoint-therapeutics-direct-to-patient-yuvezzi-program-unlock-wider-access-in-the-presbyopia-market/ 2026-04-04T06:52:45+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Why-Tenpoint-Therapeutics-is-betting-on-direct-to-patient-access-to-expand-YUVEZZI-uptake-in-presbyopia-e1775285528164.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Why-Tenpoint-Therapeutics-is-betting-on-direct-to-patient-access-to-expand-YUVEZZI-uptake-in-presbyopia-e1775285528164.webp https://pharmadevicenews.com/can-abbisko-therapeutics-turn-irpagratinib-into-the-first-approved-fgfr4-therapy-for-hepatocellular-carcinoma/ 2026-04-05T05:02:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-better-life-sciences-lyme-testing-push-matters-more-for-access-than-for-diagnosis-alone/ 2026-04-05T05:12:21+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Better-Life-Science-bets-on-Tick-Bite-Hero-as-prevention-messaging-meets-consumer-diagnostics-e1775365894242.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Better-Life-Science-bets-on-Tick-Bite-Hero-as-prevention-messaging-meets-consumer-diagnostics-e1775365894242.webp https://pharmadevicenews.com/scinai-immunotherapeutics-doubles-cdmo-revenue-but-can-the-recipharm-deal-change-the-bigger-picture/ 2026-04-05T06:01:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-nuvation-bio-building-the-next-idh1-glioma-contender-with-safusidenib-and-sigma/ 2026-04-05T06:06:48+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-accent-therapeutics-aacr-2026-atx-295-update-reveals-about-the-next-wave-of-precision-oncology-targets/ 2026-04-05T17:12:47+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-soligenix-is-trying-to-turn-tolerability-and-treatment-logistics-into-a-differentiated-regulatory-and-commercial-story/ 2026-04-05T17:20:06+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-pangia-biotechs-urine-biopsy-data-may-matter-more-than-the-headline-sensitivity-figure-suggests/ 2026-04-05T17:25:46+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-avencell-therapeutics-is-using-avc-203-to-test-whether-allogeneic-car-t-can-move-beyond-manufacturing-bottlenecks/ 2026-04-05T17:29:15+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-glenmark-pharmaceuticals-ryaltris-commercialization-shift-means-for-allergy-drug-competition/ 2026-04-05T17:38:34+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/lupin-closes-visufarma-deal-but-can-branded-ophthalmology-drive-the-next-phase-of-growth/ 2026-04-05T17:44:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-caliways-cbl-514-and-tirzepatide-combination-data-could-reveal-about-obesity-treatment-next/ 2026-04-05T17:48:30+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-oncolytics-biotech-inc-s-fda-meeting-means-for-pelareorep-commercialization/ 2026-04-07T00:52:12+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-tenvie-therapeutics-is-testing-whether-neuroinflammation-can-become-the-next-obesity-treatment-frontier/ 2026-04-07T01:14:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/does-vas-101-solve-a-long-standing-delivery-problem-in-curcumin-based-osteoarthritis-treatment/ 2026-04-07T03:14:36+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/esmo-euracan-adds-chemosat-to-uveal-melanoma-guidance-as-delcath-systems-strengthens-clinical-position/ 2026-04-07T03:26:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-evommune-turn-evo756-into-a-cross-indication-inflammatory-franchise-with-migraine-next/ 2026-04-07T03:29:23+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-the-nexus-pharmaceuticals-cyclophosphamide-launch-reveals-about-competition-in-sterile-generic-oncology-drugs/ 2026-04-07T03:32:49+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-abions-abn202-may-be-aiming-beyond-trop2-antibody-drug-conjugate-resistance/ 2026-04-07T03:35:50+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-alcon-redefining-the-enhanced-monofocal-category-with-clareon-truplus-at-ascrs-2026/ 2026-04-07T03:46:56+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Alcon-launches-Clareon-TruPlus-as-cataract-lens-market-shifts-toward-low-trade-off-vision-gains-e1775533576948.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Alcon-launches-Clareon-TruPlus-as-cataract-lens-market-shifts-toward-low-trade-off-vision-gains-e1775533576948.webp https://pharmadevicenews.com/can-zivo-bioscience-finally-scale-zivolife-after-securing-cyanotech-as-its-manufacturing-partner/ 2026-04-07T03:50:35+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-vyomes-vt-1953-data-could-reshape-supportive-oncology-care-in-advanced-cancer-wounds/ 2026-04-07T03:54:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-florida-cancer-specialists-contributed-to-a-study-that-may-change-kras-g12d-cancer-treatment/ 2026-04-07T03:57:05+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-affinia-therapeutics-upbeat-trial-reveals-about-the-next-phase-of-inherited-heart-failure-gene-therapy/ 2026-04-07T04:04:54+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-bausch-lombs-ascrs-2026-data-slate-matters-for-premium-iol-competition-and-dry-eye-care/ 2026-04-07T04:07:44+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/is-glaukos-building-a-multi-franchise-ophthalmology-platform-through-epioxa-and-glaucoma-implants/ 2026-04-07T04:11:40+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-zeiss-turn-ophthalmology-workflow-software-into-the-next-battleground-in-cataract-care/ 2026-04-07T04:14:41+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/imbed-biosciences-wins-cms-hcpcs-code-for-microlyte-painguard-but-will-billing-clarity-translate-into-wound-care-adoption/ 2026-04-07T04:26:13+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-currax-and-peek-make-oral-obesity-treatment-easier-to-access-for-self-funded-employers/ 2026-04-07T04:29:26+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-bambusa-therapeutics-bbt001-data-are-drawing-attention-in-atopic-dermatitis-beyond-a-routine-phase-1-update/ 2026-04-07T04:32:10+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-anixa-biosciences-phase-2-breast-cancer-vaccine-push-matters-more-than-the-manufacturing-deal-itself/ 2026-04-07T04:34:31+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-sim0505s-fast-track-designation-reshape-the-development-outlook-for-nextcure-inc-in-ovarian-cancer/ 2026-04-07T14:10:28+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-inhibikase-therapeutics-pivotal-pah-study-may-become-a-major-2026-biotech-catalyst/ 2026-04-07T18:05:55+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-electrocore-inc-s-first-ptsd-patient-enrollment-could-become-a-more-important-2026-medtech-catalyst-than-it-first-appears/ 2026-04-07T18:39:11+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-the-latest-merakris-therapeutics-data-may-sharpen-industry-focus-on-refractory-wound-healing/ 2026-04-07T19:56:31+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-meiji-seika-pharma-is-using-singapore-to-scale-its-asean-vaccine-and-pharma-strategy/ 2026-04-08T03:42:11+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-intervenes-first-30-recana-cases-could-reshape-treatment-for-venous-in-stent-restenosis/ 2026-04-08T03:50:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/nexus-gets-fda-approval-can-endospan-finally-crack-the-hardest-segment-in-endovascular-aortic-repair/ 2026-04-08T03:56:32+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Endospan-wins-FDA-approval-for-NEXUS-aortic-arch-stent-graft-system-opening-a-new-chapter-in-complex-arch-repair-scaled-e1775620517543.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Endospan-wins-FDA-approval-for-NEXUS-aortic-arch-stent-graft-system-opening-a-new-chapter-in-complex-arch-repair-scaled-e1775620517543.webp https://pharmadevicenews.com/parnell-expands-u-s-manufacturing-footprint-with-noble-pharma-acquisition-amid-supply-continuity-pressures/ 2026-04-08T04:09:17+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/acadia-pharmaceuticals-broadens-rett-syndrome-treatment-flexibility-with-daybue-stix-rollout-in-the-united-states/ 2026-04-08T04:12:57+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-alcon-turn-baseball-fandom-into-a-growth-engine-for-systane-in-canadas-dry-eye-category/ 2026-04-08T04:19:28+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-the-terns-acquisition-matters-more-for-mercks-long-term-pipeline-strategy-than-its-near-term-revenue/ 2026-04-08T04:32:23+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-galderma-is-turning-alastin-into-a-clinic-workflow-strategy-not-just-a-skincare-brand/ 2026-04-08T06:13:35+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-tubulis-gives-gilead-more-than-just-another-antibody-drug-conjugate-asset/ 2026-04-08T06:18:27+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-arrowhead-pharmaceuticals-expand-plozasiran-without-the-ionis-patent-fight-becoming-a-commercial-overhang/ 2026-04-08T06:30:21+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-reyobiqs-latest-regulatory-milestone-may-reshape-the-pediatric-neuro-oncology-landscape/ 2026-04-08T15:31:06+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-biora-therapeutics-biojet-platform-may-reshape-needle-free-delivery-for-peptides-and-antibodies/ 2026-04-08T15:58:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-bioxcel-therapeutics-latest-bxcl501-milestone-could-mean-for-neuropsychiatric-care/ 2026-04-08T17:19:01+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/could-renovorx-be-building-a-stronger-medtech-oncology-moat-through-global-patent-expansion/ 2026-04-08T17:52:48+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-sparian-biosciences-phase-1-launch-of-sbs-147-could-reshape-the-non-opioid-pain-treatment-landscape/ 2026-04-09T21:39:02+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/zentalis-pharmaceuticals-aligns-denali-and-aspenova-trials-with-evolving-ovarian-cancer-treatment-landscape/ 2026-04-09T22:06:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-novo-nordisk-may-be-lowering-one-of-the-biggest-operational-barriers-in-glp-1-distribution/ 2026-04-09T22:29:31+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-junctions-grail-tie-up-do-what-clinical-data-alone-could-not-for-galleri-adoption/ 2026-04-10T04:06:19+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/What-Junctions-Galleri-rollout-says-about-the-next-phase-of-multi-cancer-screening-adoption-e1775793939622.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/What-Junctions-Galleri-rollout-says-about-the-next-phase-of-multi-cancer-screening-adoption-e1775793939622.webp https://pharmadevicenews.com/arkbio-pushes-ak0406-into-first-in-human-testing-but-can-a-long-acting-flu-antiviral-carve-out-real-clinical-space/ 2026-04-10T04:09:59+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-innovent-biologics-tri-specific-ibi3055-matters-in-the-race-to-deplete-both-b-cells-and-plasma-cells/ 2026-04-10T04:13:40+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/galderma-backs-new-evidence-for-sculptra-and-restylane-in-fast-evolving-patient-demand-segments/ 2026-04-10T07:24:32+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-sobis-empaveli-approval-in-canada-may-change-the-rare-kidney-disease-treatment-landscape/ 2026-04-10T18:03:37+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/how-telix-pharmaceuticals-limited-may-be-building-a-stronger-neuro-oncology-diagnostics-franchise/ 2026-04-10T18:23:28+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-verrica-pharmaceuticals-vp-315-data-may-reveal-about-the-future-of-skin-cancer-immunotherapy/ 2026-04-10T18:41:06+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-lupin-limited-gain-ground-in-cardiometabolic-generics-with-united-states-dapagliflozin-launch/ 2026-04-11T04:03:07+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/cuc-america-expands-msk-embolization-strategy-with-dr-yuji-okuno-and-dr-osman-ahmed-collaborations/ 2026-04-11T04:07:04+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-to-watch-as-ideaya-biosciences-reports-optimum-02-topline-results-in-uveal-melanoma/ 2026-04-11T04:10:41+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-iaso-bio-and-instituto-butantan-make-car-t-therapy-affordable-for-brazils-public-health-system/ 2026-04-11T04:42:37+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-apotex-crack-the-complex-generic-code-for-semaglutide-before-the-glucagon-like-peptide-1-market-resets/ 2026-04-11T04:45:51+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-miracells-smart-m-cell-fda-clearance-could-reshape-the-prp-and-bmac-device-market/ 2026-04-11T05:26:37+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Miracell-FDA-clearance-opens-new-test-for-SMART-M-CELL-in-regenerative-medicine-e1775885161116.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Miracell-FDA-clearance-opens-new-test-for-SMART-M-CELL-in-regenerative-medicine-e1775885161116.webp https://pharmadevicenews.com/why-pendulum-therapeutics-is-taking-its-microbiome-platform-beyond-metabolic-health-with-mayo-clinic/ 2026-04-11T07:13:13+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/whitehawk-therapeutics-sharpens-hwk-016-case-as-muc16-emerges-as-a-stronger-adc-target-in-gynecologic-cancers/ 2026-04-11T07:38:58+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-metavias-higher-dose-titration-strategy-could-matter-more-than-the-first-patient-milestone-itself/ 2026-04-11T08:20:37+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/plus-therapeutics-reimbursement-push-gains-traction-as-ama-grants-cnside-a-dedicated-pla-code/ 2026-04-11T15:15:48+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-zemprocitinib-help-lynk-pharmaceuticals-break-into-chinas-crowded-atopic-dermatitis-market/ 2026-04-11T15:25:08+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Lynk-Pharmaceuticals-moves-closer-to-China-launch-as-NMPA-accepts-zemprocitinib-NDA-for-atopic-dermatitis-e1775920990130.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Lynk-Pharmaceuticals-moves-closer-to-China-launch-as-NMPA-accepts-zemprocitinib-NDA-for-atopic-dermatitis-e1775920990130.webp https://pharmadevicenews.com/why-dualitybios-china-filing-for-trastuzumab-pamirtecan-matters-in-the-her2-breast-cancer-adc-race/ 2026-04-11T15:35:22+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-reyobiq-improve-plus-therapeutics-path-in-pediatric-high-grade-glioma-and-ependymoma/ 2026-04-11T15:40:48+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Plus-Therapeutics-wins-orphan-drug-designation-for-REYOBIQ-in-pediatric-malignant-gliomas-e1775922003400.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Plus-Therapeutics-wins-orphan-drug-designation-for-REYOBIQ-in-pediatric-malignant-gliomas-e1775922003400.webp https://pharmadevicenews.com/why-vivatides-therapeutics-54m-series-a-matters-for-extrahepatic-rna-therapeutics/ 2026-04-11T15:43:52+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/what-eric-j-daniels-appointment-means-for-plus-therapeutics-and-its-cns-oncology-pipeline/ 2026-04-11T15:47:09+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/why-corcept-therapeutics-now-faces-a-bigger-execution-test-after-lifyorlis-rosella-success/ 2026-04-12T07:08:38+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-tae-life-sciences-turn-bnct-into-a-credible-radio-immunotherapy-platform-for-hard-to-treat-cancers/ 2026-04-12T07:12:08+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/assertio-garda-deal-analysis-what-the-rolvedon-focused-takeover-means-for-specialty-pharma-investors/ 2026-04-12T07:15:25+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png https://pharmadevicenews.com/can-tecnis-puresee-help-johnson-johnson-win-the-next-phase-of-premium-cataract-surgery/ 2026-04-12T07:34:42+00:00 https://pharmadevicenews.com/wp-content/uploads/2026/04/Johnson-Johnson-builds-the-case-for-TECNIS-PureSee-as-surgeons-rethink-premium-IOL-trade-offs-e1775979212796.webp https://pharmadevicenews.com/wp-content/uploads/2026/04/Johnson-Johnson-builds-the-case-for-TECNIS-PureSee-as-surgeons-rethink-premium-IOL-trade-offs-e1775979212796.webp https://pharmadevicenews.com/does-verastem-oncologys-updated-ramp-201-dataset-change-the-outlook-for-low-grade-serous-ovarian-cancer-treatment/ 2026-04-12T07:38:21+00:00 https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png